europabio.org
Last updated: 3/28/2026valid
Independent Directory - Important Information
This llms.txt file was publicly accessible and retrieved from europabio.org. LLMS Central does not claim ownership of this content and hosts it for informational purposes only to help AI systems discover and respect website policies.
This listing is not an endorsement by europabio.org and they have not sponsored this page. We are an independent directory service with no affiliation to the listed domain.
Copyright & Terms: Users should respect the original terms of service of europabio.org. If you believe there is a copyright or terms of service violation, please contact us at support@llmscentral.com for prompt removal. Domain owners can also claim their listing.
Current llms.txt Content
Generated by All in One SEO v4.9.4.1, this is an llms.txt file, used by LLMs to index the site. # Europabio Europabio ## Sitemaps - [XML Sitemap](https://www.europabio.org/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [Niconex Medical joins EuropaBio: Driving Regulatory Insight Within European Biotech](https://www.europabio.org/niconex-medical-joins-europabio-driving-regulatory-insight-within-european-biotech/) - [Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe](https://www.europabio.org/bene-meat-technologies-joins-europabio-advancing-cultivated-meat-in-europe/) - [Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026](https://www.europabio.org/call-for-tender-eu-biotech-and-life-sciences-alliance-mep-group-secretariat-services-2026/) - [The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies](https://www.europabio.org/the-association-ofbiopharmaceutical-manufacturers-in-latvia-bral-joins-europabio-promoting-access-to-innovative-therapies/) - [OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States](https://www.europabio.org/oecd-a-comparison-of-the-innovation-and-regulatory-environments-for-biotechnology-and-biosolutions-across-the-european-union-and-the-united-states/) - [Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe](https://www.europabio.org/ecolab-life-sciences-joins-europabio-helping-shape-the-future-of-life-sciences-manufacturing-in-europe/) - [EuropaBio Consultation Response: Public Procurement Directives](https://www.europabio.org/europabio-consultation-response-public-procurement-directives/) - [Germany: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.](https://www.europabio.org/germany-industrial-bioeconomy-dialogue-platform-of-the-federal-ministry-for-economic-affairs-and-energy-bmwe-position-paper-on-amending-the-european-gmo-legal-framework-for-microorganisms/) - [EuropaBio recommendations for the food and feed safety Omnibus](https://www.europabio.org/europabio-recommendations-for-the-food-and-feed-safety-omnibus/) - [BIOTECH AUSTRIA joins EuropaBio: Fostering Austrian Biotech Collaboration](https://www.europabio.org/biotech-austria-joins-europabio-fostering-austrian-biotech-collaboration/) - [Response to the EC Call for Evidence on the Advanced Materials Act](https://www.europabio.org/response-to-the-ec-call-for-evidence-on-the-advanced-materials-act/) - [Ribbon Bio GmbH joins EuropaBio: Redefining Scientific Possibility through Synthetic DNA Innovation](https://www.europabio.org/ribbon-bio-gmbh-joins-europabio-redefining-scientific-possibility-through-synthetic-dna-innovation/) - [EU Food & Feed Safety Simplification Package clears regulatory roadblocks for biotech innovation](https://www.europabio.org/eu-food-feed-safety-simplification-package-clears-regulatory-roadblocks-for-biotech-innovation/) - [Higher ambition for EU Biotech](https://www.europabio.org/higher-ambition-for-eu-biotech/) - [Industrial Biotechnology Members Case Studies](https://www.europabio.org/industrial-biotechnology-case-studies-8341/) - [Lacidofil®: The Original Formula for A Resilient Gut Microbiome](https://www.europabio.org/lacidofil-the-original-formula-for-a-resilient-gut-microbiome/) - [Prenatis™: Maintaining Healthy Pregnancy and Subsequent Optimal Gut Microbiome in Babies](https://www.europabio.org/prenatis-maintaining-healthy-pregnancy-and-subsequent-optimal-gut-microbiome-in-babies/) - [Progress for biotech innovation in General Pharmaceutical Legislation – maximise with the Biotech Act](https://www.europabio.org/progress-for-biotech-innovation-in-general-pharmaceutical-legislation-maximise-with-the-biotech-act/) - [Slovenia Biotech Hills joins EuropaBio: Elevating Slovenia’s Biotech Ecosystem in Europe](https://www.europabio.org/slovenia-biotech-hills-joins-europabio-elevating-slovenias-biotech-ecosystem-in-europe/) - [OECD: Boosting biotechnology innovation through agile regulation and finance instruments](https://www.europabio.org/oecd-boosting-biotechnology-innovation-through-agile-regulation-and-finance-instruments/) - [Bioeconomy strategy sets the right pathway for Europe](https://www.europabio.org/bioeconomy-strategy-sets-the-right-pathway-for-europe/) - [Hungarian Biotechnology Association joins EuropaBio: Strengthening Hungary’s Biotech Voice in Europe](https://www.europabio.org/hungarian-biotechnology-association-joins-europabio-strengthening-hungarys-biotech-voice-in-europe/) - [Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech](https://www.europabio.org/vial-joins-europabio-reimagining-drug-development-with-hyper-scalable-biotech/) - [EuropaBio response to the EU Biotech Act public consultation](https://www.europabio.org/europabio-response-to-the-eu-biotech-act-public-consultation/) - [EuropaBio recommendations for the Circular Economy Act](https://www.europabio.org/europabio-recommendations-for-the-circular-economy-act/) - [Healthcare Associations warn of risks from PFAS restriction approach - failure to assess the impact on the availability of human and animal medicines](https://www.europabio.org/healthcare-associations-warn-of-risks-from-pfas-restriction-approach-failure-to-assess-the-impact-on-the-availability-of-human-and-animal-medicines/) - [PLA – plant the future!](https://www.europabio.org/pla-plant-the-future/) - [Lactic acid and biosurfactants from food waste for sustainable cleaning products](https://www.europabio.org/lactic-acid-and-biosurfactants-from-food-waste-for-sustainable-cleaning-products/) - [Transforming CO2 into proteins](https://www.europabio.org/transforming-co2-into-proteins/) - [Public Consultation Response to the European Innovation Act proposal](https://www.europabio.org/public-consultation-response-to-the-european-innovation-act-proposal/) - [Public Consultation Response to the European Commission’s 28th Regime proposal](https://www.europabio.org/public-consultation-response-to-the-european-commissions-28th-regime-proposal/) - [EuropaBio Annual Report 2025](https://www.europabio.org/europabio-annual-report-2025/) - [Industrial Decarbonisation Accelerator Act – EuropaBio Position](https://www.europabio.org/industrial-decarbonisation-accelerator-act-europabio-position/) - [EuropaBio Position on the Critical Medicines Act](https://www.europabio.org/europabio-position-on-the-critical-medicines-act/) - [Life Sciences Strategy Embraces Biotech for Global Impact](https://www.europabio.org/life-sciences-strategy-embraces-biotech-for-global-impact/) - [Biotech & Life-Sciences roadmap](https://www.europabio.org/europabio-conclusions-on-patient-bioforum-2025-2/) - “EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms” - [EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced](https://www.europabio.org/europabio-agm-2025-association-chair-executive-committee-and-board-announced/) - [Health Biomanufacturing: Feedstock for Preparedness and Resilience](https://www.europabio.org/health-biomanufacturing-feedstock-for-preparedness-and-resilience/) - [EuropaBio recommendations for the Bioeconomy Strategy](https://www.europabio.org/europabio-recommendations-for-the-bioeconomy-strategy/) - [Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges](https://www.europabio.org/hawkwood-biotech-joins-europabio-supporting-industrial-biotech-with-their-critical-challenges/) - [Joint industry definitions of fermentation and precision fermentation](https://www.europabio.org/joint-industry-definitions-of-fermentation-and-precision-fermentation/) - [EuropaBio conclusions on Patient BioForum 2025](https://www.europabio.org/europabio-conclusions-on-patient-bioforum-2025/) - “EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms” - [EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union](https://www.europabio.org/europabio-position-on-the-eu-biotech-act-prosperity-resilience-and-leadership-for-the-european-union/) - [The EU economic and scientific future starts with the EU Biotech Act](https://www.europabio.org/the-eu-economic-and-scientific-future-starts-with-the-eu-biotech-act/) - [The GPL must include biotech & life science to unleash EU innovation](https://www.europabio.org/the-gpl-must-include-biotech-life-science-to-unleash-eu-innovation/) - [EuropaBio response to EC Call for evidence for an evaluation of “Apply AI Strategy – strengthening the AI continent”](https://www.europabio.org/europabio-response-to-ec-call-for-evidence-for-an-evaluation-of-apply-ai-strategy-strengthening-the-ai-continent/) - [Open Letter of Business and Agri-Food Industry stakeholders on the need for a high-performing EFSA to boost the competitiveness of the EU agri-food sector](https://www.europabio.org/open-letter-of-business-and-agri-food-industry-stakeholders-on-the-need-for-a-high-performing-efsa-to-boost-the-competitiveness-of-the-eu-agri-food-sector/) - [Biotech startups and scaleups are drivers of economic innovation in Europe](https://www.europabio.org/biotech-startups-and-scaleups-are-drivers-of-economic-innovation-in-europe/) - [DANSK BIOTEK joins EuropaBio: Promoting Danish Biotechnology](https://www.europabio.org/dansk-biotek-joins-europabio-promoting-danish-biotechnology/) - [European Biotech Week 2025:Championing the Future of Biotechnology](https://www.europabio.org/european-biotech-week-2025championing-the-future-of-biotechnology/) - [Ensuring Biotech Integration in the Single Market](https://www.europabio.org/ensuring-biotech-integration-in-the-single-market/) - [Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World](https://www.europabio.org/adisseo-joins-europabio-feeding-animals-sustainably-around-the-world/) - [Boosting Attractiveness of the EU for ATMP Developers](https://www.europabio.org/boosting-attractiveness-of-the-eu-for-atmp-developers/) - [EuropaBio position on the EU Life Sciences Strategy](https://www.europabio.org/europabio-position-on-the-eu-life-sciences-strategy/) - [EU biotechnology competitiveness for the future; high level dialogue with EVP Séjourné](https://www.europabio.org/eu-biotechnology-competitiveness-for-the-future-high-level-dialogue-with-evp-sejourne/) - [Building EU biotech strength beyond tariffs](https://www.europabio.org/building-eu-biotech-strength-beyond-tariffs/) - [EFIB 2025 Brussels Statement](https://www.europabio.org/efib-2025-brussels-statement/) - [A gene on a quest: the adventures of Jen](https://www.europabio.org/a-gene-on-a-quest-the-adventures-of-jen/) - [US: Bold Goals for US Biotechnology and Biomanufacturing](https://www.europabio.org/bold-goals-for-us-biotechnology-and-biomanufacturing/) - [Response to the EC Call for Evidence for an evaluation of ''EU rules on medical devices and in vitro diagnostics''](https://www.europabio.org/response-to-the-ec-call-for-evidence-for-an-evaluation-of-eu-rules-on-medical-devices-and-in-vitro-diagnostics/) - [Measuring the Economic Footprint of the Biotechnology Industry in the European Union](https://www.europabio.org/measuring-the-economic-footprint-of-the-biotechnology-industry-in-the-european-union/) - [Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio](https://www.europabio.org/biotech-as-a-critical-economic-asset-for-europe-wifor-institute-study-updated-for-europabio/) - [Secure financing is key to boost EU biotech innovation](https://www.europabio.org/secure-financing-is-key-to-boost-eu-biotech-innovation/) - [Response to the European Commission Call for Evidence for the EU Startup and Scaleup Strategy](https://www.europabio.org/europabio-response-to-the-european-commission-call-for-evidence-for-the-eu-startup-and-scaleup-strategy/) - [Response to the Call for Evidence on the evaluation of the Public Procurement Directives](https://www.europabio.org/response-to-the-call-for-evidence-on-the-evaluation-of-the-public-procurement-directives/) - [Biotech innovation is key to EU’s autonomy and resilience](https://www.europabio.org/biotech-innovation-is-key-to-eus-autonomy-and-resilience/) - [Implementation of the Net-Zero Industry Act](https://www.europabio.org/implementation-of-the-net-zero-industry-act/) - [PRIMED Launches 2nd Open Call](https://www.europabio.org/primed-launches-2nd-open-call/) - [Sartorius joins EuropaBio: Delivering biomanufacturing](https://www.europabio.org/sartorius-joins-europabio-delivering-biomanufacturing/) - [The EU Biotech Act - EuropaBio Vision Paper](https://www.europabio.org/the-eu-biotech-act-europabio-vision/) - [Rare Disease Day: A Day Defined by Numbers and Community](https://www.europabio.org/rare-disease-day-a-day-defined-by-numbers-and-community/) - [EuropaBio response to the Call for Evidence on the Critical Medicines Act](https://www.europabio.org/europabio-response-to-the-call-for-evidence-on-the-critical-medicines-act/) - [EuropaBio’s Vision for a Bold EU Biotech Act](https://www.europabio.org/europabios-vision-for-a-bold-eu-biotech-act/) - [Biotech in a strong agri-food system for a competitive and resilient Europe](https://www.europabio.org/biotech-in-a-strong-agri-food-system-for-a-competitive-and-resilient-europe/) - [Synonym joins EuropaBio: Together for Advancing the Global Bioeconomy](https://www.europabio.org/synonym-joins-europabio-together-for-advancing-the-global-bioeconomy/) - [“Ambition, vision and urgency for biotechnology”, EuropaBio reacts to the Biotechnology and Biomanufacturing Initiative](https://www.europabio.org/ambition-vision-and-urgency-for-biotechnology-europabio-reacts-to-the-biotechnology-and-biomanufacturing-initiative/) - [European industries call for a bold and impactful Biotechnology and Biomanufacturing Initiative](https://www.europabio.org/european-industries-call-for-a-bold-and-impactful-biotechnology-and-biomanufacturing-initiative/) - Cross sectoral industries have come together to champion the European Commission’s forthcoming Biotechnology and Biomanufacturing Initiative through a position paper which calls for bold ambi-tion, and five core principles to ensure impactful industrial growth. - [Industry and biotech representatives welcome the EC Initiative “Boosting Biotechnology and Biomanufacturing in the EU”](https://www.europabio.org/industry-and-biotech-representatives-welcome-the-ec-initiative-boosting-biotechnology-and-biomanufacturing-in-the-eu/) - Cross sectoral industries have come together to champion the European Commission’s forthcoming Biotechnology and Biomanufacturing Initiative through a position paper which calls for bold ambi-tion, and five core principles to ensure impactful industrial growth. - [A New European Competitiveness Deal is the first step for EU Biotech Act](https://www.europabio.org/a-new-european-competitiveness-deal-is-the-first-step-for-eu-biotech-act/) - [A Biotech Act for Europe: INVENT – MAKE – APPROVE - USE](https://www.europabio.org/a-biotech-act-for-europe-invent-make-approve-use/) - [EuropaBio calls for ambitious role of biotech following EC Competitiveness Compass](https://www.europabio.org/europabio-calls-for-ambitious-role-of-biotech-following-ec-competitiveness-compass/) - [Biotech is a key driver for a strong and united Europe](https://www.europabio.org/biotech-is-a-key-driver-for-a-strong-and-united-europe/) - [German Association of Biotechnology Industries: Biotech regulation: Making Europe fit for the future](https://www.europabio.org/dib-biotech-regulation-making-europe-fit-for-the-future/) - [Microorganisms & industrial biotechnology: challenges and opportunities for Europe](https://www.europabio.org/microorganisms-industrial-biotechnology-challenges-and-opportunities-for-europe/) - [India: BioE3 Policy - Biotechnology for Economy, Environment and Employment](https://www.europabio.org/india-bioe3-policy-biotechnology-for-economy-environment-and-employment-2024/) - [France Biotech: Biomédicaments et bioproduction](https://www.europabio.org/france-biomedicaments-et-bioproduction/) - [EU: Biomass supply and uses in the EU](https://www.europabio.org/eu-biomass-supply-and-uses-in-the-eu/) - [EU: Exploring the global landscape of biotech innovation: Preliminary insights from patent analysis](https://www.europabio.org/eu-exploring-the-global-landscape-of-biotech-innovation-preliminary-insights-from-patent-analysis/) - [Vintura joins EuropaBio: Creating meaningful impact for patients and health systems](https://www.europabio.org/vintura-joins-europabio-creating-meaningful-impact-for-patientsand-health-systems/) - [Bronkhorst High-Tech joins EuropaBio: Fostering Biomanufacturing Excellence](https://www.europabio.org/bronkhorst-high-tech-joins-europabio-fostering-biomanufacturing-excellence/) - [Biomanufacturing: Europe's Industrial Future](https://www.europabio.org/biomanufacturing-europes-industrial-future/) - [NIBRT joins EuropaBio: Excellence in biopharmaceutical manufacturing processes](https://www.europabio.org/nibrt-joins-europabio-excellence-in-biopharmaceutical-manufacturing-processes/) - [EuropaBio Response to the Commission Public Consultation on the Single Market Strategy 2025](https://www.europabio.org/europabio-response-to-the-commission-public-consultation-on-the-single-market-strategy-2025/) - [Bio Base Europe Pilot Plant joins EuropaBio: Driving Sustainable Biotech Innovation](https://www.europabio.org/bio-base-europe-pilot-plant-joins-europabio-driving-sustainable-biotech-innovation/) - [SMEs in Europe’s bioeconomy and agri-food landscape](https://www.europabio.org/smes-in-europes-bioeconomy-and-agri-food-landscape/) - [Enduro Genetics joins EuropaBio: Improving Bioproduction at Scale](https://www.europabio.org/enduro-genetics-joins-europabio-improving-bioproduction-at-scale/) - [ShakeUp Factory joins EuropaBio: Championing EU Agri-foodtech Pioneers](https://www.europabio.org/shakeup-factory-joins-europabio-championing-eu-agri-foodtech-pioneers/) - [MAP Group joins EuropaBio: supporting patient access in Europe](https://www.europabio.org/map-group-joins-europabio-supporting-patient-access-in-europe/) - [Joint Industry Statement on JSC capacity](https://www.europabio.org/joint-industry-statement-on-jsc-capacity/) - [OM Pharma joins EuropaBio: Transforming Immune Health](https://www.europabio.org/om-pharma-joins-europabio-transforming-immune-health/) - [Feedstock: The building blocks of EU's sustainability and resilience](https://www.europabio.org/feedstock-the-building-block-of-eus-sustainability-and-resilience/) - [Innovating for Food Security: how biotechnology can support the right to food](https://www.europabio.org/innovating-for-food-security-how-biotechnology-can-support-the-right-to-food/) - Happy Sustainable Gastronomy Day! June 18 marks the UN Sustainable Gastronomy Day, celebrating different cuisines, their ingredients, how the food is grown and how it gets to our markets and plates. - [EuropaBio joins the European APPROVALS project](https://www.europabio.org/europabio-joins-the-european-approvals-project/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [The Future of Biotech: The Role of Legislation on Investment for Innovation – Recommendations](https://www.europabio.org/the-future-of-biotech-the-role-of-legislation-on-investment-for-innovation-recommendations/) - [Probiotic Group joins EuropaBio: Green Microbial-Based Care Solutions](https://www.europabio.org/probiotic-group-joins-europabio-green-microbial-based-care-solutions/) - [Fermenting Sustainability](https://www.europabio.org/fermenting-sustainability/) - Happy Sustainable Gastronomy Day! This UN Day, celebrated on 18 June, is dedicated to sustainable food production and consumption in the context of local culinary traditions. Did you know that biotechnology – the use of living organisms to make products – is both a key aspect of many culinary traditions as well as a cornerstone of sustainable food production? The reason for this is fermentation. The theme of 2023 Sustainable Gastronomy Day is ‘Local Flavours, Preserving Global Heritage’. Fermentation, from the most traditional to the most innovative examples, is a key part of local and global food traditions and plays a crucial role in the sustainable food systems of today and tomorrow. - [Council position on the Detergents Regulation: Biotechnology supports greener and safer cleaning](https://www.europabio.org/council-position-on-the-detergents-regulation-biotechnology-supports-greener-and-safer-cleaning/) - [VERAMARIS® – Transforming Aquaculture using Biotechnology](https://www.europabio.org/veramaris-transforming-aquaculture-using-biotechnology/) - [Sustainable natural vanillin production through yeast fermentation](https://www.europabio.org/sustainable-natural-vanillin-production-through-yeast-fermentation/) - [Producing more with less: Towards sustainable agriculture with microbial inoculants](https://www.europabio.org/probiotics-science-based-natural-products-as-antibiotic-alternatives-2/) - [The world’s first plant for the production of 1,4 bio-butanediol from renewable resources](https://www.europabio.org/the-worlds-first-plant-for-the-production-of-14-bio-butanediol-from-renewable-resources/) - [LALSTOP G46 WG - Dependable Pathogen Control for Farmers](https://www.europabio.org/lalstop-g46-wg-dependable-pathogen-control-for-farmers/) - [Microalgae to preserve the planet’s limited resources](https://www.europabio.org/microalgae-to-preserve-the-planets-limited-resources/) - [CLEARWOOD®: A sustainable alternative to Patchouli essential oil for the fragrance industry](https://www.europabio.org/clearwood-a-sustainable-alternative-to-patchouli-essential-oil-for-the-fragrance-industry/) - [Biosurfactants – Clean and sustainable](https://www.europabio.org/biosurfactants-clean-and-sustainable/) - [Probiotics – science-based natural products as antibiotic alternatives](https://www.europabio.org/probiotics-science-based-natural-products-as-antibiotic-alternatives/) - [Good Health Starts in the Gut with HOWARU® Probiotics](https://www.europabio.org/good-health-starts-in-the-gut-with-howaru-probiotics/) - [Naturally Better Performance with Designed Enzymatic Biomaterials™](https://www.europabio.org/naturally-better-performance-with-designed-enzymatic-biomaterials/) - [Rheticus – Specialty Chemicals from CO2](https://www.europabio.org/rheticus-specialty-chemicals-from-co2/) - [Driving Profitability and Sustainability in the U.S. Fuel Ethanol Industry](https://www.europabio.org/driving-profitability-and-sustainability-in-the-u-s-fuel-ethanol-industry/) - [Lactic acid and ethanol co-producing yeast for making sour beer](https://www.europabio.org/lactic-acid-and-ethanol-co-producing-yeast-for-making-sour-beer/) - [Verdad – natural preservation of food](https://www.europabio.org/verdad-natural-preservation-of-food/) - [Hidden Heroes: How microorganisms are shaping Europe's future](https://www.europabio.org/hidden-heroes-how-microorganisms-are-shaping-europes-future/) - [Safety aspects of microorganisms deliberately released into the environment](https://www.europabio.org/safety-aspects-of-microorganisms-deliberately-released-intothe-environment/) - Safety aspects of microorganisms deliberately released into theenvironmentDownload - [Biotechnology in the framework of Europe’s agri-food future](https://www.europabio.org/biotechnology-in-the-framework-of-europes-agri-food-future/) - EuropaBio, the leading voice for the biotechnology industry in Europe, has joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSURTIUM, launched on January 12th, 2024, and supported by the European Union’s Horizon Europe Program. - [EuropaBio Annual Report 2024](https://www.europabio.org/europabio-2024-annual-report/) - [Biotech Starter Kit - Why does Intellectual Property matter for biotechnologies?](https://www.europabio.org/biotech-starter-kit-why-does-intellectual-property-matter-for-biotechnologies/) - [PRIMED 2nd General Assembly](https://www.europabio.org/primed-2nd-general-assembly/) - EuropaBio, the leading voice for the biotechnology industry in Europe, has joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSURTIUM, launched on January 12th, 2024, and supported by the European Union’s Horizon Europe Program. - [EFSA recommends the same approach for all microorganisms](https://www.europabio.org/efsa-recommends-the-same-approach-for-all-microorganisms/) - [Biotech Starter Kit - Why is the NGT for Plants Regulation Important for Biotechnology?](https://www.europabio.org/biotech-starter-kit-why-is-the-ngt-for-plants-regulation-important-for-biotechnology/) - [Biotech Starter Kit - The EU General Pharmaceutical Legislation](https://www.europabio.org/biotech-starter-kit-the-eu-general-pharmaceutical-legislation/) - [Biotech Starter Kit - Why is the Detergents Regulation Important for Biotechnology?](https://www.europabio.org/biotech-starter-kit-why-is-the-detergents-regulation-important-for-biotechnology/) - [What is needed to make full use of the potential of microorganisms in Europe?](https://www.europabio.org/what-is-needed-to-make-full-use-of-the-potential-of-microorganisms-in-europe/) - [EuropaBio Congratulates Ursula von der Leyen on Re-election as COM President](https://www.europabio.org/europabio-congratulates-ursula-von-der-leyen-on-re-election-as-com-president/) - In the shaping of the next European Framework Programme for Research and Innovation (FP10), we, the undersigned 95 European associations representing key European RD&I stakeholders, hereby urge the EU Institutions to significantly increase the current budget in view of FP10 and to make pan-European collaborative research the cornerstone of FP10, answering industrial needs by excellence. - [World Economic Forum: Accelerating the tech-driven bioeconomy](https://www.europabio.org/world-economic-forum-accelerating-the-tech-driven-bioeconomy/) - [EuropaBio AGM Welcomes New Board Representatives and Association Members](https://www.europabio.org/europabio-agm-welcomes-new-board-representatives-and-association-members/) - [Joint Statement for an Ambitious FP10](https://www.europabio.org/joint-statement-for-an-ambitious-fp10/) - In the shaping of the next European Framework Programme for Research and Innovation (FP10), we, the undersigned 95 European associations representing key European RD&I stakeholders, hereby urge the EU Institutions to significantly increase the current budget in view of FP10 and to make pan-European collaborative research the cornerstone of FP10, answering industrial needs by excellence. - [Biotech as a key technology for the Council Strategic Agenda 2024-2029](https://www.europabio.org/biotech-as-a-key-technology-for-the-council-strategic-agenda-2024-2029/) - [Biotech Starter Kit - Compulsory Licensing for Crisis Management](https://www.europabio.org/biotech-starter-kit-compulsory-licensing-for-crisis-management/) - [Biotech Starter Kit - Boosting Biotechnology and Biomanufacturing in the EU](https://www.europabio.org/europabio-starter-kit-boosting-biotechnology-and-biomanufacturing-in-the-eu/) - [EuropaBio response to the public consultation on the revision of the EU Variation Regulation](https://www.europabio.org/europabio-response-to-the-public-consultation-on-the-ec-draft-delegated-regulation-as-regards-the-examination-of-variations-to-the-terms-of-marketing-authorisations-for-medicinal-products-for-human-us/) - [Embracing the Taste of Cultivated Meat](https://www.europabio.org/embracing-the-taste-of-cultivated-meat/) - Happy Sustainable Gastronomy Day! June 18 marks the UN Sustainable Gastronomy Day, celebrating different cuisines, their ingredients, how the food is grown and how it gets to our markets and plates. - [European Biotech Week: Showcasing the Future of Biotechnology](https://www.europabio.org/european-biotech-week-showcasing-the-future-of-biotechnology/) - EuropaBio and Members are proud to launch the 12th edition of European Biotech Week (#EBW2024), which will take place across Europe from 24 September to 1 October 2024. - [Biotechnology is a Critical Technology: Roadmap to a Globally Competitive and Resilient EU](https://www.europabio.org/biotechnology-is-a-critical-technology-roadmap-to-a-globally-competitive-and-resilient-eu/) - [Prague.bio joins EuropaBio: Integrating Biotech in the Czech Republic](https://www.europabio.org/prague-bio-joins-europabio-integrating-biotech-in-the-czech-republic/) - [Europe’s Biotechnology & Biomanufacturing Future Starts Today](https://www.europabio.org/europes-biotechnology-biomanufacturing-future-starts-today/) - [EuropaBio takes Chair of International Council of Biotechnology Associations](https://www.europabio.org/europabio-takes-chair-of-international-council-of-biotechnology-associations/) - [EU: A sustainable Bioeconomy for Europe - Updated Bioeconomy Strategy](https://www.europabio.org/european-union-a-sustainable-bioeconomy-for-europe-updated-bioeconomy-strategy/) - [Cultivated Meat: What It Is and How It Is Made](https://www.europabio.org/cultivated-meat/) - [Council conclusions reaffirm the critical role of biotechnology for a competitive Europe](https://www.europabio.org/council-conclusions-reaffirm-the-critical-role-of-biotechnology-for-a-competitive-europe/) - EuropaBio welcomes the Competitiveness Council conclusions outlining a vision for ‘a competitive European industry driving our green, digital and resilient future’. - [Biotechnology is a key contributor to the Net-Zero Industry Act](https://www.europabio.org/biotechnology-is-a-key-contributor-to-the-net-zero-industry-act-2/) - EuropaBio welcomes the European Parliament’s vote on the Net-Zero Industry Act (NZIA), underscoring the pivotal role of biotechnology in achieving carbon neutrality across industries aligned with the Green Deal goals. - [China: China Manufacturing 2025](https://www.europabio.org/china-china-manufacturing-2025/) - [India: National Biotechnology Development Strategy 2021-2025](https://www.europabio.org/india-national-biotechnology-development-strategy-2021-2025/) - [Japan: Bioeconomy Strategy Featuring Points](https://www.europabio.org/oecd-japan-bioeconomy-strategy-featuring-points/) - [UK: Innovation Strategy: Leading the future by creating it](https://www.europabio.org/uk-innovation-strategy-leading-the-future-by-creating-it/) - [US: Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy](https://www.europabio.org/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/) - [Canada: Biomanufacturing and Life Sciences Strategy](https://www.europabio.org/canada-biomanufacturing-and-life-sciences-strategy/) - [US: Report to the President: Biomanufacturing to Advance the Bioeconomy](https://www.europabio.org/report-to-the-president-biomanufacturing-to-advance-the-bioeconomy-us/) - [US: The US Biomanufacturing Economy: Value Added, Supply Chains, Cost, Sustainability, and Efficiency](https://www.europabio.org/us-the-us-biomanufacturing-economy-value-added-supply-chains-cost-sustainability-and-efficiency/) - [US: Department of Defense Biomanufacturing Strategy](https://www.europabio.org/us-department-of-defense-biomanufacturing-strategy/) - [US: Building the Bioworkforce of the Future](https://www.europabio.org/building-the-bioworkforce-of-the-future-us/) - [US: National Security Commission on Emerging Biotechnology Interim Report](https://www.europabio.org/us-national-security-commission-on-emerging-biotechnology-interim-report/) - [US: Building a Resilient Biomass Supply - A plan to Enable the Bioeconomy in America](https://www.europabio.org/us-building-a-resilient-biomass-supply-a-plan-to-enable-the-bioeconomy-in-america/) - [US: The Coordinated Framework for the Regulation of Biotechnology](https://www.europabio.org/us-the-coordinated-framework-for-the-regulation-of-biotechnology/) - [World Economic Forum: Accelerating the Biomanufacturing Revolution](https://www.europabio.org/world-economic-forum-accelerating-the-biomanufacturing-revolution/) - [Olon & Blue Horizon: To make the Bioeconomy real, develop for scalability and creditworthiness](https://www.europabio.org/olon-blue-horizon/) - [SEBOIO: The European Life Science Investment Attractiveness Report Fourth Edition 2023 Time to Act](https://www.europabio.org/seboio-the-european-life-science-investment-attractiveness-report-fourth-edition-2023-time-to-act/) - [BCG & Synonym: Breaking the Cost Barrier in Biomanufacturing](https://www.europabio.org/bcg-synonym-breaking-the-cost-barrier-in-biomanufacturing/) - [International Advisory Council on Global Bioeconomy: Bioeconomy globalization: Recent trends and drivers of national programs and policies](https://www.europabio.org/iacgb-bioeconomy-globalization-recent-trends-and-drivers-of-national-programs-and-policies/) - [GFI: Trends in cultivated meat scale-up and bioprocessing](https://www.europabio.org/gfi-trends-in-cultivated-meat-scale-up-and-bioprocessing/) - [EuropaBio response to NOU 2023 - 18 Gene technology in a sustainable future](https://www.europabio.org/europabio-response-to-nou-2023-18-gene-technology-in-a-sustainable-future/) - [Microorganisms as a factory and as a product](https://www.europabio.org/microorganisms-as-a-factory-and-as-a-product/) - [Made in Belgium for Europe - EuropaBio National Associations Belgium Council Presidency Summit](https://www.europabio.org/made-in-belgium-for-europe-europabio-national-associations-belgium-council-presidency-summit/) - [Joint Statement on the EC Initiative: Boosting Biotechnology and Biomanufacturing in the EU](https://www.europabio.org/joint-statement-on-the-ec-initiative-boosting-biotechnology-and-biomanufacturing-in-the-eu/) - A global technology and market race is underway within biotechnology and biomanufacturing. Successful regions will lead innovation, manufacturing and trade across multiple sectors, with competitive and sustainable next generation economies and strong global trade presence - [WHC Lab joins EuropaBio: Excellence in Brewery & Distillery Fermentation](https://www.europabio.org/whc-lab-joins-europabio-excellence-in-brewery-distillery-fermentation/) - [Biocatalyst Foundation joins EuropaBio: Connecting the Baltic Biotechnology Ecosystem](https://www.europabio.org/biocatalyst-foundation-joins-europabio-connecting-the-baltic-biotechnology-ecosystem/) - [Biomanufacturing Policy Summit Report 2024: Policy pathways for biomanufacturing in Europe](https://www.europabio.org/biomanufacturing-policy-summit-report-2024-policy-pathways-for-biomanufacturing-in-europe/) - [LanzaTech joins EuropaBio: Recycling Carbon for a Sustainable Future](https://www.europabio.org/lanzatech-joins-europabio-recycling-carbon-for-a-sustainable-future/) - [Exploring Industrial Biotech: The Series](https://www.europabio.org/exploring-industrial-biotech-the-series/) - [Industrial biotech needs to break bureaucracy barriers](https://www.europabio.org/industrial-biotech-needs-to-break-bureaucracy-barriers/) - EuropaBio welcomes the European Parliament’s vote on the Net-Zero Industry Act (NZIA), underscoring the pivotal role of biotechnology in achieving carbon neutrality across industries aligned with the Green Deal goals. - [Formo joins EuropaBio: Advancing Dairy Sustainability Through Innovation](https://www.europabio.org/formo-joins-europabio-advancing-dairy-sustainability-through-innovation/) - [The adventures of Max the microorganism](https://www.europabio.org/the-adventures-of-max-the-microorganism-2/) - [EuropaBio warns of risks to patient access to health biotech innovation within Joint Clinical Assessment Implementing Act](https://www.europabio.org/europabio-warns-of-risks-to-patient-access-to-health-biotech-innovation-within-joint-clinical-assessment-implementing-act/) - [Revision of the EU General Pharmaceutical Legislation: more of a compromise than a robust view on the future of biotech innovation in Europe](https://www.europabio.org/revision-of-the-eu-general-pharmaceutical-legislation-more-of-a-compromise-than-a-robust-view-on-the-future-of-biotech-innovation-in-europe/) - [Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity to speed up access to innovative medicines for European patients](https://www.europabio.org/life-science-industry-concerns-over-the-workability-of-eu-hta-europe-cannot-miss-out-on-the-opportunity-to-speed-up-access-to-innovative-medicines-for-european-patients/) - [Connecting legislation to biomanufacturing – Europe faces its future](https://www.europabio.org/connecting-legislation-to-biomanufacturing-europe-faces-its-future/) - “Get legislation right to incentivise biomanufacturing investment and implement it with speed and coherence across Member States” was the clear message from EuropaBio’s second Biomanufacturing Policy Summit - [Syensqo joins EuropaBio: Accelerating Innovation in Biotechnology](https://www.europabio.org/syensqo-joins-europabio-accelerating-innovation-in-biotechnology/) - [Standing Ovation joins EuropaBio: Animal Free Dairy Through Precision Fermentation](https://www.europabio.org/standing-ovation-joins-europabio-animal-free-dairy-through-precision-fermentation/) - [Biomanufacturing Global Series: Europe's opportunity to grow](https://www.europabio.org/biomanufacturing-global-series/) - The EU biotech and biomanufacturing initiative is a unique opportunity for the EU to take urgent and immediate actions to support the scale up of the EU biotech and biomanufacturing sector. - [Europe 2040: Tomorrow is Today](https://www.europabio.org/europe-2040-tomorrow-is-today/) - [EuropaBio Statement on the vote on the ENVI Committee on the revision of the EU General Pharmaceutical Legislation](https://www.europabio.org/europabio-statement-on-the-vote-on-the-envi-committee-on-the-revision-of-the-eu-general-pharmaceutical-legislation/) - [EuropaBio welcomes European Parliament vote on compulsory licensing regulation but expresses concerns about undermining of intellectual property rights](https://www.europabio.org/europabio-welcomes-european-parliament-vote-on-compulsory-licensing-regulation-but-expresses-concerns-about-undermining-of-intellectual-property-rights/) - [EuropaBio joins the PRIMED PROJECT CONSORTIUM](https://www.europabio.org/europabio-joins-the-primed-project-consurtium/) - EuropaBio, the leading voice for the biotechnology industry in Europe, has joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSURTIUM, launched on January 12th, 2024, and supported by the European Union’s Horizon Europe Program. - [Biotech recognised in regulation for Europe’s future: EuropaBio welcomes European Parliament’s vote on Strategic Technologies for Europe Platform Regulation](https://www.europabio.org/biotech-recognised-in-regulation-for-europes-future-europabiowelcomes-european-parliaments-vote-on-strategic-technologies-foreurope-platform-regulation/) - The European Parliament’s vote on Strategic Technologies for Europe Platform (STEP) represents an important first move to ensure European industry remains competitive and innovative. EuropaBio welcomes the inclusion of biotech according to the OECD definition as a strategic technology for Europe. - [Gourmey joins EuropaBio: Pioneering Sustainable Cultivated Meat](https://www.europabio.org/gourmey-joins-europabio-pioneering-sustainable-cultivated-meat/) - [Measuring the Economic Footprint of the Biotechnology Industry in Europe (WifOR Study Update)](https://www.europabio.org/measuring-the-economic-footprint-of-the-biotechnology-industry-in-europe/) - [EC Initiative on Biotechnology and Biomanufacturing: Principles for an impactful Europe](https://www.europabio.org/ec-initiative-on-biotechnology-and-biomanufacturing-principles-for-an-impactful-europe/) - A global technology and market race is underway within biotechnology and biomanufacturing. Successful regions will lead innovation, manufacturing and trade across multiple sectors, with competitive and sustainable next generation economies and strong global trade presence - [EU biotech and biomanufacturing Initiative: Key asks for Industrial Biotechnology](https://www.europabio.org/eu-biotech-and-biomanufacturing-initiative-key-asks-for-industrial-biotechnology/) - The EU biotech and biomanufacturing initiative is a unique opportunity for the EU to take urgent and immediate actions to support the scale up of the EU biotech and biomanufacturing sector. - [Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe](https://www.europabio.org/europabio-statement-on-the-evaluation-of-the-cross-border-healthcare-directive-2/) - [EuropaBio welcomes and warns on New Genomic Techniques European Parliament vote](https://www.europabio.org/europabio-welcomes-and-warns-on-new-genome-techniques-european-parliament-vote/) - The New Genomic Techniques (NGTs) legislation vote in the European Parliament is a welcome modernisation of Europe’s biotechnology innovation, food security and climate change response. However, EuropaBio red flags the dangerous fragmentation and weakening of industrial policy with the ban on patenting of NGT plants. - [Europe’s Biotech Innovators at risk… the General Pharmaceutical Legislation must prioritise innovation](https://www.europabio.org/europes-biotech-innovators-at-risk-the-general-pharmaceutical-legislation-must-prioritise-innovation/) - [Biomanufacturing Policy Summit 2024 - Policy pathways for biomanufacturing in Europe](https://www.europabio.org/biomanufacturing-policy-summit-2024-policy-pathways-for-biomanufacturing-in-europe/) - The Biomanufacturing Policy Summit will host its 2nd edition in March 2024. The invite-only half-day summit hosted by EuropaBio brings together stakeholders including industry representatives and policymakers, to discuss Europe’s ambitions for biomanufacturing and the tangible legislative, regulatory and strategic pathways. - [Reflection and renewal for industrial biotechnology in Europe: EuropaBio launches EFIB Rotterdam Statement 2023](https://www.europabio.org/reflection-and-renewal-for-industrial-biotechnology-in-europe/) - [EuropaBio Patient BioForum 2023: Roundtable on Advancing Solutions for Unmet Medical Needs](https://www.europabio.org/europabio-patient-bioforum-2023-roundtable-on-advancing-solutions-for-unmet-medical-needs/) - The EuropaBio Patient BioForum convened on 30 November 2023, bringing together a diverse group of stakeholders, including patient advocates, representatives from the biotech community, and European Institutions. Find the full Event Report and Press Release here. - [Inter-association letter to raise our concern about the proposed definition of "natural polymers" in the REACH restriction of microplastics](https://www.europabio.org/inter-association-letter-to-raise-our-concern-about-the-proposed-definition-of-natural-polymers-in-the-reach-restriction-of-microplastics/) - [Agri-Food Chain Coalition launches EU Strategic Agenda 2024-2029](https://www.europabio.org/agri-food-chain-coalition-launches-eu-strategic-agenda-2024-2029/) - The Agri-Food Chain Coalition (AFCC) has published a recommendation for the EU Strategic Agenda 2024-2029 to include the strengthening of the European food autonomy and resilience as well as enhancing the competitiveness and sustainability of the entire EU-Agri food chain. - [Wojciech Nowak, Novartis, appointed as new Chair of EuropaBio’s Healthcare Council](https://www.europabio.org/wojciech-nowak-novartis-appointed-as-new-chair-of-europabios-healthcare-council/) - [Factsheet - Supporting small biotechs in the revision of EU pharmaceutical legislation](https://www.europabio.org/factsheet-supporting-small-biotechs-in-the-revision-of-eu-pharmaceutical-legislation/) - Small biotech companies are the unsung heroes of the healthcare industry, driving innovation and improving patient access. They've been pivotal in developing transformative therapies and technologies. Collaboration is key to their success, but they face challenges. - [A global Europe - the role of transformative legislation for biotech. EuropaBio Nacional Associations Spanish Council Presidency Summit](https://www.europabio.org/a-global-europe-the-role-of-transformative-legislation-for-biotech-europabio-nacional-associations-spanish-council-presidency-summit/) - The Spanish Presidency of the Council of the European Union has established several priorities for the second half of 2023 to ensure Europe's global position and strategic autonomy, including promoting the transition towards a more sustainable agri-food production model and strengthening EU's health autonomy through European-based innovation. - [EFIB Rotterdam Statement 2023](https://www.europabio.org/efib-rotterdam-statement-2023/) - As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate and Work Programme, EuropaBio reviews European strategies and ambitions where biotechnology plays a key role. Ursula von der Leyen’s State of the European Union address of 13 September announced an ‘EU Biotech and Biomanufacturing Initiative’ under the heading of ‘An Economy that Works for People’1. Europe needs to be ambitious for this, particularly when considering the ongoing changes in global perspective on biotechnology which were highlighted in the 2022 Vilnius Statement. - [DNA Script joins EuropaBio: Advancing Enzymatic DNA Synthesis Technology](https://www.europabio.org/dna-script-joins-europabio-advancing-enzymatic-dna-synthesis-technology/) - [Innovative biotech industry can support Europe’s health resilience and autonomy](https://www.europabio.org/innovative-biotech-industry-can-support-europes-health-resilience-and-autonomy/) - [SICOS joins EuropaBio: Strengthening French fine chemicals and biotech industry](https://www.europabio.org/sicos-joins-europabio-strengthening-french-fine-chemicals-and-biotech-industry/) - [The Future of Health is Biotech: EuropaBio's Position on the Revision of the EU Pharmaceutical Legislation](https://www.europabio.org/the-future-of-health-is-biotech-europabios-position-on-the-revision-of-the-eu-pharmaceutical-legislation/) - EuropaBio, the leading voice for the biotechnology industry in Europe, has released its position on the proposed revision of the EU General Pharmaceutical Legislation (GPL), underlining the vital role of biotech in shaping the future of healthcare. - [Biomanufacturing Library: A living repository](https://www.europabio.org/biomanufacturing-library-a-living-repository/) - EuropaBio is launching a biomanufacturing library as part of its commitment to deliver the best insights and lead the way on biomanufacturing in Europe. - [Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)](https://www.europabio.org/measuring-the-economic-footprint-of-the-biotechnology-industry-in-europe-wifor-study/) - The purpose of this study is to estimate the economic impact of the production activities of European enterprises applying biotechnology in their research and manufacturing processes. - [EU Industrial Forum report: Advanced Manufacturing at the heart of a resilient, sustainable and competitive Europe](https://www.europabio.org/eu-industrial-forum-report-advanced-manufacturing-at-the-heart-of-a-resilient-sustainable-and-competitive-europe/) - [EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion](https://www.europabio.org/europabio-and-alexion-rare-conversations-take-two-keeping-rare-disease-patients-in-the-centre-of-discussion/) - On February 4th, Alexion continued its RareConversations event series in cooperation with EuropaBio. - [Rare Disease Week 2021 - Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi](https://www.europabio.org/rare-disease-week-2021-interview-with-dr-ravi-rao-head-of-research-development-chief-medical-officer-at-sobi/) - Read EuropaBios interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi, on the occasion of Rare Disease Week 2021. - [Abolis joins EuropaBio: Sustainable Bio-Based Products](https://www.europabio.org/abolis-joins-europabio-sustainable-bio-based-products/) - Abolis joins EuropaBio: Sustainable Bio-Based Products. - [Abolis joins the EuropaBio 25th Anniversary in 2021](https://www.europabio.org/abolis-joins-the-europabio-25th-anniversary-in-2021/) - EuropaBio is delighted to announce that Abolis has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor. - [Interview with... Kristina Eskenazi, Chair of Health & Life Sciences Cluster Bulgaria](https://www.europabio.org/interview-with-kristina-eskenazi-chair-of-health-life-sciences-cluster-bulgaria/) - EuropaBio sat down with new National Association Member from Bulgaria, to find out their plans for their national activities within an international framework. - [Health and Life Sciences Cluster Bulgaria joins EuropaBio: AI as enabler of biotech growth](https://www.europabio.org/health-and-life-sciences-cluster-bulgaria-joins-europabio-ai-as-enabler-of-biotech-growth/) - EuropaBio is delighted to announce that Health and Life Sciences Cluster Bulgaria has joined EuropaBio. - [The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations](https://www.europabio.org/the-lithuanian-biotechnology-association-joins-europabio-its-time-to-put-lithuania-on-a-map-of-the-most-biotech-savvy-nations/) - EuropaBio is delighted to announce that the Lithuanian Biotechnology Association joins EuropaBio - [Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential](https://www.europabio.org/kaffe-bueno-joins-europabio/) - EuropaBio is delighted to announce that Kaffe Bueno joined the association as a corporate member. - [Interview with... Krijn de Nood, Co-Founder & CEO at Meatable](https://www.europabio.org/interview-with-krijn-de-nood-co-founder-ceo-at-meatable/) - EuropaBio sat down with new Member Meatable, to find out about their journey from creation in 2018. - [Interview with... Juan Medina, Co-Founder & CEO at Kaffe Bueno](https://www.europabio.org/interview-with-kaffe-bueno/) - EuropaBio sat down with new corporate member Kaffe Bueno, to find out more about the future of coffee. - [EuropaBio sat down with new member MabDesign, to find out about its work with the French biopharmaceutical industry](https://www.europabio.org/europabio-sat-down-with-new-member-mabdesign-2/) - [EuropaBio sat down with new member AB Enzymes, to find out about their highly customizable enzymes solutions](https://www.europabio.org/europabio-sat-down-with-new-member-ab-enzymes/) - [Remilk joins EuropaBio: recreating dairy that makes the world a better place](https://www.europabio.org/remilk-joins-europabio/) - [EuropaBio sat down with new Member Remilk, to learn more about the future of sustainable food production](https://www.europabio.org/europabio-sat-down-with-new-member-remilk-to-learn-more-about-the-future-of-sustainable-food-production/) - 2022_02_G_I_Interview-with-RemilkDownload - [European Week Against Cancer 2022 - Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi](https://www.europabio.org/european-week-against-cancer-2022-interview-with-santiago-aguirre-market-lead-europe-oncology-sanofi/) - 2022_05_H_I_Interview-with-SanofiDownload - [Phytolon joins EuropaBio: natural food colours for better health and environmental sustainability](https://www.europabio.org/phytolon-joins-europabio-natural-food-colours-for-better-health-and-environmental-sustainability/) - 2022_07_G_PR_Phytolon-joins-EuropaBioDownload - [EuropaBio sat down with new Member Phytolon, to learn more about the future of natural food colours](https://www.europabio.org/europabio-sat-down-with-new-member-phytolon-to-learn-more-about-the-future-of-natural-food-colours/) - 2022_07_G_O_Interview-with-PhytolonDownload - [Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet](https://www.europabio.org/bon-vivant-joins-europabio-dairy-products-with-a-lower-impact-on-human-health-animals-and-planet/) - 2022_09_G_PR_Bon-Vivant-joins-EuropaBioDownload - [EuropaBio sat down with new Member Bon Vivant, to learn more about the future of alternative dairy proteins](https://www.europabio.org/europabio-sat-down-with-new-member-bon-vivant-to-learn-more-about-the-future-of-alternative-dairy-proteins/) - 2022_09_G_O_Interview-with-Bon-VivantDownload - [Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework](https://www.europabio.org/freget-glaser-associes-joins-europabio-steering-the-innovation-potential-through-a-secure-legal-framework/) - 2022_09_G_PR_Freget-Glaser-joins-EuropaBioDownload - [EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology](https://www.europabio.org/europabio-sat-down-with-new-member-freget-glaser-associes-to-learn-more-about-investment-and-growth-opportunities-for-european-biotechnology/) - 2022_09_G_O_Interview-with-Freget-GlaserDownload - [SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions](https://www.europabio.org/senseup-joins-europabio-leveraging-the-power-of-bio-tech-for-sustainable-and-commercially-viable-solutions/) - 2022_12_G_PR_SenseUp-joins-EuropaBioDownload - [EuropaBio sat down with new member SenseUp, to find out about the natural evolution approach for novel protein and RNA products](https://www.europabio.org/europabio-sat-down-with-new-member-senseup/) - 2022_12_G_O_Interview-with-New-Member-SenseUpDownload - [The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry](https://www.europabio.org/the-association-of-biotechnological-companies-bioforum-joins-europabio-representing-polish-biotech-at-european-legislative-fora-and-involving-polish-companies-in-the-debate-about-the-future-of-the-ind/) - [EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe](https://www.europabio.org/europabio-sat-down-with-new-member-association-of-biotechnological-companies-bioforum-to-find-out-how-they-champion-biotech-in-central-and-eastern-europe/) - [SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins](https://www.europabio.org/swiftpharma-joins-europabio-pioneering-sustainable-scalable-and-affordable-plant-made-therapeutic-proteins/) - [Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders](https://www.europabio.org/disc-medicine-joins-europabio-life-changing-medicines-for-patients-with-hematologic-disorders/) - EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member. - [21st.BIO joins EuropaBio: helping accelerate the World’s quest for sustainable food and materials](https://www.europabio.org/21st-bio-joins-europabio-helping-accelerate-the-worlds-quest-for-sustainable-food-and-materials/) - EuropaBio is delighted to announce that 21st.BIO has joined as an Associate SME member. - [Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids](https://www.europabio.org/ajinomoto-europe-joins-europabio-unlocking-the-power-of-amino-acids/) - EuropaBio is pleased to announce that Ajinomoto Europe has joined as a corporate member. - [SwedenBIO joins EuropaBio: helping innovative companies succeed!](https://www.europabio.org/swedenbio-joins-europabio-helping-innovative-companies-succeed/) - EuropaBio is pleased to announce that SwedenBIO has joined as a National Association Council (NAC) member. - [bioMérieux joins EuropaBio: Advancing QC testing for innovative therapies](https://www.europabio.org/biomerieux-joins-europabio-advancing-qc-testing-for-innovative-therapies/) - EuropaBio is pleased to announce that bioMérieux has joined the association as Corporate Member. bioMérieux is a family-owned biotechnology company founded in France. Since 1963, it has been at the forefront of ground-breaking advancements in the field of in vitro diagnostics, making significant contributions to improving public health worldwide. bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. - [Genopole joins EuropaBio: French biotechnology on a global scale](https://www.europabio.org/genopole-joins-europabio-french-biotechnology-on-a-global-scale/) - [What do EuropaBio Members recommend for successful biomanufacturing in Europe?](https://www.europabio.org/what-do-europabio-members-recommend-for-successful-biomanufacturing-in-europe/) - On 27th April, EuropaBio organised a webinar to follow-up on the Biomanufacturing Policy Summit and officially release the policy recommendations resulting from the summit discussions and post-analysis. The outcome was a set of 10 policy recommendations that will be further developed by EuropaBio and shared in due course with policymakers and wider audience. - [EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe](https://www.europabio.org/europabio-and-p-bio-launch-the-national-associations-council-summit-2021-building-on-biotechnology-from-vaccines-to-economic-growth-for-europe/) - EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe - [Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe](https://www.europabio.org/webinar-report-measuring-the-economic-footprint-of-the-biotechnology-industry-in-europe/) - Webinar Report. - [How soon can we respond to COVID-19?](https://www.europabio.org/how-soon-can-we-respond-to-covid-19/) - The development of a vaccine or an antiviral treatment is a long and complex process. So why are we hearing that a vaccine against COVID-19 may be ready in a year from now, or even sooner? - [Novartis is proud to support the EuropaBio 25th Anniversary](https://www.europabio.org/novartis-is-proud-to-support-the-europabio-25th-anniversary/) - EuropaBio is delighted to announce that Novartis has joined EuropaBio’s 25th Anniversary Celebration Programme as a Sponsor. - [EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years](https://www.europabio.org/europabio-members-nominate-europes-biotechnology-landmarks-from-the-last-25-years/) - We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them. - [Big Changes Start Small](https://www.europabio.org/big-changes-start-small/) - [EuropaBio’s Vision for Europe: Innovation, Investment, Excellence](https://www.europabio.org/europabios-vision-for-europe-innovation-investment-excellence/) - [#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee](https://www.europabio.org/efib2023-registration-is-now-open-get-your-ticket-today-and-benefit-from-the-early-bird-fee/) - EuropaBio invites you to register for the 16th edition of the European Forum for Industrial Biotechnology and the Bioeconomy organized together with local partners HollandBIO and ChemistryNL. On 24-25 October, EFIB brings you to cosmopolitan Rotterdam, at De Doelen ICC, a unique meeting place with a breathtaking view of the city center. - [Dr. Sarah Reisinger, dsm-firmenich, appointed as new Chair of EuropaBio](https://www.europabio.org/dr-sarah-reisinger-dsm-firmenich-appointed-as-new-chair-of-europabio/) - Today, EuropaBio’s General Assembly confirmed the appointment of Dr. Sarah Reisinger as the new Chair of the association. Sarah Reisinger is the Chief Science & Research Office at dsm-firmenich. - [Factsheet - The Biotech Journey: From Bench to Patients](https://www.europabio.org/factsheet-the-biotech-journey-from-bench-to-patients/) - Innovations in healthcare biotechnology come from a vast array of stakeholders working with each other over extensive periods of time. In this factsheet we embark on a journey through the intricate ecosystem of healthcare biotechnology and highlight the time, expertise, and resources it takes to get innovative biotechnologies from bench to patient. - [Become a partner of European Biotech Week 2022](https://www.europabio.org/become-a-partner-of-european-biotech-week-2022/) - [A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe](https://www.europabio.org/a-new-european-innovation-agenda-biotechnology-will-help-achieve-a-healthier-more-sustainable-and-autonomous-europe/) - [Considering microorganisms and New Genomic Techniques: on the need for a new GMO legislation in the European Union](https://www.europabio.org/considering-microorganisms-and-new-genomic-techniques-on-the-need-for-a-new-gmo-legislation-in-the-european-union/) - 2022_06_I_O_Considering-microorganisms-and-New-Genomic-TechniquesDownload - [Unlocking the Promise of Gene Therapy](https://www.europabio.org/unlocking-the-promise-of-gene-therapy/) - [Value of Biotech](https://www.europabio.org/value-of-biotech/) - [Factsheet - A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare](https://www.europabio.org/factsheet-long-journey-to-care-or-why-its-time-for-an-ambitious-eu-framework-for-a-cross-border-healthcare/) - Cross-border healthcareDownload - [Factsheet - A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe](https://www.europabio.org/factsheet-a-new-european-innovation-agenda-biotechnology-will-help-achieve-a-healthier-more-sustainable-and-autonomous-europe-2/) - A New European Innovation AgendaDownload - [Recombinant DNA in fermentation products is of no regulatory relevance](https://www.europabio.org/recombinant-dna-in-fermentation-products-is-of-no-regulatory-relevance/) - 2022_07_IB_Article_rDNA-in-fermentation-products-is-of-no-regulatory-relevanceDownload - [Factsheet - European Health Data Space](https://www.europabio.org/factsheet-european-health-data-space/) - European-Health-Data-SpaceDownload - [Factsheet - Increased regulatory efficiency; what we need for the next generation of medicine](https://www.europabio.org/factsheet-increased-regulatory-efficiency-what-we-need-for-the-next-generation-of-medicine/) - Increased regulatory efficiency - what we need for the next generation of medicineDownload - [Factsheet - Sustainable Investment and the EU Bioeconomy](https://www.europabio.org/factsheet-sustainable-investment-and-the-eu-bioeconomy/) - Fact sheet template (52)Download - [Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics](https://www.europabio.org/vision-for-europe-innovation-investment-excellence-thomas-bols-ptc-therapeutics/) - [Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia](https://www.europabio.org/vision-for-europeinnovation-investment-excellence-tineke-van-hooland-bio-be-essenscia/) - [Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer](https://www.europabio.org/vision-for-europeinnovation-investment-excellence-yordan-aleksandrov-pfizer/) - [European Biotech Week 2022 starts today!](https://www.europabio.org/european-biotech-week-2022-starts-today/) - EBW-starts-today-1Download - [Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe](https://www.europabio.org/biotech-smes-are-the-heart-of-europes-healthcare-ecosystem-hear-their-voice-2/) - [Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio](https://www.europabio.org/vision-for-europe-innovation-investment-excellence-claire-skentelbery-europabio/) - [Factsheet - Vision for Europe: Innovation](https://www.europabio.org/factsheet-vision-for-europe-innovation/) - Europabio-Factsheets-Page1_InnovationDownload - [Factsheet - Vision for Europe: Investment](https://www.europabio.org/factsheet-vision-for-europe-investment/) - Europabio-Factsheets-Page2_InvestmentDownload - [Factsheet - Vision for Europe: Excellence](https://www.europabio.org/factsheet-vision-for-europe-excellence/) - Europabio-Factsheets-Page3_ExcellenceDownload - [Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe](https://www.europabio.org/ensuring-the-full-potential-of-ehds/) - 2022_10_H_O_EHDS-Consensus-StatementDownload - [Leave no pathway unexplored](https://www.europabio.org/leave-no-pathway-unexplored/) - [Do your best and do not forget, there will always be a next time!](https://www.europabio.org/do-your-best-and-do-not-forget-there-will-always-be-a-next-time/) - [“Life is like a box of chocolates, you never know what you’ll get”](https://www.europabio.org/life-is-like-a-box-of-chocolates-you-never-know-what-youll-get/) - [The review of the general pharmaceutical legislation: an opportunity that should not be missed?](https://www.europabio.org/the-review-of-the-general-pharmaceutical-legislation-an-opportunity-that-should-not-be-missed/) - Read it online - [EUBA position on the JRC LCA Methodology](https://www.europabio.org/euba-position-on-the-jrc-lca-methodology/) - [EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe's innovation, investment and excellence in biotechnology](https://www.europabio.org/europabio-national-associations-council-summit-2022-modernised-regulation-and-legislation-will-deliver-the-potential-of-european-biotechnology-2/) - [Registration is now open for #EFIB2022: benefit from the early bird fee](https://www.europabio.org/registration-now-open-for-efib2022-benefit-from-the-early-bird-fee/) - [EFIB 2022 Start-up Village: applications are open!](https://www.europabio.org/efib-2022-start-up-village-applications-are-open/) - [EuropaBio Response to the Public Consultation on Blood, tissues and cells for medical treatments & therapies](https://www.europabio.org/europabio-response-to-the-public-consultation-on-blood-tissues-and-cells-for-medical-treatments-therapies/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments](https://www.europabio.org/europabio-patient-bioforum-advancing-patient-access-to-innovative-treatments/) - 2021_05_H_PR_Patient-BioForum-18-MayDownload - [European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation](https://www.europabio.org/european-biotech-week-2021-europabio-invites-national-biotech-communities-to-celebrate-science-and-innovation/) - Press-release_Biotech-weekDownload - [EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare](https://www.europabio.org/europabios-response-to-the-ec-consultation-on-patients-rights-in-cross-border-healthcare/) - [EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised](https://www.europabio.org/europabio-response-to-the-european-commission-public-consultation-on-the-regulation-for-orphan-medicinal-products-and-paediatrics-the-value-brought-by-the-technology-to-patients-and-society-should-be/) - [EuropaBio response to the Public Consultation 'Digital Health Data and Services – The European Health Data Space'](https://www.europabio.org/europabio-response-to-the-public-consultation-digital-health-data-and-services-the-european-health-data-space/) - [EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics](https://www.europabio.org/europabio-response-to-the-european-commission-public-consultation-on-the-regulations-for-orphan-medicinal-products-and-paediatrics/) - EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations. - [EuropaBio comments on the public consultation on blue bioeconomy](https://www.europabio.org/europabio-comments-on-the-public-consultation-on-blue-bioeconomy/) - EuropaBio comments on the public consultation on blue bioeconomy. - [EuropaBio response to the Public consultation on European bioeconomy policy: stocktaking and future developments](https://www.europabio.org/public-consultation-on-european-bioeconomy-policy-stocktaking-and-future-developments/) - EuropaBio comments on the public consultation on blue bioeconomy. - [EuropaBio response to the public consultation on the roadmap on Sustainable Food Systems](https://www.europabio.org/europabio-response-to-the-public-consultation-on-the-roadmap-on-sustainable-food-systems/) - [Registration is open to the main events of the 10th edition of the European Biotech Week](https://www.europabio.org/registration-is-open-to-the-main-events-of-the-10th-edition-of-the-european-biotech-week/) - 2022_09_G_PR_EBW2022_Launch-of-EuropaBio-Events-Press-Release-1Download - [European Biotech Week 2022: Bringing Biotech to Local Communities](https://www.europabio.org/european-biotech-week-2022-bringing-biotech-to-local-communities/) - 2022_10_G_PR_European-Biotech-Week-2022_ReportDownload - [Europe’s potential in advanced Biomanufacturing at the centre of EFIB 2022 discussions](https://www.europabio.org/europes-potential-in-advanced-biomanufacturing-at-the-centre-of-efib-2022-discussions/) - EFIB-2022-after-event_PR_finalDownload - [The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?](https://www.europabio.org/the-revision-of-the-orphan-medicines-regulation-is-an-opportunity-will-europe-seize-it/) - [Policy Proposal for New Genomic Techniques - Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides](https://www.europabio.org/policy-proposal-for-new-genomic-techniques-joint-letter-to-the-eu-vice-president-frans-timmermans-and-the-eu-commissioner-stella-kyriakides/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products](https://www.europabio.org/revision-of-the-detergents-regulation-europabio-policy-asks-for-microbial-based-cleaning-products/) - The European Commission’s proposal for plants produced by certain new genomic techniques (NGT legislation) is a sign of its commitment to timely and relevant policymaking to ensure food security and tackle environmental challenges such as climate change and biodiversity loss. - [For The Love of Science](https://www.europabio.org/for-the-love-of-science/) - On the occasion of the International Day of Women and Girls in Science - [EuropaBio sat down with new member ProductLife, to find out about their long-term goals Interview with... Xavier Duburcq, CEO at ProductLife Group](https://www.europabio.org/europabio-sat-down-with-new-member-productlife-2/) - EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform. - [Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA](https://www.europabio.org/interview-with-ingmar-hoerr-curevac-founder-and-holder-of-the-first-patents-associated-with-mrna/) - EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform. - [Interview with Claire Skentelbery, Director General, EuropaBio on the 15th Edition of the European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)](https://www.europabio.org/interview-with-claire-skentelbery-director-general-europabio-on-the-15th-edition-of-the-european-forum-for-industrial-biotechnology-and-the-bioeconomy-efib/) - [EuropaBio Statement on the Russian Invasion of Ukraine](https://www.europabio.org/europabio-statement-on-the-russian-invasion-of-ukraine/) - [EuropaBio response to the Call for Evidence on Soil health – protecting, sustainably managing and restoring EU soils](https://www.europabio.org/europabio-response-to-the-public-consultation-on-the-roadmap-on-sustainable-food-systems-2/) - [EuropaBio published policy recommendations for the healthcare and industrial biotechnology sectors](https://www.europabio.org/europabio-publishes-policy-recommendations-for-healthcare-and-industrial-biotechnology/) - [Opinion: A long journey to care, or why it's time for an ambitious EU framework for a cross-border healthcare](https://www.europabio.org/a-long-journey-to-care-or-why-its-time-for-an-ambitious-euframework-for-a-cross-border-healthcare/) - [EuropaBio SME BioForum: a new voice for the biotechnology SME community in Europe](https://www.europabio.org/europabio-sme-bioforum-a-new-voice-for-the-biotechnology-sme-community-in-europe/) - [Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio](https://www.europabio.org/jamie-wilkinson-new-healthcare-biotechnology-director-at-europabio/) - 2022_05_HC_PR_New-HC-Director-1Download - [EuropaBio participates at the BIO International Convention 2022 in San Diego](https://www.europabio.org/europabio-participates-at-the-bio-international-convention-2022-in-san-diego/) - 2022_06_G_PR_EuropaBio-at-BIO-2022Download - [EuropaBio’s Claire Skentelbery elected as new Vice-chair of ICBA](https://www.europabio.org/europabios-claire-skentelbery-elected-as-new-vice-chair-of-icba/) - [DSM’s Patricia Malarkey appointed as new Chair of EuropaBio](https://www.europabio.org/dsms-patricia-malarkey-appointed-as-new-chair-of-europabio/) - [EuropaBio Statement on the publication of the New European Innovation Agenda](https://www.europabio.org/europabio-statement-on-the-publication-of-the-new-european-innovation-agenda/) - [EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)](https://www.europabio.org/europabio-statement-on-the-proposal-for-a-regulation-on-substances-of-human-origin-soho/) - 2022_07_HC_O_EuropaBio-Statement-BTCDownload - [EuropaBio position on the European Health Data Space proposal](https://www.europabio.org/europabio-position-on-the-european-health-data-space-proposal/) - 2022_06_H_O_European-Health-Data-Space-FactsheetDownload 2022_07_H_PP_EuropaBio-position-on-the-European-Health-Data-Space-proposalDownload - [EuropaBio response to the public consultation on the proposal for a Regulation on substances of human origin (SoHO)](https://www.europabio.org/europabio-response-to-the-public-consultation-on-the-proposal-for-a-regulation-on-substances-of-human-origin-soho/) - EuropaBio response public consultation SoHODownload - [EuropaBio celebrates its inaugural Healthcare BioForum](https://www.europabio.org/europabio-celebrates-its-inaugural-healthcare-bioforum/) - 2022_10_H_PR_EuropaBio-Healthcare-BioForumDownload - [A new initiative for building a more competitive Europe: EuropaBio announces Biomanufacturing Platform](https://www.europabio.org/a-new-initiative-for-building-a-more-competitive-europeeuropabio-announces-biomanufacturing-platform/) - Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms - [Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022](https://www.europabio.org/europabio-healthcare-bioforum-october-2022/) - EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology. - [Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework](https://www.europabio.org/enabling-patient-access-to-transformational-therapeutic-innovations-modernising-the-eus-cross-border-healthcare-framework/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [EuropaBio presents EFIB Vilnius Statement to European policymakers](https://www.europabio.org/europabio-presents-efib-vilnius-statement-to-european-policymakers/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach](https://www.europabio.org/europabios-2022-patient-bioforum-addresses-the-challenges-of-patients-with-unmet-medical-needs-and-calls-for-multi-stakeholder-approach/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases](https://www.europabio.org/rare-disease-moonshot-scaling-up-public-private-partnerships-to-accelerate-research-into-worlds-rarest-diseases/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor](https://www.europabio.org/europabio-principles-for-genetic-testing-and-testing-for-genetically-driven-risk-factor/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform](https://www.europabio.org/europabio-launches-industry-advisory-group-for-new-biomanufacturing-platform/) - [EuropaBio launches SME BioForum in Rare Diseases](https://www.europabio.org/europabio-launches-sme-bioforum-in-rare-diseases/) - [EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach](https://www.europabio.org/europabios-2022-patient-bioforum-sets-out-recommendations-to-address-the-challenges-of-patients-with-unmet-medical-needs-and-calls-for-multi-stakeholder-approach/) - [Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio](https://www.europabio.org/vlad-olteanu-new-healthcare-public-affairs-director-at-europabio/) - [Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future](https://www.europabio.org/vision-clarity-and-enabling-the-drivers-for-europes-biomanufacturing-future/) - EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member. - [Unlocking the Potential of Biotechnology Innovation for Patients](https://www.europabio.org/unlocking-the-potential-of-biotechnology-innovation-for-patients/) - Advanced therapies have ground-breaking therapeutic potential for patients, including in currently underserved areas, bringing the possibility of a cure to life-threatening conditions with a one-off treatment. - [A global Europe - the role of transformative legislation: EuropaBio National Associations Council Summit 2023 (Spanish Presidency)](https://www.europabio.org/a-global-europe-the-role-of-transformative-legislation-europabio-national-associations-council-summit-2023-spanish-presidency/) - EuropaBio and its member AseBio, the Spanish Association of Biotechnology Companies, are delighted to invite you to the third National Associations Council (NAC) annual Presidency Summit. - [EuropaBio welcomes the publication of the revision of the EU Pharmaceutical Legislation](https://www.europabio.org/europabio-welcomes-the-publication-of-the-revision-of-the-eu-pharmaceutical-legislation/) - A supportive and future-proof EU Pharmaceutical Legislation is critical to ensure that Europe can fully benefit from healthcare biotechnology innovations for patients, society, and economic development. - [Celebrating bioeconomy and biotechnology on DNA Day and Earth Day](https://www.europabio.org/celebrating-bioeconomy-and-biotechnology-on-dna-day-and-earth-day/) - DNA Day is celebrated on 25 April and this year marked 70 years since the publication of the structure of the DNA molecule in 1953 by James Watson, Francis Crick and Rosalind Franklin in 1953 . - [EuropaBio response to the public consultation on EU Taxonomy Environmental Delegated Act](https://www.europabio.org/europabio-response-to-the-public-consultation-on-eu-taxonomy-environmental-delegated-act/) - EuropaBio supports the Commission’s intent in developing sustainable financing as part of the Green Deal and welcomes the opportunity to provide feedback on the draft Taxonomy Delegated Act for environmental objectives. - [Dr Anne-Gaëlle Collot new Industrial Biotechnology Director at EuropaBio](https://www.europabio.org/dr-anne-gaelle-new-industrial-biotechnology-director-at-europabio/) - EuropaBio is pleased to announce that Dr Anne-Gaëlle Collot joins EuropaBio’s Industrial Biotechnology team as Industrial Biotechnology Director. - [EuropaBio Biomanufacturing Definition 101: What is biomanufacturing and how does it play a role in our lives?](https://www.europabio.org/europabio-biomanufacturing-definition-101-what-is-biomanufacturing-and-how-does-it-play-a-role-in-our-lives/) - Biomanufacturing is the use of biological mechanisms to i) synthesize products ii) act as tools or iii) undertake processes, at a scale required for commercial use. - [Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski](https://www.europabio.org/policy-proposal-for-new-genomic-techniques-joint-letter-to-eu-vice-president-frans-timmermans-and-eu-commissioners-stella-kyriakidesand-janusz-wojciechowski/) - EuropaBio, together with 20 agri-food value chain associations, co-signed a joint letter to the European Commission, reiterating their support of the Commission’s plans for a legislative proposal on plants obtained by New Genomic Techniques (NGTs) and call for an enabling and proportionate regulatory framework. - [<a href="https://www.europabio.org/europabio-response-to-public-consultation-on-the-evaluation-of-patient-rights-in-cross-border-healthcare/">EuropaBio Response to Public Consultation on </a>Horizon Europe – interim evaluation](https://www.europabio.org/europabio-response-to-public-consultation-on-horizon-europe-interim-evaluation/) - EuropaBio provided input to the European Commission’s interim evaluation of Horizon Europe. The EU should continue to develop the various pillars of Horizon Europe to make full use of its scientific and industrial excellence and to help foster a stronger and more resilient research and innovation ecosystem for biotechnology across Europe. - [Helping Europe Deliver for Rare Disease Patients](https://www.europabio.org/helping-europe-deliver-for-rare-disease-patients/) - [EUBA position on the European Commission's Proposal for a Revised Packaging and Packaging Waste Regulation](https://www.europabio.org/euba-position-on-the-european-commissions-proposal-for-a-revised-packaging-and-packaging-waste-regulation/) - The European Bioeconomy Alliance (EUBA)*, representing 14 leading European organisations from various sectors active in the bioeconomy, supports the intentions of the Commission’s proposal for a revised Regulation on Packaging and Packaging Waste (PPWR)1 to make all packaging reusable and recyclable by 2030. EUBA considers the move towards a circular economy essential and calls for a stronger support of the bioeconomy sector in the Commission’s legislative proposal to deliver on the sustainability and climate goals set out in the EU Green Deal. - [EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023](https://www.europabio.org/europabio-biomanufacturing-and-pharma-legislation-in-the-spotlight-at-the-bio-international-convention-2023/) - Brussels, May 2023 – EuropaBio flies the flag for European biotechnology at the highly anticipated BIO International Convention 2023, scheduled to take place in Boston, MA on 5-8 June and one of the largest biotech industry events worldwide with 100+ interactive sessions across 4 days covering all aspects of business, policy, trade and science. - [Biomanufacturing is vital to Europe’s future – EuropaBio’s Biomanufacturing Platform calls for ambition and action](https://www.europabio.org/biomanufacturing-is-vital-to-europes-future-europabios-biomanufacturing-platform-calls-for-ambition-and-action/) - EuropaBio sets in stone the first European recommendations on biomanufacturing with the publication of its Biomanufacturing Policy Summit 2023 report. - [The NGT proposal is an important step towards Europe’s bioeconomy-driven strategic autonomy, competitiveness and sustainability ambitions](https://www.europabio.org/the-ngt-proposal-is-an-important-step-towards-europes-bioeconomy-driven-strategic-autonomy-competitiveness-and-sustainability-ambitions/) - “EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms” - [Reform of the EU General Pharmaceutical Legislation Joint Position Paper on the Hospital Exemption Scheme for ATMPs](https://www.europabio.org/reform-of-the-eu-general-pharmaceutical-legislation-joint-position-paper-on-the-hospital-exemption-scheme-for-atmps/) - In the context of the revision of the EU General Pharmaceutical Legislation, this paper puts forward joint recommendations from ARM (Alliance for Regenerative Medicine), EFPIA (European Federation of Pharmaceutical Industries and Associations), EuropaBio, EUCOPE (European Confederation of Pharmaceutical Entrepreneurs) and ISCT (International Society for Cell & Gene Therapy), for the reform of the Hospital Exemption (HE) scheme for Advanced Therapy Medicinal Products (ATMPs). - [EuropaBio position paper for the proposal on establishing a framework of measures for strengthening Europe’s net-zero technology products manufacturing ecosystem (Net-Zero Industry Act)](https://www.europabio.org/europabio-position-paper-for-the-proposal-on-establishing-a-framework-of-measures-for-strengthening-europes-net-zero-technology-products-manufacturing-ecosystem-net-zero-industry-act/) - “EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms” - [EuropaBio position on the proposal for a Regulation on compulsory licensing for crisis management](https://www.europabio.org/europabio-position-on-the-proposal-for-a-regulation-on-compulsory-licensing-for-crisis-management/) - On 28 July 2023, EuropaBio published its position on the proposal for a Regulation on compulsory licensing for crisis management as part of its ongoing work to protect biotech innovation in Europe. - [European Biotech Week: Showcasing the Transformative Power of Biotechnology](https://www.europabio.org/european-biotech-week-showcasing-the-transformative-power-of-biotechnology/) - EuropaBio and Members are proud to launch the 11th edition of European Biotech Week (#EBW2023), which will take place across Europe from 25 September to 1 October 2023. - [SwiftPharma launches ‘Changing the global paradigm for biomanufacturing in plants’ October 23, Rotterdam](https://www.europabio.org/swiftpharma-launches-changing-the-global-paradigm-for-biomanufacturing-in-plants-october-23-rotterdam/) - [European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework](https://www.europabio.org/european-commission-proposal-on-new-genomic-techniques-a-first-step-towards-modernizing-the-eu-gmo-framework/) - The European Commission’s proposal for plants produced by certain new genomic techniques (NGT legislation) is a sign of its commitment to timely and relevant policymaking to ensure food security and tackle environmental challenges such as climate change and biodiversity loss. - [EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive](https://www.europabio.org/europabio-statement-on-the-evaluation-of-the-cross-border-healthcare-directive/) - 2022_05_H_S_CBHDDownload - [EuropaBio Response to the publication of the Bioeconomy Strategy Progress Report](https://www.europabio.org/europabio-response-to-the-publication-of-the-bioeconomy-strategy-progress-report/) - 2022_06_I_PR_EuropaBio-Response-to-Bioeconomy-Strategy-Progress-ReportDownload - [Towards an accurate accounting for carbon from biomass in the Product Environmental Footprint (PEF)](https://www.europabio.org/towards-an-accurate-accounting-for-carbon-from-biomass-in-the-product-environmental-footprint-pef/) - [Advanced therapy medicinal products: SMEs call for a better investment environment in Europe](https://www.europabio.org/advanced-therapy-medicinal-products-smes-call-for-a-better-investment-environment-in-europe/) - [The Essential Role of Enzymes | The unintended impact of the REACH revision on Enzymes – and consequences for EU Green Deal Objectives](https://www.europabio.org/the-essential-role-of-enzymes/) - 2022_09_I_PP_AMFEP-EuropaBio-paper-on-the-essentiality-of-food-feed-and-technical-enzymesDownload 2022_09_I_PP_AMFEP-EuropaBio-position-paper-the-unintended-consequences-of-the-REACH-revision-for-enzymesDownload - [Biotech SMEs are the heart of Europe's healthcare ecosystem - hear their voice.](https://www.europabio.org/biotech-smes-are-the-heart-of-europes-healthcare-ecosystem-hear-their-voice/) - [#EFIB2022: Industrial biotechnology community comes together in Vilnius next week](https://www.europabio.org/efib2022-industrial-efibiotechnology-community-comes-together-in-vilnius-next-week/) - [Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms](https://www.europabio.org/call-for-more-effective-eu-regulation-of-clinical-trials-with-advanced-therapy-medicinal-products-consisting-of-or-containing-genetically-modified-organisms/) - Call for more effective EU regulation of clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms - [EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation](https://www.europabio.org/europabio-comments-on-the-draft-delegated-act-on-climate-related-objectives-under-the-taxonomy-regulation/) - EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation. - [Joint Statement: Comitology Reform Threatens Innovation](https://www.europabio.org/joint-statement-comitology-reform-threatens-innovation/) - 2020_12_G_PP_Comitology Joint StatementDownload - [Revision of the EU legislation on medicines for children and rare diseases](https://www.europabio.org/revision-of-the-eu-legislation-on-medicines-for-children-and-rare-diseases/) - Read our submission to the European Commission’s Inception Impact Assessment titled “Revision of the EU legislation on medicines for children and rare diseases“. - [European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation](https://www.europabio.org/european-biotech-associations-letter-to-the-european-commission-regarding-the-ongoing-evaluation-of-the-orphan-medicinal-products-regulation/) - Read the European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation. - [Building a European Health Union](https://www.europabio.org/building-a-european-health-union/) - EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity. - [EuropaBio draft response to the IIA on European Health Data Space](https://www.europabio.org/europabio-draft-response-to-the-iia-on-european-health-data-space/) - EuropaBio welcomes the European Commission’s plan to begin a discussion with stakeholders to develop the EHDS. - [EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare](https://www.europabio.org/europabio-response-to-public-consultation-on-the-evaluation-of-patient-rights-in-cross-border-healthcare/) - EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases. - [European Health Emergency Preparedness and Response Authority (HERA) Consultation - EuropaBio's Feedback](https://www.europabio.org/european-health-emergency-preparedness-and-response-authority-hera-consultation-europabios-feedback/) - On February 24th, EuropaBio submitted its feedback to the HERA Consultation. - [Catalent joins the EuropaBio 25th Anniversary in 2021](https://www.europabio.org/catalent-joins-the-europabio-25th-anniversary-in-2021/) - EuropaBio is delighted to announce that Catalent has joined EuropaBio’s 25th Anniversary Celebration Programme as a major sponsor. - [EuropaBio Statement – Vaccine production scale up: International collaboration remains the key](https://www.europabio.org/europabio-statement-vaccine-production-scale-up-international-collaboration-remains-the-key/) - EuropaBio Statement – Vaccine production scale up: International collaboration remains the key. - [EuropaBio response to the EGE report ‘Ethics of Genome Editing’](https://www.europabio.org/europabio-response-to-the-ege-report-ethics-of-genome-editing/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [Inscripta joins EuropaBio: delivering global biotechnology advances](https://www.europabio.org/inscripta-joins-europabio-delivering-global-biotechnology-advances/) - EuropaBio is delighted to announce that Inscripta has joined EuropaBio as an associate member. - [Interview with... Dr. Jim Lalonde, Head of Microbial Business Area at INSCRIPTA](https://www.europabio.org/interview-with-inscripta/) - EuropaBio sat down with new Member Inscripta, to find out what gets them fired up with their ground breaking ‘benchtop biofoundry’ Onyx™. - [UNION Therapeutics joins EuropaBio: building a pipeline for inflammation and infectious diseases](https://www.europabio.org/union-therapeutics-joins-europabio-building-a-pipeline-for-inflammation-and-infectious-diseases/) - EuropaBio is delighted to announce that UNION Therapeutics has joined the association as a corporate member. - [Interview with... Dr. Kim Domela Kjøller, CEO at UNION Therapeutics](https://www.europabio.org/interview-with-dr-kim-domela-kjoller-ceo-at-union-therapeutics/) - EuropaBio sat down with new Member UNION Therapeutics, to find out about its novel anti-infective programme and how it can support Covid treatment in vulnerable patients. - [Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU](https://www.europabio.org/online-roundtable-report-an-eu-vision-for-life-science-and-biotechnology-for-a-healthy-and-sustainable-eu/) - Webinar Report. - [EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities](https://www.europabio.org/europabio-invited-industrial-biotech-smes-to-learn-about-eu-policy-priorities/) - Webinar Report. - [EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU](https://www.europabio.org/europabio-proposes-how-to-increase-competitiveness-of-biotechnology-sector-in-the-eu/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [Interview with... Agne Vaitkeviciene, Executive Director of LBTA](https://www.europabio.org/interview-with-agne-vaitkeviciene/) - EuropaBio sat down with new National Association Member from Lithuania. - [EuropaBio on NGT study: A positive step towards delivering innovation](https://www.europabio.org/europabio-proposes-how-to-increase-competitiveness-of-biotechnology-sector-in-the-eu-2/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [EuropaBio launches a new Biopharmaceutical Strategy Group](https://www.europabio.org/https-www-europabio-org-wp-content-uploads-2021-05-biopharmaceutical-group_news-release/) - Biopharmaceutical-group_news-releaseDownload - [EuropaBio celebrated its inaugural National Associations Council Summit: Collaborations and trust are vital to build a responsive and competetive biotech sector in Europe](https://www.europabio.org/europabio-celebrated-its-inaugural-national-associations-council-summit-collaborations-and-trust-are-vital-to-build-a-responsive-and-competetive-biotech-sector-in-europe/) - IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency. - [Meatable joins EuropaBio: together towards a more sustainable food industry](https://www.europabio.org/meatable-joins-europabio-together-towards-a-more-sustainable-food-industry/) - EuropaBio is pleased to announce that Meatable has joined the organization as an associate member. - [IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge](https://www.europabio.org/ip-waiver-for-covid-19-vaccines-is-a-misguided-and-ineffective-response-to-a-shared-global-challenge/) - 2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines - EuropaBio's Position - [EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies](https://www.europabio.org/eu-industrial-strategy-2020-europabio-welcomes-increased-focus-on-competitiveness-and-resilience-driven-by-innovation-and-advanced-technologies/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [EuropaBio comments on the designation of official laboratories for animal and plant health and safe food and feedstuffs](https://www.europabio.org/europabio-comments-on-the-designation-of-official-laboratories-for-animal-and-plant-health-and-safe-food-and-feedstuffs/) - EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation. - [EuropaBio comments on the new EU soil strategy](https://www.europabio.org/europabio-comments-on-the-new-eu-soil-strategy/) - EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation. - [EUBA Statement on Revised draft Delegated Act on climate-related objectives](https://www.europabio.org/euba-statement-on-revised-draft-delegated-act-on-climate-related-objectives/) - EuropaBio Statement – Vaccine production scale up: International collaboration remains the key. - [Lallemand joins EuropaBio: new global opportunities for industrial biotechnology](https://www.europabio.org/lallemand-joins-europabio-new-global-opportunities-for-industrial-biotechnology/) - EuropaBio is pleased to announce that Lallemand has joined the organization as a corporate member. - [Interview with Bill Nankervis, Executive Vice President and Chief Operating Officer, Lallemand Group of Companies](https://www.europabio.org/interview-with-bill-nankervis-executive-vice-president-and-chief-operating-officer-lallemand-group-of-companies/) - EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology. - [Advanced Therapies bring tranformational value to European patients](https://www.europabio.org/advanced-therapies-bring-tranformational-value-to-european-patients/) - ATMPs_news-release_finalDownload - [Decentralised clinical trials, the future of clinical research](https://www.europabio.org/decentralised-clinical-trials/) - The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials. - [Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation](https://www.europabio.org/eu-industrial-strategy-2020-europabio-welcomes-increased-focus-on-competitiveness-and-resilience-driven-by-innovation-and-advanced-technologies-2/) - EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet. - [Enabling NGT products to contribute to sustainability: The role of Industrial Biotechnology](https://www.europabio.org/enabling-ngt-products-to-contribute-to-sustainability-the-role-of-industrial-biotechnology/) - [EuropaBio meets EMA to exchange views on topics of common interest](https://www.europabio.org/europabio-meets-ema-to-exchange-views-on-topics-of-common-interest/) - 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5 - [Jobs & Growth Generated by Industrial Biotechnology in Europe](https://www.europabio.org/jobs-growth-generated-by-industrial-biotechnology-in-europe/) - The economic impact of the biotech sector today and beyond. - [Bioeconomy Factsheets](https://www.europabio.org/bioeconomy-factsheets/) - [Industrial biotechnology - Contributing towards achieving the UN global Sustainable Development Goals](https://www.europabio.org/industrial-biotechnology-contributing-towards-achieving-the-un-global-sustainable-development-goals/) - The economic impact of the biotech sector today and beyond. - [Statement: As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products](https://www.europabio.org/statement-as-eu-court-ruling-risks-blocking-innovation-the-european-biotech-industry-calls-for-science-based-political-decision-making-on-genome-edited-products/) - As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products. - [Case Studies demonstrating Industrial Biotech contribution to UN SDGs](https://www.europabio.org/case-studies-demonstrating-industrial-biotech-contribution-to-un-sdgs/) - As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy. - [Advanced Medicinal Therapies - Step Up The Healthcare Revolution Now](https://www.europabio.org/advanced-medicinal-therapies-step-up-the-healthcare-revolution-now/) - Read about the outcomes of our working policy breakfast in the European Parliament, hosted by MEPs Claudia Gamon and Tomislav Sokol, in cooperation with ARM, the Alliance for Regenerative Medicine. - [EuropaBio Advanced Therapy](https://www.europabio.org/europabio-advanced-therapy/) - EuropaBio invites EU decision-makers to engage with us and our healthcare biotech members who are leading the field in advanced therapies. - [Open Letter to Member States on the EU Court Ruling on Mutagenesis](https://www.europabio.org/open-letter-to-member-states-on-the-eu-court-ruling-on-mutagenesis/) - Open Letter to Member States on the EU Court Ruling on Mutagenesis. - [EuropaBio Healthcare Manifesto](https://www.europabio.org/europabio-healthcare-manifesto/) - EuropaBio Healthcare Manifesto. - [Joint Statement for an Ambitious Horizon Europe Programme](https://www.europabio.org/joint-statement-for-an-ambitious-horizon-europe-programme/) - Joint statement of 93 associations representing key European research & innovation stakeholders calling for ambitious Horizon Europe programme. - [Industrial Biotechnology – Enabling a Circular Bioeconomy in Europe](https://www.europabio.org/industrial-biotechnology-enabling-a-circular-bioeconomy-in-europe/) - Read our call to action to the European decision makers to enable a circular bioeconomy in Europe. - [What if we could prevent childhood blindness](https://www.europabio.org/what-if-we-could-prevent-childhood-blindness/) - Genome editing dysfunctional cells in the eye could be a cure for one type of childhood blindness. - [What if we could transform wood into food preservatives?](https://www.europabio.org/what-if-we-could-transform-wood-into-food-preservatives/) - Converting plant biomass into high-value chemicals with the help of improved microorganisms. - [What if we could find new tools in the fight against cancer](https://www.europabio.org/what-if-we-could-find-new-tools-in-the-fight-against-cancer/) - There are many types of cancer and many causes that lead to cancer, making the science of finding anti cancer drugs a challenge. - [What if we could heal sick blood cells](https://www.europabio.org/what-if-we-could-heal-sick-blood-cells/) - When “adult” blood causes illnesses, rejuvenating blood cells might be a remedy - [Create ‘living drugs’ that treat cancer](https://www.europabio.org/create-living-drugs-that-treat-cancer/) - Treatment for certain cancers has taken a huge leap forward thanks to new “living drugs”, created through biotechnology. - [What if we used algae to make biofuel?](https://www.europabio.org/what-if-we-used-algae-to-make-biofuel/) - Adjusting a specific algae gene with genome editing, enabling the algae to be a feedstock for biofuels. - [EuropaBio comments on the Circular Economy Action Plan](https://www.europabio.org/europabio-comments-on-the-circular-economy-action-plan/) - EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy. - [Reduce the depletion of small fish in our oceans](https://www.europabio.org/reduce-the-depletion-of-small-fish-in-our-oceans/) - Our ocean’s resources are limited, and the world’s growing population cannot continue to take fish from the seas indefinitely. - [Create immunotherapy treatments for cancer](https://www.europabio.org/create-immunotherapy-treatments-for-cancer/) - Immunotherapy has a long history of use against cancer: in the 1890’s bacteria was injected into a tumour in an attempt to encourage a response by the immune system against the cancer. - [What if we could definitively cure AIDS](https://www.europabio.org/what-if-we-could-definitively-cure-aids/) - A combination of antiviral therapy and genome editing has succeeded in removing the HIV virus from infected mice. - [A Vision for a EU Life Science and Biotechnology Strategy](https://www.europabio.org/a-vision-for-a-eu-life-science-and-biotechnology-strategy/) - In January 2020, EuropaBio finalised a vision document with key recommendations for stimulating a successful life sciences and biotechnology ecosystem in the EU. - [What if we used biology instead of chemistry for manufacturing?](https://www.europabio.org/what-if-we-used-biology-instead-of-chemistry-for-manufacturing/) - Converting plant biomass into high-value chemicals with the help of improved microorganisms. - [Let's Beat Cancer with Innovation!](https://www.europabio.org/lets-beat-cancer-with-innovation/) - Biotechnology in the fight against cancer - read our newest blog post. - [European Bioeconomy Alliance (EUBA) comments on the European Climate Law Roadmap](https://www.europabio.org/european-bioeconomy-alliance-euba-comments-on-the-european-climate-law-roadmap/) - EuropaBio welcomes the foreseen new Circular Economy Action Plan and the plan to publish it with the Industrial Strategy. - [Strike Rare Diseases at the Root!](https://www.europabio.org/strike-rare-diseases-at-the-root/) - Read our newest blog on the occasion of Rare Disease Day on the 29th of February. - [Biotechnology spearheads the fight against COVID-19](https://www.europabio.org/biotechnology-spearheads-the-fight-against-covid-19/) - Learn how biotechnology can contribute towards fighting COVID-19 in our latest blog post. - [World Haemophilia Week - Interview with Philip Wood (Sobi)](https://www.europabio.org/world-haemophilia-week-interview-with-philip-wood-sobi/) - During World Haemophilia Week, we caught up with Sobi's Head of Haematology, Philip Wood. - [World Haemophilia Day - A Message from Paul Perrault (CSL Behring)](https://www.europabio.org/world-haemophilia-day-a-message-from-paul-perrault-csl-behring/) - On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring. - [World Haemophilia Day - Interview with Dr. Ian Winburn (Pfizer)](https://www.europabio.org/world-haemophilia-day-interview-with-dr-ian-winburn-pfizer/) - On the occasion of World Haemophilia Day we had the pleasure to interview Dr. Ian Winburn, Global Medical Lead within Pfizer’s Rare Disease Business Unit. - [Primary Immunodeficiencies Week - Interview Johan Prevot (IPOPI)](https://www.europabio.org/primary-immunodeficiencies-week-interview-johan-prevot-ipopi/) - On the occasion of World PI Week we interviewed Johan Prevot, Executive Director of the International Patient Organisation for Primary Immunodeficiencies (IPOPI). - [World Haemophilia Day - Interview with Amanda Bok (EHC)](https://www.europabio.org/world-haemophilia-day-interview-with-amanda-bok-ehc/) - The 30th anniversary of World Haemophilia Day helps to illustrate the importance to support the bleeding disorders community. Read our interview with Amanda Bok, CEO of the European Haemophilia Consortium (EHC) & Co-Chair of EuropaBio's Patients BioForum. - [Clinical Trials and Coronavirus](https://www.europabio.org/clinical-trials-and-coronavirus/) - Check out the latest news on coronavirus clinical trials. - [CRISPR and Coronavirus](https://www.europabio.org/crispr-and-coronavirus/) - A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19. - [EuropaBio reply letter to European Patients' Forum's call on COVID-19](https://www.europabio.org/europabio-reply-letter-to-european-patients-forums-call-on-covid-19/) - EuropaBio reply letter to EPF's call on COVID-19. - [EuropaBio position on Germline Genome Editing](https://www.europabio.org/europabio-position-on-germline-genome-editing-2/) - EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet. In medicine, genome editing offers the prospect of saving lives and tackling some of the most devastating genetic diseases. - [The impact of COVID-19 on patients with chronic or life-threatening conditions](https://www.europabio.org/clinical-trials-and-coronavirus-2/) - Read our latest blog on the impact of the pandemic on patients with chronic diseases and rare conditions around the globe. - [Joint statement on the EU Climate Law](https://www.europabio.org/joint-statement-on-the-eu-climate-law/) - Read our joint statement on the ambitious EU Climate Law. - [EU-UK Future Relations – Joint Letter Life Sciences Coalition](https://www.europabio.org/eu-uk-future-relations-joint-letter-life-sciences-coalition/) - The pharmaceutical and biotechnology industries are doing everything in their power to prepare for all scenarios and need the support of the European Union to ensure that we can fulfil our promise to the patients who we serve. - [Joint response of EuropaBio and BIO on the EU Data Strategy Consultation](https://www.europabio.org/europabio-response-to-the-work-programme-of-the-ehealth-stakeholder-group/) - Joint response of EuropaBio and BIO on the EU Data Strategy Consultation. - [Genome-Edited Products and Projects: Resources and Examples](https://www.europabio.org/genome-edited-products-and-projects-resources-and-examples/) - This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech - [Novartis’s Andrew Topen appointed as new Chairman of EuropaBio](https://www.europabio.org/novartiss-andrew-topen-appointed-as-new-chairman-of-europabio/) - Novartis’s Andrew Topen appointed as new Chairman of EuropaBio. - [Genome editing FAQ](https://www.europabio.org/genome-editing-faq/) - Genome editing is an advance in biological tools with the potential for a wide range of applications. - [Application of the ATMP Hospital Exemption in the EU](https://www.europabio.org/application-of-the-atmp-hospital-exemption-in-the-eu/) - EuropaBio and its members would like to engage the European Commission and all relevant stakeholders in a discussion on the future use of the HE in the context of the new EU Pharmaceutical Strategy and its accompanying actions. - [EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making](https://www.europabio.org/europabio-on-use-of-real-world-data-rwd-and-real-world-evidence-rwe-for-regulatory-decision-making/) - EuropaBio Position Paper on the use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making. - [EuropaBio Key Messages to 94th Pharmaceutical Committee - 28 May 2021](https://www.europabio.org/europabio-key-messages-to-94th-pharmaceutical-committee/) - [Joint Statement: The Data Act is a leap into the unknown](https://www.europabio.org/joint-statement-the-data-act-is-a-leap-into-the-unknown/) - 2020_12_G_PP_Comitology Joint StatementDownload - [How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference](https://www.europabio.org/how-do-we-live-in-a-bioeconomy-europabio-at-the-swedish-eu-council-presidency-conference/) - EuropaBio Industrial Biotechnology Director Agnes Borg took part in the Swedish EU Council Bioeconomy conference. She presented on the importance of food as a key part of the bioeconomy - [Can the Pharmaceutical Strategy Deliver for Europe?](https://www.europabio.org/can-the-pharmaceutical-strategy-deliver-for-europe/) - [Europe's Rare Disease SMEs raise their voice for success](https://www.europabio.org/europes-rare-disease-smes-raise-their-voice-for-success/) - On February 28th 2023, Rare Disease Day, EuropaBio's Small and Medium-sized Enterprises (SME) Platform hosted a session on rare diseases and invited European SMEs... - [Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines](https://www.europabio.org/pragmatic-ip-solutions-and-strong-collaborations-will-ensure-faster-global-access-to-vaccines/) - [EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities](https://www.europabio.org/europabio-invited-healthcare-biotech-smes-to-learn-about-eu-policy-priorities/) - [Interview with Cyrille Pauthenier, CEO of Abolis Biotechnologies - The Bio-Synthesis Architects](https://www.europabio.org/interview-with-cyrille-pauthenier-ceo-of-abolis-biotechnologies-the-bio-synthesis-architects/) - EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology. - [EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines](https://www.europabio.org/epsco-council-conclusions-europabio-calls-for-more-pragmatic-approach-addressing-access-availability-and-affordability-of-medicines/) - EuropaBio on EPSCO conclusionsDownload - [Technology Park Ljubljana joins EuropaBio: better world through better technology](https://www.europabio.org/technology-park-ljubljana-joins-europabio-better-world-through-better-technology/) - EuropaBio is pleased to announce that Technology Park Ljubljana has joined the organization as part of the National Associations Council. - [Interview with... Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana](https://www.europabio.org/interview-with-dr-jernej-pintar-ceo-and-head-of-tech-community-at-technology-park-ljubljana/) - EuropaBio sat down with new Member Technology Park Ljubljana, to find out about their journey from creation in 1994. - [EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes](https://www.europabio.org/ev-biotech-joins-europabio/) - EuropaBio is pleased to announce that EV Biotech has joined the organization as an Associate Member. - [A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property](https://www.europabio.org/a-declaration-from-members-of-the-worlds-biotechnology-sector-on-global-access-to-covid-vaccines-treatments-and-the-role-of-intellectual-property/) - We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them. - [Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites](https://www.europabio.org/call-for-tender-europabio-requires-maintenance-and-development-services-for-its-four-websites/) - [Artificial intelligence: investing in new technologies in healthcare](https://www.europabio.org/artificial-intelligence-investing-in-new-technologies-in-healthcare/) - What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells? - [EuropaBio Comments on the Roadmap on Restoring Sustainable Carbon Cycles](https://www.europabio.org/europabio-comments-on-the-roadmap-on-restoring-sustainable-carbon-cycles/) - [EuropaBio sat down with new Member IFF, to find out about their focus on health and well-being, product performance, and user satisfaction](https://www.europabio.org/europabio-sat-down-with-new-member-iff-to-find-out-about-their-focus-on-health-and-well-being-product-performance-and-user-satisfaction/) - EuropaBio sat down with new Member to find out about their focus on health and well-being, product performance, and user satisfaction. - [IFF joins EuropaBio: Applying Science and Creativity for a Better World](https://www.europabio.org/iff-joins-europabio-applying-science-and-creativity-for-a-better-world/) - EuropaBio is pleased to announce that IFF has joined the association as a corporate member. - [EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks](https://www.europabio.org/europabio-patient-bio-forum-challenges-and-future-potential-of-european-reference-networks/) - [Olon joins EuropaBio - Quality and Sustainability: A Modern Industrial Vision that Starts from Respect and Protection of the Environment](https://www.europabio.org/olon-joins-europabio/) - EuropaBio is pleased to announce that Olon has joined as an associate member. - [Puratos joins EuropaBio: Striving to Offer Healthier Solutions Every Day](https://www.europabio.org/puratos-joins-europabio/) - EuropaBio is pleased to announce that Puratos has joined the association as a corporate member. - [EuropaBio sat down with new Member Puratos, to find out the secret behind their centenary success](https://www.europabio.org/europabio-sat-down-with-new-member-puratos/) - EuropaBio sat down with new Member Puratos to find out the secret behind their centenary success. - [EuropaBio Response to the Inception Impact Assessment for Legislation for Plants Produced from Certain New Genomic Techniques (NGTs)](https://www.europabio.org/europabio-response-to-the-inception-impact-assessment-for-legislation-for-plants-produced-from-certain-ngts/) - [Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem](https://www.europabio.org/healthy-planet-healthy-people-a-pathway-for-green-transition-in-the-biopharmaceutical-ecosystem/) - [EuropaBio Comments on the Roadmap on a Policy Framework on Biobased, Biodegradable and Compostable Plastics](https://www.europabio.org/europabio-comments-on-the-roadmap-on-a-policy-framework-on-biobased-biodegradable-and-compostable-plastics/) - [EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform](https://www.europabio.org/europabio-sat-down-with-new-member-olon/) - EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform. - [What is the use of innovation if it cannot be implemented? Or why consumers have the last word](https://www.europabio.org/what-is-the-use-of-innovation-if-it-cannot-be-implemented-or-why-consumers-have-the-last-word/) - Read it online - [EuropaBio: Revision of the EU general pharmaceuticals legislation for a healthier tomorrow](https://www.europabio.org/europabio-revision-of-the-eu-general-pharmaceuticals-legislation-for-a-healthier-tomorrow/) - [EuropaBio National Associations Council Summit 2022: modernised regulation and legislation will deliver the potential of European biotechnology](https://www.europabio.org/europabio-national-associations-council-summit-2022-modernised-regulation-and-legislation-will-deliver-the-potential-of-european-biotechnology/) - [European Commission Initiative Improves Information for Patients on Biosimilar Medicines](https://www.europabio.org/the-path-forward-for-a-green-transition-highlighted-at-efib2020/) - European Commission Initiative Improves Information for Patients on Biosimilar Medicines. - [“Buying Innovative” in the Healthcare Biotech Market in Europe](https://www.europabio.org/buying-innovative-in-the-healthcare-biotech-market-in-europe/) - This paper proposes key steps to consider when purchasing biological medicines, looking at each stage of the procurement process. - [EuropaBio statement on European Parliament report on EU options for improving access to medicines](https://www.europabio.org/europabio-statement-on-european-parliament-report-on-eu-options-for-improving-access-to-medicines/) - EuropaBio notes the adoption by the European Parliament of the report on EU options for improving patient access to medicines on 2 March 2017, in Brussels. - [Biosimilar SmPC Recommendations](https://www.europabio.org/biosimilar-smpc-recommendations/) - This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label. - [EuropaBio launches recommendations to enhance transparency of biosimilar labels](https://www.europabio.org/europabio-launches-recommendations-to-enhance-transparency-of-biosimilar-labels/) - This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label. - [Joint Press Release on ATMPs and GMOs in Europe](https://www.europabio.org/joint-press-release-on-atmps-and-gmos-in-europe/) - Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms - [From Patent to Patient - The importance of IP rewards and incentives](https://www.europabio.org/from-patent-to-patient-the-importance-of-ip-rewards-and-incentives/) - The system of IP rewards and incentives exists and works together to allow adequate time for the companies and investors to recoup their years of investment and fully realise clinical value before their inventions become part of the public domain and can be used by others. - [European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages](https://www.europabio.org/european-commission-launches-what-i-need-to-know-about-biosimilar-medicines-information-for-patients-in-23-eu-languages/) - This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label. - [BREXIT Life Sciences Coalition - Joint Position Paper](https://www.europabio.org/brexit-life-sciences-coalition-joint-position-paper/) - The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit the European Union. - [European health community issues key questions Article 50 negotiations must answer for patients and public health](https://www.europabio.org/european-health-community-issues-key-questions-article-50-negotiations-must-answer-for-patients-and-public-health/) - The European Health Community has warned that time is running out to secure patients’ interests in Brexit negotiations. With Phase 2 of the negotiations looming, health groups across Europe have drawn up a list of crucial unanswered questions that must be answered by the EU and UK negotiators to ‘put patients first’ in the negotiations. - [Statement in response to the EU Council ratifying the Brexit transition deal](https://www.europabio.org/statement-in-response-to-the-eu-council-ratifying-the-brexit-transition-deal/) - The associations representing the European and British life science industry have today responded to the European Council approving terms of the transition period agreed between the UK Government and EU. - [SPC waiver risks downgrading the EU as a hub for Health Innovation](https://www.europabio.org/spc-waiver-risks-downgrading-the-eu-as-a-hub-for-health-innovation/) - As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines. - [Joint Pharmaceutical Industry Statement on the Commission’s Proposal for a Regulation on Health Technology Assessment (HTA)](https://www.europabio.org/joint-pharmaceutical-industry-statement-on-the-commissions-proposal-for-a-regulation-on-health-technology-assessment-hta/) - The Pharmaceutical Industry generally welcomes the European Commission’s Proposal for a Regulation on HTA. - [Chemically Synthesized Proteins Referencing Biological Medicinal Products](https://www.europabio.org/chemically-synthesized-proteins-referencing-biological-medicinal-products/) - A EuropaBio white paper calling for: equal assessment transparency; equal measures for traceability and adverse event reporting; and a level playing field for market access. - [Joint Statement on HE and Partnerships](https://www.europabio.org/joint-statement-on-he-and-partnerships/) - Health industries call for a rapid adoption of Horizon Europe, its missions and partnerships. - [Export Manufacturing Waiver for Supplementary Protection Certificates: a red flag for investment in EU healthcare biotech](https://www.europabio.org/export-manufacturing-waiver-for-supplementary-protection-certificates-a-red-flag-for-investment-in-eu-healthcare-biotech/) - As the Association representing the European biotechnology industry, EuropaBio is fully committed to the development of a legislative environment which facilitates the creation of EU jobs and growth as well as new solutions to healthcare challenges. - [Joint Statement on Horizon Europe](https://www.europabio.org/joint-statement-on-horizon-europe/) - Health industries welcome unprecedented progress leading to an adoption of Horizon Europe, its areas for missions and partnerships. - [Achieving the Potential of Genome Editing: the Perspective of the European Biotech Industry](https://www.europabio.org/achieving-the-potential-of-genome-editing-the-perspective-of-the-european-biotech-industry/) - EuropaBio, the voice of the biotech industry, has developed this paper to bring the latest views from the developers and users of genome editing tools and applications. - [EuropaBio Patients BioForum - Key Messages](https://www.europabio.org/europabio-patients-bioforum-key-messages/) - Read the key recommendations of the EuropaBio Patients BioForum to the new EU institutions. - [EuropaBio position on Germline Genome Editing](https://www.europabio.org/europabio-position-on-germline-genome-editing/) - EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet. - [EuropaBio Position & Policy Recommendations to support EU ATMP Innovation](https://www.europabio.org/europabio-position-policy-recommendations-to-support-eu-atmp-innovation/) - To ensure the EU remains a leader in ATMP innovation, this paper outlines and elaborates EuropaBio’s position and policy recommendations to the European Commission across three key focus areas. - [European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers](https://www.europabio.org/european-industry-trade-and-supply-chain-needs-to-respond-to-covid-19-joint-letter-to-the-eu-trade-ministers/) - European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers. - [ACCELERATE FAIR Initiative Letter of Support](https://www.europabio.org/accelerate-fair-initiative-letter-of-support/) - We do appreciate the efforts led by the FAIR Initiative and hope to continue to partner with ACCELERATE to speed up the delivery of innovative therapies to children and adolescents. - [EuropaBio observations in response to Europe’s Beating Cancer Plan](https://www.europabio.org/europabio-observations-in-response-to-europes-beating-cancer-plan/) - EuropaBio welcomes the European Commission’s commitment to develop a European plan to fight cancer and is supportive of its overarching approach in tackling all key stages of the disease: prevention, early diagnosis, treatment, and quality of life. Above all, we strongly advocate the employment of supportive measures for health innovation to ensure that novel cancer treatments move from the laboratory to the hospital bedside as swiftly as possible. - [EuropaBio response to the Work Programme of the eHealth Stakeholder Group](https://www.europabio.org/europabio-response-to-the-work-programme-of-the-ehealth-stakeholder-group-2/) - Read our response on the eHSG Work Programme 2020-2022. - [EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy](https://www.europabio.org/europabio-response-to-the-public-consultation-on-the-roadmap-for-an-eu-pharmaceutical-strategy/) - EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy. - [Joint Statement on the Health Innovation Partnership Proposal](https://www.europabio.org/joint-statement-on-the-health-innovation-partnership-proposal/) - Health industry sectors, representing pharmaceutical and medical technology companies welcome the publication of the Partnership Proposal as a significant milestone towards a European Partnership for Health Innovation. - [Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations](https://www.europabio.org/europabio-response-to-the-work-programme-of-the-ehealth-stakeholder-group-3/) - Read our Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations. - [EuropaBio Patient engagement with the European Medicines Agency](https://www.europabio.org/europabio-patient-engagement-with-the-european-medicines-agency/) - EuropaBio Patient engagement with the European Medicines Agency - [EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association](https://www.europabio.org/europabio-announces-dr-claire-skentelbery-as-new-director-general-of-the-association/) - EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association. - [EuropaBio welcomes the EU strategy on Covid-19 therapeutics](https://www.europabio.org/europabio-welcomes-the-eu-strategy-on-covid-19-therapeutics/) - [Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies](https://www.europabio.org/treatment-without-borders-the-eu-case-for-equitable-patient-access-to-advanced-therapies/) - [MetGen receives John Sime Award and Plantics becomes PitchFest winner at #EFIB2018](https://www.europabio.org/metgen-receives-john-sime-award-and-plantics-becomes-pitchfest-winner-at-efib2018/) - Wealth of innovation on display at annual showcase event demonstrates Europe’s strong response to SDG challenges and potential of the circular bioeconomy. - [United Kingdom Exiting from EU – BREXIT. Life Sciences Industry CoalitionUK Exiting from EU – Life Sciences Industry Coalition](https://www.europabio.org/united-kingdom-exiting-from-eu-brexit-life-sciences-industry-coalitionuk-exiting-from-eu-life-sciences-industry-coalition/) - The life science industry is highly integrated across Europe and regulated under EU law through a sophisticated system of legal and regulatory arrangements involving EU Institutions, MS and national competent authorities. - [EuropaBio welcomes renewed commitment to the EU Bioeconomy](https://www.europabio.org/europabio-welcomes-renewed-commitment-to-the-eu-bioeconomy/) - EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy. - [#EFIB2018 – Toulouse hosts 11th edition of leading Industrial Biotech Conference highlighting the breakthroughs and potential of the circular bioeconomy](https://www.europabio.org/efib2018-toulouse-hosts-11th-edition-of-leading-industrial-biotech-conference-highlighting-the-breakthroughs-and-potential-of-the-circular-bioeconomy/) - Speakers will call for Europe to continue their commitment to building a sustainable, circular bioeconomy. - [Vision for a Circular Bio-Society](https://www.europabio.org/vision-for-a-circular-bio-society/) - BIC and fifteen organisations set out joint Vision for Europe’s bioeconomy future – a circular bio-society. - [#EFIB2019 – EuropaBio hosts 12th annual Industrial Biotech and Bioeconomy Conference](https://www.europabio.org/efib2019-europabio-hosts-12th-annual-industrial-biotech-and-bioeconomy-conference/) - As the new European Institutions draw up political guidelines and goals to address climate and sustainability challenges, this year’s conference will highlight the sector’s latest achievements and the potential of a circular bioeconomy for Europe. - [Wealth of innovation on display & bio-based winners revealed at EFIB 2019 in Brussels](https://www.europabio.org/wealth-of-innovation-on-display-bio-based-winners-revealed-at-efib-2019-in-brussels/) - The John Sime Award for the best innovation presentation delivered at EFIB 2019 was granted to Guillaume Daoulas, Head of Strategic Marketing at Ÿnsect. In the exhibition, a new area was featuring 20 academic posters. The prize of the best academic poster was awarded to Thomas Gassler from the University of Natural Resources and Life Sciences, Vienna. - [Inter-association letter to the European Commission and Member States](https://www.europabio.org/inter-association-letter-to-the-european-commission-and-member-states/) - [Industrial biotechnology solutions for sustainable agriculture](https://www.europabio.org/industrial-biotechnology-solutions-for-sustainable-agriculture/) - Read our new report on industrial biotech solutions that support the objectives of the CAP revision programme. - [European Bioeconomy Alliance (EUBA) Position on the EU Green Deal](https://www.europabio.org/european-bioeconomy-alliance-euba-position-on-the-eu-green-deal/) - The European Bioeconomy Alliance (EUBA), of which EuropaBio is a founding member, today published its position on the EU Green Deal. - [EuropaBio highlights synergies between biotechnology and Farm to Fork and Biodiversity Strategy ambitions](https://www.europabio.org/europabio-highlights-synergies-between-biotechnology-and-farm-to-fork-and-biodiversity-strategy-ambitions/) - EuropaBio's reaction on the publication of the Farm to Form and Biodiversity Strategies of the European Commission. - [EuropaBio position on the EU Biodiversity Strategy for 2030](https://www.europabio.org/europabio-position-on-the-eu-biodiversity-strategy-for-2030/) - Read our position on the EU 2030 Biodiversity Strategy. - [EuropaBio position paper on the Farm to Fork Strategy](https://www.europabio.org/europabio-position-paper-on-the-farm-to-fork-strategy/) - Read our position paper on the Farm to Fork strategy. - [#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference](https://www.europabio.org/efib2020-goes-digital-europabio-hosts-13th-annual-european-industrial-biotechnology-and-bioeconomy-conference/) - As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy. - [Nobel Prize for Genome Editing Pioneers](https://www.europabio.org/nobel-prize-for-genome-editing-pioneers/) - Brussels, 7 October 2020: Today, genome editing pioneers Emmanuelle Charpentier and Jennifer A. Doudna have been awarded the Nobel Prize in Chemistry 2020 - [Create sustainable bio-based and biodegradable plastics](https://www.europabio.org/create-sustainable-bio-based-and-biodegradable-plastics/) - Bioplastics are plastics which are bio-based, biodegradable or both. Bio-based plastics are produced from biomass, which helps to decrease our dependence on fossil carbon resources (the feedstock for conventional plastics). They can offer significant CO2 emissions savings compared to conventional plastics. - [EuropaBio Statement on the EU Pharmaceutical Strategy](https://www.europabio.org/europabio-statement-on-the-eu-pharmaceutical-strategy/) - EuropaBio looks forward to working closely with the European institutions to ensure the Pharmaceutical Strategy delivers for European patients and establishes a framework that enables a successful life sciences sector for the medium to long-term. - [An EU IP Action Plan for strong industrial ecosystems](https://www.europabio.org/an-eu-ip-action-plan-for-strong-industrial-ecosystems/) - An EU IP Action Plan for strong industrial ecosystems - [The Business of Biotechnology: Growing for Europe’s tomorrow](https://www.europabio.org/the-business-of-biotechnology-growing-for-europes-tomorrow/) - Read EuropaBio Report ‘Measuring the Economic Footprint of the Biotechnology Industry in Europe’ - [EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme](https://www.europabio.org/europabio-celebrates-25-years-of-biotech-innovation/) - EuropBio, Europe’s leading life sciences industry association, kicks off 2021 celebrations to mark its foundation a quarter of a century ago. - [EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open](https://www.europabio.org/efib-2021-delivering-the-eu-green-deal-industrial-biotechnology-into-business-registration-is-open/) - EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open - [Inter-association letter to the EU Ministers of Agriculture and DG SANTE](https://www.europabio.org/inter-association-letter-to-the-eu-ministers-of-agriculture-and-dg-sante/) - [EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future](https://www.europabio.org/efib-2021-launch-event-biotech-community-discussed-innovation-solutions-for-a-sustainable-future/) - [Europe celebrates life science with European Biotech Week 2021](https://www.europabio.org/europe-celebrates-life-science-with-european-biotech-week-2021/) - [#EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal](https://www.europabio.org/efib2021-industrial-biotechnology-in-the-business-spotlight-for-eu-green-deal/) - [EFIB Vienna Statement 2021](https://www.europabio.org/efib2021-industrial-biotechnology-in-the-business-spotlight-for-eu-green-deal-2/) - [#EFIB2021: Industry sets up the Business vision to deliver Green Deal ambitions](https://www.europabio.org/efib2021-industry-sets-up-the-business-vision-to-deliver-green-deal-ambitions/) - [European Biotech Week 2021: Telling the stories of European Biotechnology](https://www.europabio.org/european-biotech-week-2021/) - [ProductLife joins EuropaBio: improving human health by delivering regulatory compliance services for the safe and effective use of medical solutions](https://www.europabio.org/productlife-joins-europabio/) - EuropaBio is pleased to announce that Olon has joined as an associate member. - [MabDesign joins EuropaBio: innovation linked to the industrial field of biotherapy](https://www.europabio.org/mabdesign-joins-europabio/) - EuropaBio is pleased to announce that Olon has joined as an associate member. - [AB Enzymes joins EuropaBio: Individual Enzyme Solutions for Individual Requirements](https://www.europabio.org/ab-enzymes-joins-europabio/) - EuropaBio is pleased to announce that Olon has joined as an associate member. - [SAVE THE DATE: EFIB 2022 goes to Vilnius, Lithuania](https://www.europabio.org/save-the-date-efib-2022-goes-to-vilnius-lithuania/) - [EuropaBio becomes a partner of a new European partnership for health](https://www.europabio.org/europabio-becomes-a-partner-of-a-new-european-partnership-for-health/) - [EuropaBio National Associations Council Summit 2022 (French Presidency): how does biotechnology deliver the Industrial strategy across sectors?](https://www.europabio.org/europabio-national-associations-council-summit-2022-french-presidency-how-does-biotechnology-deliver-the-industrial-strategy-across-sectors/) - [EuropaBio signs EU Code of Conduct](https://www.europabio.org/europabio-signs-eu-code-of-conduct/) - [EuropaBio Statement on Rare Disease Day](https://www.europabio.org/europabio-statement-on-rare-diseases-day/) - [The role of enzymes as key enablers in the green transition and in enabling the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance](https://www.europabio.org/the-role-of-enzymes-as-key-enablers-in-the-green-transition-and-in-enabling-the-european-commissions-sustainability-ambitions-in-the-eu-taxonomy-and-sustainable-finance/) - 2022_08_I_PP_AMFEP-EuropaBio-Position-on-TaxonomyDownload - [The time to act is now! Biotechnology for global transformation](https://www.europabio.org/the-time-to-act-is-now-biotechnology-for-global-transformation/) - [Delivering Europe's ambitions in rare disease](https://www.europabio.org/delivering-europes-ambitions-in-rare-disease/) ## Pages - [Home](https://www.europabio.org/) - [Staff](https://www.europabio.org/staff/) - [APROVALS Project](https://www.europabio.org/aprovals-project/) - [PRIMED](https://www.europabio.org/primed-project/) - [Vacancies](https://www.europabio.org/vacancies/) - [Biomanufacturing Platform](https://www.europabio.org/biomanufacturing-platform-5480/) - [About us](https://www.europabio.org/about-us/) - [Legal & cookies](https://www.europabio.org/legal-cookies/) - [Patient BioForum](https://www.europabio.org/patient-bio-forum/) - [The EU Biotech Act](https://www.europabio.org/the-eu-biotech-act/) - [SME Platform](https://www.europabio.org/sme-platform/) - [Healthcare Biotechnology Council](https://www.europabio.org/healthcare-biotech-council/) - [National Associations Council](https://www.europabio.org/national-associations/) - [Industrial Biotech Council](https://www.europabio.org/industrial-biotech-council/) - [EFIB](https://www.europabio.org/efib/) - [European Biotech Week](https://www.europabio.org/european-biotech-week/) - [Membership](https://www.europabio.org/membership/) - [Contact us for membership](https://www.europabio.org/become-a-member/) - [Members](https://www.europabio.org/members/) - [Vision for Europe](https://www.europabio.org/vision-for-europe/) - [National Associations Survey - National Recovery Plan](https://www.europabio.org/national-associations-survey-national-recovery-plan/) - [EuropaBio Working Groups & Committee](https://www.europabio.org/europabio-working-groups-committee/) - [EuropaBio Membership Application - SME](https://www.europabio.org/europabio-membership-application-sme/) - [EuropaBio Membership Application - NAC/BioCluster](https://www.europabio.org/europabio-membership-application-nac-biocluster/) - [EuropaBio Membership Application - Corporate Company](https://www.europabio.org/europabio-membership-application-corporate-company/) - [EuropaBio Membership Application - Associate Member Company](https://www.europabio.org/europabio-membership-application-associate-member-company/) - [25th Anniversary Timeline](https://www.europabio.org/25th-anniversary/timeline/) - [Impact of the EU's General Pharmaceutical Legislation on Europe’s innovation ecosystem and biotechnology companies](https://www.europabio.org/study-impact-of-the-general-pharmaceutical-legislation/) - [Contact us](https://www.europabio.org/contact-us/) - [25th Anniversary](https://www.europabio.org/25th-anniversary/) - [Library](https://www.europabio.org/library/) - [Newsroom](https://www.europabio.org/newsroom/) - [Biotechnology in our Lives](https://www.europabio.org/biotechnology-in-our-lives/) - [Microorganisms](https://www.europabio.org/microorganisms-8058/) - [Privacy Policy](https://www.europabio.org/privacy-policy/) ## Events - [Special feature: Biotech Act Part I – Dr Claire Skentelbery, Director General EuropaBio @ BIO-Europe Spring 2026](https://www.europabio.org/event/special-feature-biotech-act-part-i-dr-claire-skentelbery-director-general-europabio-bio-europe-spring-2026/) - Join our Director General Dr Claire Skentelbery at BIO-Europe Spring on the 23rd of March for an afternoon session dedicated to the EU Biotech Act Part 1. The EU Biotech Act represents a landmark piece of legislation aimed at positioning Europe as a global leader in biotech. Structured in two parts, the legislative program seeks - [EU Pharmaceutical Law Forum 2026](https://www.europabio.org/event/eu-pharmaceutical-law-forum-2026/) - We are thrilled to announce our partnership with the EU Pharmaceutical Law Forum, one of the most significant events for legal and compliance professionals in the pharmaceutical industry.This forum is a cornerstone for discussing the latest developments in EU pharmaceutical law, regulatory frameworks, and compliance strategies. It brings together industry leaders, legal experts, and policymakers to - [The EU Biotech Act: Europe’s ambition for biotechnology](https://www.europabio.org/event/the-eu-biotech-act-europes-ambition-for-biotechnology/) - Join Director General Sandra Gallina and EuropaBio to explore the EU Biotech Act proposal, published in December 2025. The webinar explores the Goal of the Act, to boost innovation, support development of biotech products and accelerate time-to-market, making use of industrial enablers and regulatory simplification. This webinar will introduce the drivers behind the Biotech Act - [CEBioForum 2026](https://www.europabio.org/event/cebioforum-2026/) - CEBioForum 2026 is a leading international biotechnology conference bringing together professionals from Central and Eastern Europe and beyond. With over 20 years of tradition, CEBioForum serves as a trusted platform for dialogue, partnership-building, and knowledge exchange across the life sciences ecosystem. The two-day event will take place in the modern spaces of CIC Warsaw, located - [World Orphan Drug Congress 2026](https://www.europabio.org/event/world-orphan-drug-congress-2026/) - The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases. Join over 1,800 senior industry leaders, gain insights from 250+ expert speakers, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement - [BioPharmaChem Impact 2026](https://www.europabio.org/event/biopharmachem-impact-2026/) - BioPharmaChem 2026 will bring together leading business leaders and experts on many pertinent topics including: realising the potential of the ecosystem, sustainability, digitalisation, the power of partnerships, resilient supply chains, the future of work, EU competitiveness and more. Delegates will enjoy unmissable networking opportunities to connect with many biopharmaceuticals, pharmaceuticals and chemicals professionals in our - [Made by Cells - Biotech Forum](https://www.europabio.org/event/made-by-cells-biotech-forum/) - Join our Director General Dr Claire Skentelbery in Finland! Join us at the Hanaholmen Cultural Center in Espoo Finland for inspiring talks on Pharma & Diagnostics, Food, Pigments and Polymers, alongside valuable networking opportunities with leading biotech innovators and stakeholders. Discover cutting-edge advancements and collaborate to shape the future of biotechnology. The event is organised - [BioSolutions UK](https://www.europabio.org/event/biosolutions-uk/) - Proud to support BioSolutions UK conference — a new platform bringing together leaders in engineering biology to accelerate growth, collaboration and real-world adoption. Biosolutions are reshaping food, agriculture, chemicals, materials and biofuels, and we’re excited to back an event championing the innovators driving this transition and strengthening the UK’s position in the global bioeconomy. Join us on 21 - [BIO-Europe Spring 2026](https://www.europabio.org/event/bio-europe-spring-2026/) - EuropaBio is joining BIO-Europe Spring 2026. BIO-Europe Spring is Europe's largest springtime biotech partnering event, bringing together over 3,700 leaders and innovators in the life sciences industry. It's designed for partnering, business development, and licensing opportunities in biotechnology and pharmaceuticals. More Info Here - [Bio Innovations Europe 2026](https://www.europabio.org/event/bio-innovations-europe-2026/) - EuropaBio is joining Bio Innovations Europe 2026 as a Headline Partner. Taking place on 10-11 June 2026 in The Hague, the event—formerly known as World Bio Markets—has seen exponential growth. Since its 2022 relaunch, pre-arranged meetings have surged from 160 to over 1,050 in 2025—a 550% increase. The 2026 edition is set to be the - [Navigating Biotech SME Funding: What's available, How it works, What's next for Europe](https://www.europabio.org/event/navigating-biotech-sme-funding-whats-available-how-it-works-whats-next-for-europe/) - Europe’s biotech sector continues to face significant financing challenges, especially during growth and scale‑up. As the EU moves forward with the landmark Biotech Act, this webinar explores the funding tools available today, how companies can access them, and what changes are needed to expand investment in European biotech. The session will provide an overview of - [EUCROF26](https://www.europabio.org/event/eucrof26/) - Building on the momentum of nearly 350 attendees at EUCROF25, EUCROF26 will once again bring together clinical research professionals from across Europe and beyond. Expect three days of high-impact networking, thought-provoking sessions, and future-focused dialogue designed to accelerate innovation and excellence in our field. Join our Director General Claire Skentelbery from 1–3 February 2026 as - [AseBio Green Innovation Forum](https://www.europabio.org/event/asebio-green-innovation-forum-2/) - AseBio announces the Green Innovation Forum2026, which will take place in Salamanca on 20–21 April 2026, positioning the city as a meeting point for green biotechnology, bioeconomy and sustainable innovation in Europe.The Green Innovation Forum is designed as a meeting point for business development, bringing together companies, startups, investors, technologycentres and institutions committed to accelerating the - [ECRD 2026: Rare Diseases in a changing & Competitive Europe](https://www.europabio.org/event/ecrd-2026-rare-diseases-in-a-changing-competitive-europe/) - ECRD is the largest, patient-led policy-shaping conference for rare diseases in Europe. The event is an instrumental tool for advancing policy objectives that improve the lives of people living with a rare disease. The overarching title of ECRD 2026 is: Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living - [IHI Brokerage Event 2025](https://www.europabio.org/event/ihi-brokerage-event-2025/) - Registration is now open for the IHI Brokerage Event 2025, which will be held in Brussels, Belgium on 4-5 November. The event is a prime opportunity for potential applicants to network and start forming consortia for IHI’s next single-stage call for proposals, which is scheduled for launch in early 2026. Registration is free but obligatory via the event and networking platform. - [Biotech & Biomanufacturing Policy Summit](https://www.europabio.org/event/biotech-biomanufacturing-policy-summit/) - EuropaBio is pleased to host its third Summit focused on biotechnology & biomanufacturing. Biotechnology is a critical technology for Europe. Delivery of innovation into market drives competitiveness, security, supply chain resilience plus societal and environmental goals. Europe must be ambitious and globally aware, with a focus on securing its biotechnology capability within fast changing global - [Pitch Perfect and Boost the EU Bioeconomy 2025](https://www.europabio.org/event/pitch-perfect-and-boost-the-eu-bioeconomy-2025/) - Pitching, Matchmaking And Networking In The Heart Of Europe! The ‘Pitch Perfect and Boost the European Bioeconomy’ event is a two day event of intense cross-border and cross-sectoral pitching, matchmaking and networking, with the aim to link industry to innovative (biobased) technologies, innovators to investors and to create new partnerships for the future and the - [Life Sciences Baltics 2025](https://www.europabio.org/event/life-sciences-baltics-2025/) - Join our Director General Claire Skentelbery at the Life Sciences Baltics 2025 conference where she will be speaking on The EU Biotech Act – leading Europe’s evolution and revolution for competitiveness. Life Sciences Baltics is the leading event in the Baltic region, connecting global life sciences professionals. This event provides unique opportunities for project initiation, - [Nordic Rare Disease Roadmap Launch at the European Parliament](https://www.europabio.org/event/nordic-rare-disease-roadmap-launch-at-the-european-parliament/) - Join us at the European Parliament on Tuesday 1 July, from 15:00 to 17:00. Members of the European Parliament Stine Bosse (Renew Europe, Denmark) and Maria Guzenina (Socialists and Democrats, Finland) are hosting the event, which coincides with Denmark assuming the Presidency of the Council of the European Union. This European Parliament event will bring - [Advanced Therapies Europe 2025](https://www.europabio.org/event/advanced-therapies-europe-2025/) - Now in its 5th year, Advanced Therapies Europe 2025 is an intentionally intimate event — limited to just 500 senior-level decision-makers — to ensure every conversation drives outcomes. Held in Barcelona, at the heart of Europe’s fast-growing biotech ecosystem, this is where strategic connections ignite progress and insights lead to action. Whether you're here to - [Nordic Rare Disease Summit 2025](https://www.europabio.org/event/nordic-rare-disease-summit-2025/) - The scene has already been set, the roadmap for change is in our hands. Taking place at the heart of Copenhagen on 16 & 17 September, alongside the Danish Presidency of the European Union, the 2025 Nordic Rare Disease Summit will gather the leading experts within academia and healthcare professionals, patients, decision-makers and industry to - [LifeScience4EU Conference 2025](https://www.europabio.org/event/lifescience4eu-conference-2025/) - Healthcare innovation is a complex, interconnected ecosystem that demands collaboration across research, industry, policy, and patient care. To navigate this landscape effectively, a systems-thinking approach is essential. LifeScience4EU Conference 2025, held under the Polish Presidency of the Council of the European Union, will bring together top experts to explore how biotechnology, digital health, and next-generation medical - [BIO Convention 2025 - Panel: The EU Policy Evolution and Revolution for Biotech](https://www.europabio.org/event/bio-convention-2025-panel-the-eu-policy-evolution-and-revolution-for-biotech/) - Join EuropaBio in Boston for the key EU policy panel taking place at BIO 2025. The EU is reshaping its biotechnology landscape, with the focus on competitiveness, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations and initiatives relevant to biotech and is an opportunity to both - [EFIB Brussels Statement – a competitive future for the EU](https://www.europabio.org/event/efib-brussels-statement-a-competitive-future-for-the-eu/) - The EFIB Brussels statement was published following the successful workshop that EuropaBio organised together with Genopole during the Bioket conference on 11 March. It looks ahead to the decisions that the EU must now take through the policies and initiatives currently in process. A key opportunity exists for societal and industrial transformation within the sustainability - [Patient BioForum 2025](https://www.europabio.org/event/patient-bioforum-2025/) - The theme of the Patient BioForum 2025 is From discovery to access: towards a patient-centric health European ecosystem. The event is hosted by MEP András Tivadar Kulja, who will hold a keynote speech, and concluding remarks will be given by MEP Stine Bosse. The panel discussion is moderated by Dr. Nicholas Whyte (Senior Director - - [BIOSPAIN 2025](https://www.europabio.org/event/biospain-2025/) - BioSpain returns to Barcelona between October 7 and 9, 2025. The benchmark fair for Spanish biotechnology will take place in Pavelló 1 of La Fira.Last year BIOSPAIN was a resounding success by convening more than 2,000 registered attendees representing 1,000 entities, 260 exhibitors from more than 34 countries and coordinating more than 5,000 one-to-one meetings - [Securing Europe’s biotech future - How can biosecurity drive competitiveness?](https://www.europabio.org/event/securing-europes-biotech-future-how-can-biosecurity-drive-competitiveness/) - Biotechnology involves the use of biological systems, organisms, or their components to develop products and solutions across industries such as healthcare, agriculture, and manufacturing. In Europe, it plays an important role in advancing medicine, sustainability, and economic growth. Europe accounts for approximately 12% of the global biotech market, and discussions continue on how to maintain - [World Orphan Drug Congress 2025](https://www.europabio.org/event/world-orphan-drug-congress-2025/) - The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases. Join over 2,000 attendees, gain insights from 250+ industry leaders, and connect with over 130 exhibitors as we bring together experts across the entire orphan drug lifecycle, discussing areas including regulatory affairs and policy to - [A Biotech & Life-Sciences Roadmap: how investment can reach European Start-ups and Scale-ups?](https://www.europabio.org/event/a-biotech-life-sciences-roadmap-how-investment-can-reach-european-start-ups-and-scale-ups/) - Europe is set for a wave of long-awaited policy action in the biotech and life sciences sectors - including through a European Startup and Scaleup Strategy, a Life Sciences Strategy, and a Biotech Act. Marking Poland's Council Presidency of the European Union, EuropaBio National Associations Council is excited to bring you the latest edition of - [Knowledge for Growth 2025](https://www.europabio.org/event/knowledge-for-growth-2025/) - Mark your calendar for Knowledge for Growth 2025, Europe’s premier life sciences conference, taking place on 8 May 2025 in the dynamic city of Antwerp, Belgium! Connect with over 1,000 life sciences professionals from 500+ companies and organisations, including decision-makers from biotech, pharma, MedTech, AgTech, and healthtech, as well as investors, universities, research institutes, policymakers, - [Unlocking efficiency through reliance: Navigating the EMA post-authorization framework](https://www.europabio.org/event/unlocking-efficiency-through-reliance-navigating-the-ema-post-authorization-framework/) - This joint webinar, organised in partnership between the EMA and the industry, aims to provide a platform for discussion and awareness on current and future EMA post-authorization framework, including variations and renewals. This event builds up on last year's session: "Regulatory Reliance Tools Unveiled – A Practical Guide by EMA." This year, we will further explore how - [NLS Days 2025](https://www.europabio.org/event/nls-days-2025/) - Nordic Life Science Days 2025 will be held, for the first time, in Gotheburg, Sweden on 13-14 October at Svenska Mässan located at Mässans Gata/Korsvägen, 412 94 Göteborg – Tel. +46 31 708 80 72 A welcome arena for business and people Nordic Life Science Days is the largest Nordic partnering conference dedicated to the - [Spinoff Bulgaria](https://www.europabio.org/event/spinoff-bulgaria/) - Spinoff Bulgaria is the largest initiative dedicated to technology transfer, science-based innovation and spinoff investments in Bulgaria and the region. The two-days format includes a wide range of keynotes, panel discussions, workshops and roundtables and offers opportunities for networking, matchmaking and the exchange of best practices. The target group are scientists, universities and TTOs as well - [Swiss Biotech Days](https://www.europabio.org/event/swiss-biotech-days/) - Since 2021, the Swiss Biotech Day has grown 40% every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2024 it attracted some 2,500 participants from more than 40 countries, including 17 international delegations.Join the Swiss Biotech Day to network, exchange ideas and explore - [German Biotechnology Days](https://www.europabio.org/event/german-biotechnology-days-2/) - DBT will take place on April 9th and 10th in Heidelberg. The event is considered the German forum for the biotechnology industry, where entrepreneurs exchange ideas with scientists and partners from politics, investors, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology, from health research to - [CEBioForum 2025](https://www.europabio.org/event/cebioforum-2025/) - We warmly invite you to participate in CEBioForum 2025, one of the key events for business and science in the biotechnology sector in Central Europe! On April 2-3, 2025, at the Cambridge Innovation Center in Warsaw, biotechnology innovation leaders, scientists, companies, and investors will gather to share knowledge, experiences, and form new partnerships. Why should - [4th Hellenic Biocluster Forum: Emerging Trends in Life Science Innovation](https://www.europabio.org/event/4th-hellenic-biocluster-forum-emerging-trends-in-life-science-innovation/) - Join the 4th Hellenic Biocluster Forum for a 2-day programme discussing all the emerging trends in Life Science Innovation! Get the opportunity to meet stakeholders from the Greek and European innovation ecosystems through B2B partnering opportunities, meet exhibitors showcasing the latest technology, pitch to investors and connect to SMEs, service providers, big pharma, and academic - [B-Trust’s 2nd masterclass: Co-Creating Trust in Biotech – Cell Factories](https://www.europabio.org/event/b-trusts-2nd-masterclass-co-creating-trust-in-biotech-cell-factories/) - How can biotechnology help shape a more sustainable food system? While scientific advancements are creating greener and more innovative ingredients, gaining consumer trust remains a key challenge.In this exclusive online masterclass, we’ll explore the role of cell factories – microorganisms that produce specialty food ingredients through fermentation – and their potential to revolutionise food production - [A Driver of European Competitiveness: The Future of European Biotech](https://www.europabio.org/event/a-driver-of-european-competitiveness-the-future-of-european-biotech/) - EuropaBio, the European association representing Bioindustries, will host an evening reception co-hosted by MEP Stine Bosse (Vice-Chair, SANT) and MEP Eszter Lakos (Member, ITRE), to discuss the role of the European biotech sector in making the European industry more competitive. Ambassador Søren Jacobsen, Deputy Permanent Representative of Denmark to the EU, and Kristin Schreiber, Director - [EU Health Summit](https://www.europabio.org/event/eu-health-summit/) - Healthy populations are essential for Europe to achieve its vision of a secure, competitive, and prosperous continent. Yet, European health systems are navigating a perfect storm: ageing populations, rising chronic diseases, and a health workforce under strain. European societies are facing combined cost-of-living, geopolitical, and climate crises with significant implications for healthcare. Amid these challenges, - [What's Next for Biotech & Biosecurity: EU & US Post Election Landscape](https://www.europabio.org/event/whats-next-for-biotech-biosecurity-eu-us-post-election-landscape/) - Join our Healthcare Public Affairs Director, Vlad Olteanu on Friday 22nd November to listen to What's next for Biotech and Biosecurity in the EU & US post elections. More information & Registerion Here - [2nd ESAB Digital Congress](https://www.europabio.org/event/2nd-esab-digital-congress/) - After the successful first digital ESAB Congress last year, the Scientific Committee has decided that a digital ESAB congress will take place again this year from November 25-27. Deadline for abstract submission: 31 October 2024 ESAB Aims to take initiatives in areas of growing scientific and industrial interest and importance in the field of applied - [SME roundtable: Towards globally competitive European SMEs](https://www.europabio.org/event/sme-roundtable-towards-globally-competitive-european-smes/) - Europe is home to a vibrant community of Biotechnology SMEs contributing to the modernisation of the European industry. European biotechnology SMEs are the main drivers for innovation in healthcare, food and feed, industrial processes and manufacturing. The Initiative on “Boosting Biotechnology and Biomanufacturing in the EU” published by the European Commission in March 2024 provides - [Advancing bio-based innovations in the food industry: Focus on fermentation](https://www.europabio.org/event/advancing-bio-based-innovations-in-the-food-industry-focus-on-fermentation/) - Join our Director General Dr Claire Skentelbery on the 12th of November in Brussels where she will be speaking at the DG GROW hosted hybrid workshop "Advancing bio-based innovations in the food industry: Focus on fermentation". The workshop will focus on the industrial applications of fermentation technologies by highlighting SMEs that are using biomass, precision - [BIO-Europe® 2024](https://www.europabio.org/event/bio-europe-2024/) - BIO-Europe® 2024 - 30th Annual International Partnering Conference Dates:November 4-6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital PartneringVenue: Stockholmsmässan Venue address: Mässvägen 1, 125 80 Stockholm Sweden Join the 30th anniversary edition of BIO-Europe, the biopharma partnering event that has grown with the industry, innovated alongside it, and remains the gathering place for meaningful - [Regulating the Future of Food Conference](https://www.europabio.org/event/regulating-the-future-of-food-conference/) - Join our Industrial Biotechnology Senior Manager Lucie McMurtry on the 23rd and 24th of October in Amsterdam where she will be speaking at the Regulating the Future of Food Conference. Global innovation in food-tech is growing at an incredible pace and there are so many amazing new products and processes out there! This innovation is - [How does a Novel Food get to your plate?](https://www.europabio.org/event/how-does-a-novel-food-get-to-your-plate/) - To celebrate the start of European Biotech Week, EuropaBio is organising a webinar to discuss the critical intersection of legislation and investment into innovation within the biotech industry. - [The Future of Biotech: The Role of Legislation within Investment for Innovation](https://www.europabio.org/event/the-future-of-biotech-the-role-of-legislation-on-investment-for-innovation/) - To celebrate the start of European Biotech Week, EuropaBio is organising a webinar to discuss the critical intersection of legislation and investment into innovation within the biotech industry. - [EFIB at BIOKET 2025](https://www.europabio.org/event/efib-at-bioket-2025/) - The Bioeconomy’s Key Enabling Technologies Conference & Exhibition EuropaBio is thrilled to announce that the European Forum for Industrial Biotechnology (EFIB), and ACDV are joining forces with BIOKET 2025 in Brussels from March 11-13. This collaboration brings a significant policy-making component to our event, providing an unparalleled opportunity to shape the bioeconomy sector's future. Join - [CPHI Milan](https://www.europabio.org/event/cphi-milan/) - EuropaBio is pleased to partner with CPHI Milan 2024, the biggest international pharmaceutical industry event for the thirty fifth anniversary edition. This year's edition held from the 8th to the 10th of October in Fiera Milano, Italy promises to a packed agenda with over 150 expert international speakers with over 100 content sessions. Join our - [Enhancing Europe's Pharma and Biotech Competitiveness and Open Strategic Autonomy](https://www.europabio.org/event/enhancing-europes-pharma-and-biotech-competitiveness-and-open-strategic-autonomy/) - Join our Director General Dr Claire Skentelbery on 2 October 2024 where she will be speaking at the Novartis & BritCham event "Enhancing Europe’s Pharma and Biotech Competitiveness and Open Strategic Autonomy". Find Out More & Register Here - [AseBio Green Innovation Forum](https://www.europabio.org/event/asebio-green-innovation-forum/) - Organized by AseBio, the Spanish Bioindustry Association, and Sodena the financial agent of the Government of Navarra, the 5th edition of the AseBio Green Innovation Forum will be held in the Baluarte convention centerof Pamplona on November 19, 2024. The event will showcase the opportunities that biotechnology can offer as a key tool in the transition - [World Orphan Drug Congress Europe 2024](https://www.europabio.org/event/world-orphan-drug-congress-europe-2024/) - The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees, hear from 250 leading speakers, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From regulation and policy to global pricing and gene therapy, the - [The European Bioplastics Conference 2024](https://www.europabio.org/event/the-european-bioplastics-conference-2024/) - We are happy to announce that the EBC 24 will take place on 10/11 December 2024 at the Titanic Hotel Berlin, Germany. The European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers, and policy makers are increasingly - [CURIOUS FUTURE INSIGHT™ CONFERENCE](https://www.europabio.org/event/curious-future-insight-conference/) - Over the millennia science & technology have steadily advanced, but key unsolved challenges remain, and much more is possible. The Curious – Future Insight™ Conference brings together some of the world’s brightest scientists and most accomplished innovators to present their work and explore the future of science and technology, solving the challenges of today and - [Europe's Biotechnology & Biomanufacturing Future](https://www.europabio.org/event/europes-biotechnology-biomanufacturing-future/) - Biotechnology is a critical technology for global economic security, health and sustainability. Europe’s world-leading research is translated into medicines, food and next generation biomanufacturing across sectors in all European regions, with employment, skills and economic growth as part of a more sustainable, healthy, autonomous and competitive Europe. The importance of biotechnology to Europe is now - [Industrial Biotechnology Day (2nd edition) - Biotechnology as key enabling technology for EU Strategies and Ambitions](https://www.europabio.org/event/industrial-biotechnology-day-2nd-edition-biotechnology-as-key-enabling-technology-for-eu-strategies-and-ambitions/) - Explore how industrial biotechnologies can achieve Europe’s environmental ambitions. Discussions will centre on exploring both regulatory frameworks and technological advancements, identifying our core strengths and opportunities, and pinpointing areas for improvement. From evaluating feedstocks and industrial capabilities to overcoming regulatory challenges, join us in shaping a sustainable path forward for the European chemical industry through - [NAC Belgian Presidency Summer Reception](https://www.europabio.org/event/nac-belgian-presidency-summer-reception/) - EuropaBio, bio.be/essenscia, and flanders.bio biotechnology associations are organising a summer reception in Brussels for its members and invited guests to mark the end of the Belgium Council Presidency of the European Union and celebrate what best is made in Belgium - (beyond waffles and beers), biotechnology! We will present the outcomes of our National Associations Council Presidency - [Biomanufacturing Policy Summit - Report Launch](https://www.europabio.org/event/europabios-biomanufacturing-policy-summit-report-launch/) - "Policy pathways for biomanufacturing in Europe" was the theme of the Biomanufacturing Policy Summit 2024. The upcoming report will summarise the Summit's keynote speeches and panel discussions and translate them into an analysis to Europe's biomanufacturing strengths, weaknesses, opportunities and threats based on specific policies and industrial examples. The report launch will also feature speakers - [RARE DISEASES FORUM 2024](https://www.europabio.org/event/rare-diseases-forum-2024/) - Against the backdrop of the Belgian EU Council Presidency, the Rare Diseases Forum 2024 brings together senior leaders from across patient organisations, industry and policy to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda. About 'The Rare Diseases Forum 2024: Securing Europe’s Competitiveness in R&D for people living with rare - [AseBio Investor Day](https://www.europabio.org/event/asebio-investor-day/) - We are thrilled to announce that AseBio will hold the fifth edition of the AseBio Investor Day at the gorgeous Kursaal conference center in San Sebastián (Spain) on the 15th of May. The AseBio Investor Day is a forum that aims to connect the Spanish biotechnology industry with national and international investors. Since its first - [EuropaBio Webinar – How will the revision EU General Pharmaceutical Legislation impact Europe’s innovation ecosystem and biotechnology companies?](https://www.europabio.org/event/europabio-webinar-how-will-the-revision-eu-general-pharmaceutical-legislation-impact-europes-innovation-ecosystem-and-biotechnology-companies/) - Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies. - [International Congress on Rare Diseases and Orphan Drugs 2024](https://www.europabio.org/event/international-congress-on-rare-diseases-and-orphan-drugs-2024/) - Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies. - [Industrial biotech: Is Europe ready to harness its potential?](https://www.europabio.org/event/industrial-biotech-is-europe-ready-to-harness-its-potential/) - A Science | Business closed-door roundtable, organised in partnership with EuropaBio – followed by networking reception Only By Invitation For more information, please contact: denitsa.nikolova@sciencebusiness.ne Click here for more information - [Biomanufacturing Policy Summit 2024 - Policy pathways for biomanufacturing in Europe](https://www.europabio.org/event/biomanufacturing-policy-summit-2024-policy-pathways-for-biomanufacturing-in-europe/) - The Biomanufacturing Policy Summit will host its 2nd edition in March 2024. The invite-only half-day summit hosted by EuropaBio brings together stakeholders including industry representatives and policymakers, to discuss Europe’s ambitions for biomanufacturing and the tangible legislative, regulatory and strategic pathways. 2023 was a year of visibility and recognition for biomanufacturing in Europe. It saw - [Made in Belgium for Europe, National Associations' Council Presidency Summit](https://www.europabio.org/event/made-in-belgium-for-europe-national-associations-council-presidency-summit/) - Whether it’s microorganisms revolutionising manufacturing or advanced therapies for rare disease patients, biotechnology is leading the way, and Belgium is on it. If you are a researcher, entrepreneur, policy wonk, or simply curious about the future of biotechnology, join us in our free online conversation. This conversation will be public and held online on February - [Europe Rare Disease Summit 2024](https://www.europabio.org/event/europe-rare-disease-summit-2024/) - Join our very own Healthcare Policy Senior Manager, Adrien Samson in Madrid where he will be speaking in the panel "Innovation, Funding and Access to Orphan Drugs: Challenges and Opportunities" between 12:15 and 13:00. - [Knowledge for Growth](https://www.europabio.org/event/knowledge-for-growth-2/) - Get ready for the touchdown of Europe's finest life sciences conference, Knowledge for Growth, on May 16, 2024, in the vibrant city of Antwerp, Belgium!Elevate your network by rubbing shoulders with decision-makers from biotech, pharma, and MedTech, alongside investors, universities, cutting-edge research institutes, policymakers, and competence providers. Join over 1000 life sciences trailblazers representing 500+ - [EU pharmaceutical legislation - Europe’s biotech innovation in the balance?](https://www.europabio.org/event/eu-pharmaceutical-legislation-europes-biotech-innovation-in-the-balance/) - Event agenda 12:00: Registration opens 12:30: Panel starts 13:45: Panel close and networking lunch 15:00: Close Confirmed Speakers Tomislav Sokol MEPMember SANT Committee, European Parliament Hilde StevensCo-director, Institute for Interdisciplinary Innovation in Healthcare (I3H), ULB Kristin ThompsonChief Operating Officer, eureKARE Vivian TsevelekiChief Operating Officer, theraCell More to be announced soon Introduction In April 2023, the - [IHI Call Days - Calls 6 & 7](https://www.europabio.org/event/ihi-call-days-calls-6-7/) - The IHI Call Days are your one-stop-shop to get detailed information on our calls for proposals and network with potential partners for your consortium. - [EFIB 2023 Rotterdam Statement wider launch](https://www.europabio.org/event/efib-2023-rotterdam-statement-wider-launch/) - Industrial biotechnology for a sustainable and resilient global Europe As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate and Work Programme, EuropaBio reviews European strategies and ambitions where biotechnology plays a key role. Ursula von der Leyen’s State of the European Union address of 13 September announced - [EuropaBio Patient BioForum 2023 Roundtable on Advancing Solutions for Unmet Medical Needs](https://www.europabio.org/event/europabio-patient-bioforum-2023-roundtable-on-advancing-solutions-for-unmet-medical-needs/) - Hybrid Event | Invitation Only EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations and the biopharmaceutical industry. In recent years, unmet medical needs have been at the core of Europe’s pharmaceutical and public health policies. To address unmet medical needs (UMN), - [BIO Europe 2023](https://www.europabio.org/event/bio-europe-2023/) - This panel will discuss what the legislation brings, its potential impact on businesses and what needs to be done to change the legislation in its journey to a final version, that it works for both, the biotech ecosystem, maintaining innovation pipelines, and patients. - [World Orphan Drug Congress](https://www.europabio.org/event/world-orphan-drug-congress/) - The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. - [TOPRA Symposium 2023: advancing global healthcare together](https://www.europabio.org/event/topra-symposium-2023-advancing-global-healthcare-together/) - Held annually since 2004, the TOPRA Symposium is Europe’s premier conference for healthcare regulatory affairs. With dedicated programme streams for human medicines, medical devices and IVDs, and veterinary medicines, the Symposium is the must-attend event in the regulatory affairs calendar. - [The economic power of biotechnology for Europe](https://www.europabio.org/event/the-economic-power-of-biotechnology-for-europe/) - The world is at a key point of industrial and societal transition, driven by advancing technology and the need for competitive, resilient and sustainable economies. Biotechnology is at the heart of this transition across all sectors and it is playing a significant role in shaping Europe’s future. - [SMEs in a Changing World: The Impact of the Revision of the Pharmaceutical Legislation on Europe’s innovative SMEs](https://www.europabio.org/event/smes-in-a-changing-world-the-impact-of-the-revision-of-the-pharmaceutical-legislation-on-europes-innovative-smes/) - In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem. - [EuropaBio National Associations Council Summit 2023 (Spanish Presidency): A global Europe - the role of transformative legislation](https://www.europabio.org/event/europabio-national-associations-council-summit-2023-spanish-presidency-a-global-europe-the-role-of-transformative-legislation/) - Spain will hold the Presidency of the Council of the European Union for the fifth time in the second half of 2023, between July 1 and December 31. In a pivotal time for the Biotechnology industry, Spain will lead the dialogue on the European Commission's proposal on new genomic techniques (NGT) and the revision of - [NAC Spanish Presidency Summer Reception](https://www.europabio.org/event/nac-spanish-presidency-summer-reception/) - EuropaBio, and AseBio, the Spanish Association of Biotechnology Companies, with the support of Merck, will host a summer reception to mark the beginning of the Spanish Council Presidency of the European Union and present the outcomes of their National Association Council Presidency Summit. The event will take place on June 27th in Brussels at Comet Meetings - [<strong>Life Sciences Baltics as a contributor to Lithuania’s innovation ecosystem</strong>](https://www.europabio.org/event/life-sciences-baltics-as-a-contributor-to-lithuanias-innovation-ecosystem/) - Life sciences in Lithuania have been a priority for the government for over a decade. Accelerating faster than almost anywhere else in Europe, the sector aims to contribute 5% to Lithuania’s GDP by 2030. The close cooperation between actors of the ecosystem is one of the reason for success. - [Industrial Biotechnologies Day](https://www.europabio.org/event/industrial-biotechnologies-day/) - CEFIC Specialty Chemicals sector groups EFCG, Biochem Europe and EFG, together with SICOS, the French industry association for Fine Chemicals and Biotech, will jointly hold their first in-person Industrial Biotechnologies Day on July 4th, 2023 in Brussels. - [EFIB 2023 - Industrial biotechnology for a sustainable and resilient global Europe](https://www.europabio.org/event/efib-2023-industrial-biotechnology-for-a-sustainable-and-resilient-global-europe/) - EuropaBio is pleased to announce that this year's edition of EFIB, Europe’s Leading Event on Industrial Biotechnology and the Bioeconomy under the title 'Industrial biotechnology for a sustainable and resilient global Europe', will take place 24-25 October 2023 in Rotterdam, The Netherlands. EuropaBio is partnering with local hosts HollandBio and ChemistryNL to bring EFIB 2023 to Rotterdam. Now in its 16th year, - [GREEK BIOPHARMA INNOVATION: Your changing world with the new EU Pharma Legislation](https://www.europabio.org/event/greek-biopharma-innovation-your-changing-world-with-the-new-eu-pharma-legislation/) - EU pharma legislation is going to change your business. What you make, where and how you sell it, and whether your business model is even viable. - [EuropaBio: BIO 2023](https://www.europabio.org/event/europabio-bio-2023/) - Biomanufacturing within healthcare represents an advance in therapeutic capabilities, as ground-breaking research translates into increased diseases that can be targeted, either for the first time or with greater efficacy, with increasingly complex interventions becoming possible. It also brings resilience and increased environmental sustainability to strained supply chains as the world strives to modernise production systems. - [ESAB-SusChem Webinar Sustainable Chemistry](https://www.europabio.org/event/esab-suschem-webinar-sustainable-chemistry/) - The European Society of Applied Biocatalysis (ESAB) and the European Technology Platform for Sustainable Chemistry (SUSCHEM) will held a Webinar on Sustainable Chemistry, chaired by Pablo Domínguez de María (Sustainable Momentum SL, ESAB Working Group Sustainable Chemistry, SusChem Management Team) and Andrés R Alcántara (Complutense Univ of Madrid, ESAB Working Group Sustainable Chemistry, SusChem Board). - [Reflection seminar and closing party around the EU presidency](https://www.europabio.org/event/reflection-seminar-and-closing-party-around-the-eu-presidency/) - On June 26-27, a Life Science conference is arranged for EU parliamentarians during Sweden's EU presidency. - [<strong>3<sup>rd</sup> Hellenic Biocluster Forum</strong>](https://www.europabio.org/event/3rd-hellenic-biocluster-forum/) - The Hellenic BioCluster is organizing its 3rd Forum on the subject of “Supporting disruptive innovation to maximize the economic and social impact of the bio-industry sector”, scheduled to be held between 15 - 17 June 2023 at Megaron Athens International Conference Centre, Athens, Greece. - [EU Healthcare and Pharmaceutical Policy in 2023: What You Need to Know](https://www.europabio.org/event/eu-healthcare-and-pharmaceutical-policy-in-2023-what-you-need-to-know/) - From the ongoing revision of the EU pharmaceutical legislation package and addressing critical supply issues to the impact of the recent Medical Device Regulation transition period extension, the challenges in EU healthcare and pharmaceutical policy are ever-evolving. - [EuropaBio Biomanufacturing Policy Summit 2023: Where next for Europe?](https://www.europabio.org/event/europabio-biomanufacturing-policy-summit-2023-where-next-for-europe/) - On 15th March, EuropaBio hosted its first Biomanufacturing Policy Summit in Brussels, with the aim of setting the vision for Europe's global innovation, competitiveness, and sustainability on biomanufacturing, while raising awareness among policy-makers. - [Development of Orphan Biologics: Challenges and Opportunities](https://www.europabio.org/event/development-of-orphan-biologics-challenges-and-opportunities/) - The development of therapies (OMPs) for rare diseases comes with distinct challenges, including patient recruitment, setting meaningful clinical endpoints, manufacturing and supply and finding the regulatory and market pathway to ensure patients can access therapy. - [DUTCH BIOTECH EVENT 2023](https://www.europabio.org/event/dutch-biotech-event-2023/) - Join us to celebrate the power of biotech at the Dutch Biotech Event 2023! About HollandBIO’s Dutch Biotech Event The program features inspiring talks by keynote speakers on biotech and entrepreneurship, followed by workshops and break-out sessions that contribute to your personal development and that of your company. In addition, there will be plenty of - [KNOWLEDGE FOR GROWTH 2023](https://www.europabio.org/event/knowledge-for-growth-2023/) - Knowledge for Growth is Europe's finest life sciences conference.For the first time the event will take place in Antwerp. The conference features an exciting programme providing vital insight into the global life sciences’ landscape, one-to-one partnering, a trade fair and more! LEARN. CONNECT. DISCOVER. The cream of the Belgian life sciences community attends flanders.bio’s annual Knowledge for Growth business conference, attracting - [International Forum on Industrial Biotechnology and Bioeconomy (IFIB)](https://www.europabio.org/event/international-forum-on-industrial-biotechnology-and-bioeconomy-ifib/) - NETWORKING AND PARTNERSHIPS IN BIOECONOMY AREA IFIB - International Forum on Industrial Biotechnology and Bioeconomy aims at strengthening the bioeconomy network in the Euro-Mediterranean area and to promote partnerships. The focus of the Forum is biotechnology, as provider of new resources for industries. It is organized into round-tables and sessions devoted to specific sub-sectors of industrial biotechnology: - [German Biotech Days 2023](https://www.europabio.org/event/german-biotech-days-2023/) - Germany's largest biotech event, the German Biotechnology Days 2023 (Deutsche Biotechnologietage, DBT), will take place on March 28th and 29th in Wiesbaden. The event is the national forum for the German biotechnology industry. The DBT brings together entrepreneurs with scientists and partners from politics, funding institutions and administration. The two-day program highlights the diverse fields of - [BIOSPAIN 2023](https://www.europabio.org/event/biospain-2023/) - BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of our delegates came from outside of Spain. This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one - [Biomanufacturing Platform - Policy Summit 2023](https://www.europabio.org/event/biomanufacturing-platform-policy-summit-2023/) - EuropaBio’s first Biomanufacturing Policy Summit will set the vision for Europe’s global innovation, competitiveness and sustainability through the lens of biomanufacturing and set a baseline for its understanding and recognition within policy. The half day meeting will bring together Members and invited stakeholders from across the policy, finance, trade, skills and regulatory spectrum surrounding biomanufacturing. - [ESAB Webinar: Advances in the Analysis of Enzymatic Reactions](https://www.europabio.org/event/esab-webinar-advances-in-the-analysis-of-enzymatic-reactions/) - PROGRAMME 10:00 - Prof. Dr. Andrew J. deMello, Institute for Chemical and Bioengineering,Department of Chemistry and Applied Biosciences, ETH Zürich, CH 8093 Zurich,Switzerland 10:30 - Prof. Dr. Aurelio Hidalgo, Universidad Autonoma de Madrid, Center for Molecular Biology "Severo Ochoa“, 28049-Madrid, Spain 11:00 - Prof. Dr. Gerhard K.E. Scriba, Friedrich Schiller University, Department of Pharmaceutical Chemistry, - [EIC – EMA Info Day: Regulatory support for the development of innovative medicines and technologies](https://www.europabio.org/event/eic-ema-info-day-regulatory-support-for-the-development-of-innovative-medicines-and-technologies/) - Join this online Info Day and discover the wide range of support services that the European Medicines Agency (EMA) provides to researchers and SMEs in the pharmaceutical and med-tech sectors. - [CLIB International Conference CIC2023](https://www.europabio.org/event/clib-international-conference-cic2023/) - From 14 to 15 February 2023, the CLIB International Conference will take place in Düsseldorf, Germany, organised by CLIB - Cluster industrial biotechnology. Under the title " Setting sail for industrial implementation" different sessions will debate how biotechnology help achieve the climate and sustainability goals. On the first day of the CIC2023, the focus will - [SME BioForum: Rare diseases](https://www.europabio.org/event/sme-bioforum-rare-diseases/) - Rare Disease Day takes place on February 28th across the globe to raise awareness among policymakers and the public about rare diseases and their impact on patient's lives and their families... - [ESAB Webinar: Biocatalytic Total Synthesis](https://www.europabio.org/event/esab-webinar-biocatalytic-total-synthesis/) - Register here - [Safe and Sustainable-by-Design: a key tool to boost innovation and growth](https://www.europabio.org/event/safe-and-sustainable-by-design-a-key-tool-to-boost-innovation-and-growth/) - Hosted by MEP Maria Spyraki Co-chair of the European Parliament Intergroup on ‘Climate Change, Biodiversity and Sustainable Development’ In October 2020, The Chemical Strategy for Sustainability (CSS) was launched by the European Commission as a core element of the European Green Deal. As the CSS sets out a vision for the EU’s chemical policy, to - [Swiss Biotech Day 2023](https://www.europabio.org/event/swiss-biotech-day-2023/) - The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2022, the conference demonstrated the impressive growth of the Swiss biotech industry and presented an exciting program with ideal networking opportunities for over 1,100 participants across the globe. In 2023, the Swiss - [CEBioForum 2023](https://www.europabio.org/event/cebioforum-2023/) - CEBioForum is a brand that has been creating a business environment related to biotechnology for over 20 years, organizing the most important event of this type in the industry, dedicated to the development of biotechnology in Poland and Europe CEBioForum 2023 will take place on April 18-19 in Warsaw Because we strongly believe that networking - [Biocatalytic Total Synthesis](https://www.europabio.org/event/biocatalytic-total-synthesis/) - This webinar is organised by ESAB - the European Society of Applied Biocatalysis, which aims at promoting the development of Applied Biocatalysis throughout Europe. - [SME BioForum 2022 - the voice of SMEs for a competitive, sustainable and healthy Europe](https://www.europabio.org/event/sme-bioforum-2022-the-voice-of-smes-for-a-competitive-sustainable-and-healthy-europe/) - EuropaBio – the European Association for Bioindustries is delighted to invite you to its first public SME BioForum event - “SME BioForum 2022 – the voice of SMEs for a competitive, sustainable and healthy Europe.” Throughout 2022, EuropaBio SME Platform, representing Europe’s biotechnology SME community across healthcare and industrial biotechnology, organised two inaugural SME BioForum - [EuropaBio Patient BioForum 2022: Toward a Common Understanding of Unmet Medical Needs](https://www.europabio.org/event/europabio-patient-bioforum-2022-toward-a-common-understanding-of-unmet-medical-needseuropabio-patient-bioforum-2022/) - EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations and the biopharmaceutical industry. In recent years, unmet medical needs have been at the core of Europe’s pharmaceutical and public health policies. Addressing unmet medical need was outline as a central to the - [17th European Bioplastics Conference](https://www.europabio.org/event/17th-european-bioplastics-conference/) - The European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers, and policy makers are increasingly streamlining their efforts to create frameworks that benefit the growth of sustainable bio-industries. Now is the time to put bioplastics at the - [EFIB 2022 Vilnius Statement wider launch](https://www.europabio.org/event/efib-2022-vilnius-statement-wider-launch/) - Industrial Biotechnology for a sustainable society: a focus for 2023 and beyond Industrial biotechnology and biomanufacturing are recognised as being part of the response to some of today’s pressing global challenges. Delivering on EU Green Deal objectives whilst strengthening resilience and independence of European industries is increasingly critical. The inaugural EFIB Statement of October 2021 created - [European Biotech Week 2022: Biotechnology for society, sustainability and economies – transformative science for a changing world](https://www.europabio.org/event/european-biotech-week-2022-biotechnology-for-society-sustainability-and-economies-transformative-science-for-a-changing-world/) - The 2022 European Biotech Week from EuropaBio opens with a look at how biotechnology is at the centre of Europe’s transformation to a healthy, sustainable and competitive economy and society. Join our Board Members from across Europe’s biotechnology spectrum to learn about biotech in action and its benefits in our every day lives, as well - [European Biotech Week 2022: At the cutting edge of biotechnology for cardiovascular diseases: A World Heart Day special edition webinar](https://www.europabio.org/event/european-biotech-week-2022-hc/) - Healthcare Biotechnology has the potential to transform how healthcare is delivered to patients, both in terms of innovative treatments, but also via use of innovative prevention, screening, and testing measures. During this webinar, which marks World Heart Day, speakers will discuss how biomarker testing for genetically inherited risk factors for cardiovascular diseases is opening up - [European Biotech Week 2022: Innovative technologies in the EU green transition – spotlight on industrial biotechnology](https://www.europabio.org/event/european-biotech-week-2022-ib/) - Industrial Biotechnology-derived products offer significant potential for contributing to overcoming many EU socio-economic and environmental challenges. It is not a new sector. On the contrary, for thousands of years the power of microbes has been harnessed in food production and beverages. In the past century, the applications for IB have expanded greatly with IB now - [ESAB Webinar: Synthetic Biology and Metabolic Engineering Tools and Methodologies](https://www.europabio.org/event/esab-webinar-synthetic-biology-and-metabolic-engineering-tools-and-methodologies/) - Register here - [Biocatalysis and Molecular Medcine](https://www.europabio.org/event/biocatalysis-and-molecular-medcine/) - ESAB and SKB are pleased to invite you to the Webinar on the new topic Biocatalysis and Molecular Medicine, bridging the communities of biocatalysis/industrial biotechnology and molecular medicine. ESAB-SKB_Webinar_29JULY2022Download - [Scientix Conference](https://www.europabio.org/event/scientix-conference/) - The 4th Scientix Conference will take place online Friday 18 and Saturday 19 November 2022. The conference, organised by European Schoolnet, is one of the major science education networking events in Europe. With 2,000 places available, the goal of the conference is to provide an overview of the challenges and opportunities in science education in - [Biocatalytic and Sustainable Chemistry: Biocatalysis and Renewables](https://www.europabio.org/event/9th-biorizon-annual-event-on-bio-aromatics/) - The next webinar of the European Society of Applied Biocatalysis (ESAB), this time together with SusChem, will take place on Friday, 24 June 2022 (14:00-16:00 CEST). The topic is “Biocatalytic and Sustainable Chemistry: Biocatalysis and Renewables”. You can look forward to the following lectures: Please be informed, that, immediately after the registration, you will receive - [10th International Congress on Biocatalysis (biocat2022)](https://www.europabio.org/event/10th-international-congress-on-biocatalysis-biocat2022-2/) - The transition from fossil to a biobased circular economy requires cutting edge technologies that ensure economic growth with environmentally responsible action. The future challenges which include utilization of natural resources, food supply, health, energy and the environment, can only be met in an interdisciplinary manner. Biocatalysis is one of the key technologies to address this complex - [LignoValue Pilot Launch & Biorizon Networking Event ](https://www.europabio.org/event/lignovalue-pilot-launch-biorizon-networking-event/) - Get informed about the latest progress in the field of biobased aromatics, and join the pre-arranged, bilateral matchmaking sessions! On 6 October 2022, Shared Research Center Biorizon & VITO's LignoValue Pilot Plant will host a live networking event at VITO in Mol, Flanders. Major industrial players, small to medium‑sized enterprises, and research and technology organisations from all - [14th Carbohydrate Bioengineering Meeting (CBM14)](https://www.europabio.org/event/10th-international-congress-on-biocatalysis-biocat2022/) - Carbohydrate Bioengineering is recognized today as a pillar of biotechnology and biological engineering. It offers major assets to face many of our modern life challenges, promote innovative medical treatments or elaborate functional food, biopharmaceuticals, active cosmetics, biomaterials, to name just a few. In particular, researches in glycobiology, multi-omic data integration, structure/function relationships, enzyme engineering, biocatalysis, biophysics and - [10th OxiZymes meeting](https://www.europabio.org/event/10th-oxizymes-meeting/) - Welcome to the 10th Edition of OxiZymes meeting! Initially specifically devoted to research activities on laccases and peroxidases, this series of conferences now cover the whole class of oxidoreductases. Building on the success of previous OxiZymes meetings, OxiZymes 2022 will emphasize the discovery of new oxidoreductases and the latest advances in their biotechnological applications. The conference - [6th International Conference Implementation of Microreactor Technology in Biotechnology](https://www.europabio.org/event/6th-international-conference-implementation-of-microreactor-technology-in-biotechnology/) - We cordially invite you to attend the 6th International Conference IMPLEMENTATION OF MICROREACTOR TECHNOLOGY IN BIOTECHNOLOGY – IMTB 2022, which will take place in Portorož, Slovenia, from 5th to 8th June 2022. The IMTB conference aims to provide a platform for people from industry and academia, working in the cross-section of microfluidics, life sciences, analytics, and bioprocess engineering. - [18th International Conference on Renewable Resources and Biorefineries (RRB 2022)](https://www.europabio.org/event/18th-international-conference-on-renewable-resources-and-biorefineries-rrb-2022/) - Biobased solutions for climate change The 18th edition of the International Conference on Renewable Resources & Biorefineries will take place in Bruges, Belgium from Wednesday 1 June until Friday 3 June 2022. Based on the previous RRB conferences, this conference is expected to welcome about 300 international participants from over 30 countries.Delegates from universities, industry, governmental and non-governmental organizations, and venture capital providers - [Rare Conversations 2022!](https://www.europabio.org/event/rare-conversations-2022-2/) - Managing uncertainties in rare disease innovation Joins us for the new episode of Rare Conversations 2022! The second episode of Rare Conversations 2022 will build on the previous Conversation about game-changing opportunities in rare disease R&D. In the first episode, different experts convened on the existence of opportunities in rare diseases, that still face obstacles - [EuropaBio: BIO 2022](https://www.europabio.org/event/europabio-bio-2022/) - BIO 2022: The big bang in pharma legislation: A European epicentre shaping global healthcare and competitive industry EuropaBio is pleased to lead a panel discussion at BIO in San Diego and invites all delegates to join us to discuss the future of healthcare innovation as impacted by European changes. 20 years ago, European pharmaceutical legislation - [IHI Kick-off and brokerage event](https://www.europabio.org/event/ihi-kick-off-and-brokerage-event/) - The Innovative Health Initiative (IHI) is launching its first calls for proposal in late June and it is time to start thinking about building partnerships at our kick-off and brokerage event. This one-day hybrid event will take place on 14 June 2022 at Hotel Le Plaza Brussels, where creating project proposals and building strong, effective consortia are - [Roundtable on leveraging private investment in health and life sciences](https://www.europabio.org/event/roundtable-on-leveraging-private-investment-in-health-and-life-sciences/) - Investments in health innovation will be central to ensure better preparedness as we are aiming both to recover from the pandemic and to better anticipate future health challenges.We are pleased to invite you to the launch of a novel report on European life science and health investment attractiveness as well as an exclusive conversation with - [Knowledge for Growth | Ghent](https://www.europabio.org/event/knowledge-for-growth/) - Knowledge for Growth is Europe's finest life sciences conference and will take place both on-site (Ghent, Belgium) and on-line, in May 2022. The cream of the Belgian life sciences community will be attending this business conference, attracting decision makers from biotech, pharma and medtech, agricultural and chemical industry as well as investors, universities, topnotch research - [SME BioForum](https://www.europabio.org/event/sme-bioforum/) - Advanced Therapy Medicinal Products (ATMPs) in Europe On May 31st, from 11h to 12h30 CET, EuropaBio - the European Association for Bioindustries, will host the first online round table discussion within its new SME BioForum. This online and invite-only meeting will focus on the business environment in Europe for Advanced Therapy Medicinal Products (ATMPs) in - [European Biotech Week 2022](https://www.europabio.org/event/european-biotech-week-2022/) - From the clothes we wear and how we wash them, the food we eat and the sources it comes from, the medicine we use to keep us healthy and even to the fuel we use to take us where we need to go, biotechnology plays an invaluable role in meeting our needs.The European Biotech Week - [EFIB 2022](https://www.europabio.org/event/efib-2022/) - EuropaBio is pleased to announce that the next edition of EFIB, Europe’s Leading Event on Industrial Biotechnology and the Bioeconomy under the title ‘Next generation economies: Industrial biotechnology for a sustainable society’, will take place 26-27 October 2022 in Vilnius, Lithuania. The Forum will be hosted by the Lithuanian Biotechnology Association (LBTA) together with Go Vilnius – - [ESAB Webinar: Advances in the Analysis of Enzymatic Reactions and Finding New Enzymes](https://www.europabio.org/event/esab-webinar-advances-in-the-analysis-of-enzymatic-reactions-and-finding-new-enzymes/) - Programme / Speakers 14:00 - 14:30: Droplet Microfluidics with Mass Spectrometry for High-Throughput Enzyme Reaction Analysis Prof. Dr. Robert T. KennedyDepartment of Chemistry, University of Michigan, Ann Abor, MI 48109, USA 14:30 - 15:00: Biomolecular engineeDroplets-on-demand platforms for the high-throughput characterisation of functional enzymes Dr. Fabrice GielenDepartment of Physics, Living Systems Institute, University of - [Rare Conversations: Game changing opportunities for the R&D community to address existing challenges in rare diseases](https://www.europabio.org/event/rare-conversations-2022/) - Join the inaugural episode of the new Rare Conversations event series in 2022, aimed at powering the next decade of rare disease innovation in Europe. The first episode will be focused on game-changing opportunities for the R&D community to address existing challenges in rare diseases. The aim is to understand what is the basis needed - [Crop Innovation & Business conference](https://www.europabio.org/event/crop-innovation-business-conference/) - On March 27-29, 2022 the CROP Innovation & Business (CropIB) conference will take place in Ghent, Belgium. CropIB is a C-level conference for management, entrepreneurs, leading scientists, investors and legal experts from the international Ag-Bio industry. During the 3-days conference the most influential trends that will affect agricultural research, crop innovation and value chain strategies will be - [Rare Paediatric Neurological Diseases: A Focus on Europe](https://www.europabio.org/event/rare-paediatric-neurological-diseases-a-focus-on-europe/) - Rare paediatric neurological conditions are debilitating diseases with significant impact on the daily lives of children and their families. Most rare diseases have neurological symptoms, and about 90% of those affecting children have major neurological effects limiting the ability to achieve key cognitive and physical development milestones. To highlight policy priorities for improving care, patient - [National Associations Council Summit 2022 | Biotechnology: Delivering Europe's Industrial Strategy Across Sectors](https://www.europabio.org/event/nac-summit-2022/) - EuropaBio’s National Associations Council (NAC) is a platform that brings together all EuropaBio’s National Associations and helps to ensure coordination of EuropaBio actions throughout Europe. The NAC represents biotechnology priorities across Europe’s Member and partner countries, working together to build long term economic and societal benefit from biotechnology across sectors. The 2022 EuropaBio National Associations - [ESAB Webinar: Enzyme Engineering](https://www.europabio.org/event/esab-webinar-enzyme-engineering/) - Preliminary Programme / Speakers 10:00: Enzyme evolution for efficient biosynthesis of biofuel and medicine Prof. Dr. Yan FengDistinguished Professor and Vice Dean, School of Life Science and Biotechnology, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University, Shanghai, China 10:30: Biomolecular engineering with microbial transglutaminase Prof. Dr. Noriho KamiyaDirector, Division of Biotechnology, Center - [AseBio Investor Day 2022 | Madrid](https://www.europabio.org/event/asebio-investor-day-2022-madrid/) - Spanish biotechnology makes up 2.8% of global production and is cited 30% more than the global average in this area. Spain is ranked 9th in scientific production in biotechnology and has the highest percentage of scientific papers in high-impact journals of any country: 83.3%. In 2018, the biotechnology sector invested nearly €770 million in R&D, - [16th European Bioplastics Conference 2021](https://www.europabio.org/event/16th-european-bioplastics-conference-2021/) - The European Bioplastics Conference, taking place from 30 November to 1 December 2021 in Berlin, is the leading business and discussion forum in Europe for the global bioplastics sector. With more and more brands and manufacturers embracing the potential of biopolymers, and with policy makers increasingly streamlining their efforts to create frameworks that benefit the - [Introducing the Innovative Health Initiative: Europe’s new partnership for health](https://www.europabio.org/event/introducing-the-innovative-health-initiative-europes-new-partnership-for-health/) - The Innovative Health Initiative (IHI) aims to build on the successes of the Innovative Medicines ... - [How can stronger IP in EU Free Trade Agreements boost productivity and economic growth in Europe?](https://www.europabio.org/event/how-can-stronger-ip-in-eu-free-trade-agreements-boost-productivity-and-economic-growth-in-europe/) - You are invited to join a virtual event seeking to discuss the economic and societal value of intellectual property rights (IPRs) for Europe. How do IPRs in EU Free Trade Agreements (FTAs) support EU strategic resilience and global competitiveness in a post-COVID world? What are the concrete benefits of robust IPRs for EU member states? - [EuropaBio 25th Anniversary | mRNA: A voyage of discovery and celebration](https://www.europabio.org/event/europabio-25th-anniversary-mrna-a-voyage-of-discovery-and-celebration/) - The existence of messenger(m) RNA was hypothesized early in the days of DNA breakthroughs in the 1960s, and research from the 1990s started to reveal its potential as a therapeutic tool. - [8th Biorizon Annual Event on Bio-Aromatics](https://www.europabio.org/event/8th-biorizon-annual-event-on-bio-aromatics/) - December 2nd, major industrial players, small to medium sized enterprises, government officials and research and technology organisations from all over the world will join Biorizon Shared Research Center to discuss the latest progress in the field of bio-aromatics and to elaborate on opportunities to accelerate biobased business together. Biorizon invites you to join, either on-site - [EFIB 2021 | Vienna Statement Launch](https://www.europabio.org/event/efib-2021-vienna-statement-launch/) - The ‘EFIB 2021 Vienna Statement’ marked the launch of an annual call to action from EuropaBio members, with policy asks and actions critical in the short term for Europe’s delivery of a bioeconomy. Developed through 2021 and published at EFIB in Vienna, the statement includes:• Next generation Europe: An urgent call to action• Industrial biotechnology: - [HealthDay.si Conference 2021: Biotech Meets Digital](https://www.europabio.org/event/healthday-si-conference-2021-biotech-meets-digital/) - Biotechnology and digital are getting closer. Due to the high development of both segments, Slovenia has a great global opportunity in this convergent field of medicine. Can good experiences from the digital healthcare ecosystem be linked to biotechnologies? Can we create something in this space that could be globally relevant? Can a new "digital Krka" - [Rare Conversations Conference | European Rare Disease Ecosystem: A Collaborative Path Forward](https://www.europabio.org/event/rare-conversations-conference-european-rare-disease-ecosystem-a-collaborative-path-forward/) - Join the inaugural Rare Conversations Conference aimed at facilitating essential discussion on the future of the rare disease and OMP ecosystem involving leading experts.The event will bring together thought leaders across regulators, payers, patient organizations, research, academia, EU institutions, industry and investors to develop inspiring ideas to advance the future of rare diseases. In four - [2nd Hellenic Biocluster Forum](https://www.europabio.org/event/2nd-hellenic-biocluster-forum/) - HBio is a strong innovation moderator, connecting and supporting industry and academia partners to develop innovative and impact science. The Hellenic Biocluster delivers connectivity to the global science and technology frontiers for more than 65 partners, with the vision to continue being a catalyst, adding value to the innovation performance of its' partners and Greece - [EuropaBio Patient Bio-Forum | European Reference Networks: challenges, achievements and opportunities](https://www.europabio.org/event/europabio-patient-bio-forum-european-research-networks-challenges-achievements-and-opportunities/) - EuropaBio, the European Association for Bioindustries, is proud to continue our platform for engaging patient and industry alike on pertinent healthcare debates: the Patient Bio-Forum. In this edition the focus will be on the impact of European Reference Networks (ERNs). With an aim to facilitate discussion between patients and medical professionals across the EU, ERNs - [EU4Health 2021 Work Programme | Info Session on HERA Procurement Calls](https://www.europabio.org/event/eu4health-2021-work-programme-info-session-on-hera-procurement-calls/) - The European Health and Digital Executive Agency (HaDEA) with the support of the European Commission organizes an info session to present three HERA’s public procurement calls launched under the EU4Health work programme 2021 (C(2021)4793 final):- HADEA/2021/OP/0005 - A Study on Bringing AMR Medical Countermeasures to the Market- HADEA/2021/OP/0006 - Feasibility Study on Stockpiling of Medical - [EuropaBio 25th Anniversary | Healthy planet, Healthy people](https://www.europabio.org/event/europabio-25th-anniversary-healthy-planet-healthy-people/) - At the time of the 25th Anniversary of EuropaBio, we would like to look to the future and the green transition that will shape healthcare for us all. - [The small companies changing the world: Meet the science and business of sustainability](https://www.europabio.org/event/the-small-companies-changing-the-world-meet-the-science-and-business-of-sustainability/) - With the Green Deal, the EU has set an ambitious strategy towards climate neutrality, transitioning to a circular economy and a more sustainable food system - [Investing in healthcare - How can the revision of the general pharmaceutical legislation better attract investors in the future?](https://www.europabio.org/event/investing-in-healthcare-how-can-the-revision-of-the-general-pharmaceutical-legislation-better-attract-investors-in-the-future/) - The evaluation and revision of the general pharmaceutical legislation is the opportunity to create a future-proof, patient-oriented and leading life science and biotechnology sector in the EU. - [Biotechnology for society - Turning science into a sustainable and healthy world](https://www.europabio.org/event/biotechnology-for-society-turning-science-into-a-sustainable-and-healthy-world/) - EuropaBio’s launch meeting for Biotech Week will share how science finds its way to an end use, whether it is a new medicine, or a product developed using new scientific processes. - [EFIB Pre-event webinar](https://www.europabio.org/event/efib-pre-event-webinar/) - Sustainability in industrial biotech innovations: life cycle assessment and beyond Get ready for EFIB 2021 by attending the kick-off webinar “Sustainability in Industrial biotech innovations: Life Cycle Assessment and beyond”, which will take place on Tuesday 21 September 2021 from 14.30 – 15.30 CET. Sustainability is the drive and purpose behind most industrial biotech innovations. But how to - [Treatment without borders: the EU case for equitable patient access to advanced therapies](https://www.europabio.org/event/treatment-without-borders-the-eu-case-for-equitable-patient-access-to-advanced-therapies/) - The EU Pharmaceutical Strategy is looking to improve patients’ access to therapies for challenging and rare conditions. The EU legislation on cross-border healthcare is an important instrument to ensure patient access to the best available care. There is an urgent need to revise this legislation to enable EU patients to access novel advanced therapies and - [German Biotechnology Days](https://www.europabio.org/event/german-biotechnology-days/) - Germany's largest biotech event, the German Biotechnology Days 2021 (Deutsche Biotechnologietage, DBT), will take place on 20th and 21st September in Stuttgart. With over 800 participants, the event is regarded as the German class reunion for biotechnology. The DBT brings together entrepreneurs with scientists and partners from politics, funding institutions and administration. In plenary sessions - [EU Matchmaking Event on COVID-19 Therapeutics](https://www.europabio.org/event/eu-matchmaking-event-on-covid-19-therapeutics/) - Building on the experience of the EU Task Force for Industrial Scale-up of COVID-19 vaccines, the European Commission will facilitate cooperation between actors in the supply chain to ensure that available therapeutics are produced in sufficient quantity as soon as possible. In the context of a surge in demand, it remains crucial to ensure the - [Changing Global Ambitions for Biotechnology Innovation: Implications and Drivers for Europe](https://www.europabio.org/event/changing-global-ambitions-for-biotechnology-innovation-implications-and-drivers-for-europ/) - EuropaBio hosts a member-only discussion session looking at ambitions for innovation and business in China, and how this impacts both the EU and US. We are delighted to welcome McKinsey’s China office to the meeting, where they will present an inside look at changing Chinese ambitions for industrial growth from innovation. Member discussion - [Changing Global Ambitions for Biotechnology Innovation: Implications and Drivers for Europe](https://www.europabio.org/event/changing-global-ambitions-for-biotechnology-innovation-implications-and-drivers-for-europe/) - [European Biotech Week 2021](https://www.europabio.org/event/european-biotech-week-2021/) - The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech Week that took place in 2013 marked the 60th anniversary of this pivotal moment in history. - [EU Healthcare Biotech Policy Priorities for SMEs](https://www.europabio.org/event/eu-healthcare-biotech-policy-priorities-for-smes/) - Join the EuropaBio Healthcare Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the ongoing revision of the basic pharmaceutical legislation and of regulations for medicines for rare and paediatric diseases, SMEs should be planning how they build and grow their businesses, whether within - [EFIB 2021 Kick-Off Webinar - How to accelerate biotech innovation for a sustainable future](https://www.europabio.org/event/efib-2021-kick-off-webinar-how-to-accelerate-biotech-innovation-for-a-sustainable-future/) - Get ready for EFIB 2021 by joining our launch webinar “How to accelerate biotech innovation for a sustainable future”. EuropaBio is pleased to announce this kick-off webinar, co-hosted by DSM and Planet B.io, both located at the Biotech Campus Delft. The webinar will feature industry, start-up, and financing perspectives on the European biotechnology innovation ecosystem. - [European Forum for Industrial Biotechnology & the Bioeconomy (EFIB)](https://www.europabio.org/event/european-forum-for-industrial-biotechnology-the-bioeconomy-efib/) - Save the date for this 14th edition!EFIB is the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy. Visit the dedicated website to secure your place today. - [Then and Now – Delivering a Successful Therapeutic to Patients](https://www.europabio.org/event/then-and-now-delivering-a-successful-therapeutic-to-patients/) - In today’s whirlwind of diagnostics, vaccines and therapeutics, we take a step back and look at how the world of development and manufacturing of biologics has evolved over the last 25 years, bringing together EuropaBio Members and 25th Anniversary Sponsor, Catalent.We look back at changing experience from the last quarter of a century in the - [Building on biotechnology: From vaccines to economic growth for Europe](https://www.europabio.org/event/building-on-biotechnology-from-vaccines-to-economic-growth-for-europe/) - EuropaBio National Associations Council Summit 2021 - Portugal EuropaBio’s National Associations Council (NAC) is a platform that brings together all EuropaBio's National Associations and helps to ensure coordination of EuropaBio actions throughout Europe. The NAC represents biotechnology priorities across Europe’s Member and partner countries, working together to build long term economic and societal benefit from - [Taking health up a gear: value of advanced therapies](https://www.europabio.org/event/taking-health-medicine-up-a-gear-value-of-advanced-therapies/) - Advanced therapies have ground-breaking therapeutic potential, particularly in disease areas where there is an unmet medical need and available therapeutic options are absent or inadequate. These therapies can bring the possibility of a cure to life-threatening conditions with a one-off treatment, thereby changing the paradigm of providing health and care to patients suffering serious, rare - [German Corona Showcase](https://www.europabio.org/event/german-corona-showcase/) - A considerable part of the global activities for the development and production of diagnostics, vaccines and drugs against Covid-19 takes place at biotech sites in German-speaking countries. The e-Vent will... Give the opportunity to discuss funding, procurement and governmental supportGive the opportunity to exchange an discuss experiences made with corona researchProvide industry insights and expert - [EuropaBio Patient BioForum: Advancing patient access to innovative treatments](https://www.europabio.org/event/europabio-patient-bioforum-advancing-patient-access-to-innovative-treatments/) - 2021 is set to be another landmark year in the area of health. It is hoped to not only relieve the burden of the COVID-19 pandemic on EU patients and healthcare systems, but also let the health community advance the great number of other priorities there are. In the EU, 2021 is set to give - [Think, Act, EUnite: A post-COVID-19 paradigm shift in European healthcare](https://www.europabio.org/event/think-act-eunite-a-post-covid-19-paradigm-shift-in-european-healthcare/) - A PUBLIC webinar sponsored by the Novartis EUnite4Health Ecosystem Team For citizens, industry, and institutions, COVID-19 was a stress test that revealed faults in our current health ecosystem. From a less-than-optimal regulatory review and approval processes which limit patient access, to an industrial manufacturing network that could be improved, and an R&D ecosystem that is not - [EU Industrial Biotech Policy Priorities for SMEs](https://www.europabio.org/event/eu-industrial-biotech-policy-priorities-for-smes/) - Join the EuropaBio Industrial Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the Green Deal, Industrial Strategy, Circular Economy and many more, SMEs can take advantage of changes and opportunities to plan and grow their business. About the EuropaBio SME Platform The SME - [International Conference on Renewable Resources & Biorefineries](https://www.europabio.org/event/international-conference-on-renewable-resources-biorefineries/) - The 17th edition of the International Conference on Renewable Resources & Biorefineries will take place in Aveiro, Portugal from Monday 6 Sept until Wednesday 8 Sept, 2021. Based on the previous RRB conferences, this conference is expected to welcome about 350 international participants from over 30 countries. Delegates from university, industry, governmental and non-governmental organizations, and venture capital providers will present their views on industrial biotechnology, sustainable - [BIO Digital 2021 - Rise](https://www.europabio.org/event/bio-digital-2021-rise/) - Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership. Join The World's Largest Global Biotech Partnering Experience From the 10th to June 18th takes place the world’s largest biotechnology partnering event BIO digital 2021, promoted by the Biotechnology Innovation Organization (BIO). This international convention represents a unique opportunity for companies and institutions related to biotechnology to obtain information of - [10th International Trade Show & Partnering](https://www.europabio.org/event/10th-international-trade-show-partnering/) - BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe. - [An EU Vision for Life Science and Biotechnology for a Healthy and Sustainable EU](https://www.europabio.org/event/an-eu-vision-for-life-science-and-biotechnology-for-a-healthy-and-sustainable-eu/) - With the ambitious target to cut greenhouse gas emissions by 55% compared to 1990 levels by 2030 and the EU Green Deal, the EU has set clear goals to transform the bloc´s economy making it more sustainable while supporting the EU recovery. Life sciences and biotechnology remain critical key-enabling technologies for the economy, generating GDP - [Nordic Life Science Days](https://www.europabio.org/event/nordic-life-science-days/) - Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an organised approach to meeting - [Innovation for Health - Shaping the Future of Healthcare](https://www.europabio.org/event/innovation-for-health-shaping-the-future-of-healthcare/) - On 15-16 April 2021, the 8th edition of Innovation for Health takes place as an online edition with hybrid aspect. Innovation for Health is the meeting place where over 900 bright minds from across Health and Life Sciences come together to shape the future of healthcare. The theme of this year's conference is immunology, a topic that, because of the - [9th Conference on CO2-based Fuels and Chemicals](https://www.europabio.org/event/9th-conference-on-co2-based-fuels-and-chemicals/) - The conference is one of the oldest and most established worldwide and has developed into a unique meeting place for the entire Carbon Capture & Utilisation (CCU) and Power-to-X industry and its customers. The first day will focus on CO2-based transport and aviation fuels, the second on CO2-based bulk and fine chemicals. CCU technologies are - [Immunology Virtual Partnering (Member Discount)](https://www.europabio.org/event/immunology-virtual-partnering-member-discount/) - Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment approaches have already been developed to curb the detrimental effects of autoimmune diseases, and the market continues to flourish. In fact, by 2025 this market is estimated to exceed a - [Empowering the Circular Bioeconomy through the EU Green Deal](https://www.europabio.org/event/empowering-the-circular-bioeconomy-through-the-eu-green-deal/) - The 2020 Circular Economy Action Plan is one of the main blocks of the European Green Deal – Europe’s new agenda for sustainable growth – including initiatives along the entire life cycle of products and aiming at rendering sustainable products the norm in the EU. It focuses on boosting circular economy processes, fostering sustainable consumption, and safeguarding that the - [Global Access to Innovations in Healthtech (GAINH) Summit](https://www.europabio.org/event/global-access-to-innovations-in-healthtech-gainh-summit/) - The Global Access to Innovations in Healthtech Summit is a biennial EXCITE International summit, a Canada based not-for-profit initiative. The 2021 edition will be organized in collaboration with HI-NL, a Dutch organization. GAINH 2021 will be the first edition taking place in Europe. The biennial summit has a unique approach that engages industry, payers, health - [All About RC(I) – Discussing the Renewable Carbon Strategy and Initiative](https://www.europabio.org/event/all-about-rci-discussing-the-renewable-carbon-strategy-and-initiative/) - Discuss the concept of renewable carbon and get answers to all your questions. Get to know the people and companies behind the Renewable Carbon Initiative and learn why your company should join. RCI members Cosun and UPM and nova-Institute will discuss and answer your questions. About the organizers The Renewable Carbon Initiative (RCI) was initiated by - [All About RC(I) – Discussing the Renewable Carbon Strategy and Initiative](https://www.europabio.org/event/all-about-rci-discussing-the-renewable-carbon-strategy-and-initiative-2/) - Discuss the concept of renewable carbon and get answers to all your questions. Get to know the people and companies behind the Renewable Carbon Initiative and learn why your company should join. RCI members Cosun and UPM and nova-Institute will discuss and answer your questions. About the organizers The Renewable Carbon Initiative (RCI) was initiated by - [Measuring the Economic Footprint of the Biotechnology Industry in Europe](https://www.europabio.org/event/measuring-the-economic-footprint-of-the-biotechnology-industry-in-europe-landscape-and-positions-for-development/) - Landscape and Positions for Economic Development: Industry and policy discussions to deliver biotechnology in Europe. European GDP benefitted by €38.5 bn in 2018, in the recent study from EuropaBio ‘Measuring the Economic Footprint of the Biotechnology Industry in Europe’. The study looked at the economic impact of the biotechnology industry within the (then) 28 European - [#EUIndustryWeek2021: The next Industrial Revolution is a Bio Revolution](https://www.europabio.org/event/euindustryweek2021-the-next-industrial-revolution-is-a-bio-revolution/) - Global challenges like COVID-19 and climate change require a range of solutions, including those coming from innovative biotechnology. Life sciences and biotechnology is a key industrial sector which can play a transformative role in securing the EU’s competitive edge in health and sustainability.From new treatments for rare diseases to bio-based products, biotechnology can revolutionize our - [BIOKET 2021](https://www.europabio.org/event/bioket-2021/) - [nova Session: Renewable Polymers: Production and Trends 2020-2025 (Member Discount)](https://www.europabio.org/event/nova-session-renewable-polymers-production-and-trends-2020-2025-member-discount/) - The only way for chemicals and plastics to become sustainable, climate-friendly and part of the circular economy is the complete substitution of fossil carbon with renewable carbon from alternative sources: biomass, CO2 and recycling. Sold out PLA in 2019 has led to the installation of increased capacities in 2020, PE and PP made from bio-based naphtha - [#EUIndustryWeek2021: Bio4Products & Rehap](https://www.europabio.org/event/euindustryweek2021-bio4products-rehap/) - Moving Towards a Competitive European Bioeconomy: Emerging Biorefinery Technologies & Pathways to Deployment For Europe to move towards a competitive bioeconomy, is it is essential that biorefinery technologies developed in the lab and at pilot scale are upscaled and deployed at an industrial scale. Industry and policy makers must work together to create commercial pathways - [KeyGene’s two-part webinar on PanGenomes: needs, value and applications (part 1)](https://www.europabio.org/event/keygenes-two-part-webinar-on-pangenomes-needs-value-and-applications/) - This two-part webinar on PanGenomes, which Keygene organizes together with an academic partner and Allen Sessions from BASF, will explain what one needs to construct PanGenomes and highlight their value in breeding and research. PanGenomes describe the available genetic diversity within, for instance, plant species, crops or germplasm collections. Because of diminishing costs of genome - [EuropaBio National Associations Council: Brexit Impact for UK and Europe (Member-only webinar)](https://www.europabio.org/event/brexit-impact-monitoring-members-only/) - As part of the EuropaBio National Associations Council, this meeting kick starts a long term Brexit monitoring Group within EuropaBio which will support members to understand and manage Brexit changes and for the National Associations Council to identify priority topics for joint communications. - [1st International Conference on Rare Diseases](https://www.europabio.org/event/1st-international-conference-on-rare-diseases/) - 1st International Conference on Rare Diseases Different infrastructures and organisational arrangements are required in each country to address the healthcare needs of its rare disease population in an effective way. Whether a single rare disease affects thousands or only a handful of individuals, they all share similar challenges to get a timely diagnosis, face the - [Oncology Virtual Partnering (Member Discount)](https://www.europabio.org/event/oncology-virtual-partnering-member-discount/) - Oncology is one of the most challenging areas for research and development, but there are critical junctures where the right environment is crucial for success - and where partnering can help bring the best science forward. At Inova, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO), - [Annual Conference on EU Law in the Pharmaceutical Sector](https://www.europabio.org/event/annual-conference-on-eu-law-in-the-pharmaceutical-sector/) - Annual Conference on EU Law in the Pharmaceutical Sector (3-5 March 2021) Objective This online conference will bring legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments, legislative initiatives and case law. Key topics Impact of recent rulings from the CJEU on supplementary protection certificates, patent settlements, and online sales - [#EUIndustryWeek2021: BIO NRW](https://www.europabio.org/event/bio-nrw-eu-industry-week/) - Driving Change – How Green Chemistry and Digitalisation lead the way to a Sustainable EconomyThe focus of their event is green chemistry and sustainable processes, focusing on how biotechnology and digitalization can contribute to the green transition. Watch the intervention from EuropaBio on on the EU perspective and what the industry suggests to drive innovation - [KeyGene’s two-part webinar on PanGenomes: needs, value and applications (part 2)](https://www.europabio.org/event/keygenes-two-part-webinar-on-pangenomes-needs-value-and-applications-part-2/) - This two-part webinar on PanGenomes, which Keygene organizes together with an academic partner and Allen Sessions from BASF, will explain what one needs to construct PanGenomes and highlight their value in breeding and research. PanGenomes describe the available genetic diversity within, for instance, plant species, crops or germplasm collections. Because of diminishing costs of genome - [BIO-Europe Spring 2021](https://www.europabio.org/event/1331/) - The “must-attend” event series has gone digital, and continues to grow from strength to strength, proving its importance and relevance to the life science sector. Building on the success and momentum created by BIO-Europe Digital 2020 this past October our upcoming BIO-Europe Spring Digital will deliver more licensing opportunities, more partnering meetings, and more hot-off-the-press - [Renewable Materials Conference](https://www.europabio.org/event/renewable-materials-conference/) - Featuring a unique concept to present all sustainable and renewable material solutions at one event: bio-based, CO2-based and recycled. This time, the conference will be held as hybrid event. 300 to 400 participants are expected. There is a growing market demand for advanced and ready-to-use sustainable material solutions with a low carbon footprint – and - [2nd International Conference on Cellulose Fibres (Member Discount)](https://www.europabio.org/event/2nd-international-conference-on-cellulose-fibres-member-discount/) ## Timeline Stories - [It's Coming...](https://www.europabio.org/timeline/its-coming-2/) - [2006: Revolution in HIV treatment. First EMA approval for single tablet regimen taken once a day](https://www.europabio.org/timeline/2006-revolution-in-hiv-treatment-first-ema-approval-for-single-tablet-regimen-taken-once-a-day/) - Nominated by: Gilead Sciences Organisation in nomination: Gilead Sciences Antiretroviral therapy (ART) has played an instrumental role in the treatment of HIV, increasing the life expectancy and quality of life of those affected. The first treatments for HIV infection required patients to adhere to complex regimens, consisting of up to 30 tablets per day, some - [2019: Large scale microbial production of next generation, zero-calorie, non-artificial EVERSWEET™ Stevia sweetener](https://www.europabio.org/timeline/2019-large-scale-microbial-production-of-next-generation-zero-calorie-non-artificial-eversweet-stevia-sweetener/) - Nominated by: DSM Organisation in nomination: DSM, Cargill Most people consume too many calories that originate from sugar, increasing the risk of being overweight or developing obesity, both of which in turn are risk-factors for non-communicable diseases including diabetes, cardio-vascular disease and cancers. Science has been searching for sugar alternatives for many decades, and biotechnology - [1996: Understanding how the immune system recognises virus-infected cells. Nobel Prize for Physiology or Medicine](https://www.europabio.org/timeline/1996-understanding-how-the-immune-system-recognises-virus-infected-cells-nobel-prize-for-physiology-or-medicine/) - Nominated by: Swiss Biotech Association Organisations in nomination: Rolf M Zinkernagel, Professor of Experimental Immunology at the University of Zurich Viruses infect host cells and reproduce inside them. Immune system killer T-cells destroy those infected cells so that the viruses can't reproduce. Professor Zinkernagel, working with Peter Doherty, discovered that in order for killer T-cells to recognize - [Improved food safety through asparaginase produced via genetically modified micro-organisms: reduced acrylamide in cooked food](https://www.europabio.org/timeline/its-coming-3/) - Nominated by: DSM Organisation in nomination: DSM and Novozymes Acrylamide can arise during the cooking process of foods via reaction of the amino acid asparagine and glucose, and is linked to negative health effects in humans, including cancer. It is particularly formed during the high temperature cooking of plant-based foods with high carbohydrate levels, such - [It's Coming...](https://www.europabio.org/timeline/its-coming/) - [2017: First Radioligand therapy (RLT) approved in Europe for the treatment of gastroenteropancreatic neuroendocrine tumours - Lutathera®](https://www.europabio.org/timeline/2017-first-radioligand-therapy-rlt-approved-in-europe-for-the-treatment-of-gastroenteropancreatic-neuroendocrine-tumours-lutathera/) - Nominated by: Novartis Organisations in nomination: Novartis Gastroenteropancreatic neuroendocrine tumours are a rare type of cancer that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum and appendix. Radio Ligand Therapy (RLT) is a form of precision medicine that, when introduced in the bloodstream, - [2014: First Industrial Fermentation-derived perfume ingredient Clearwood®](https://www.europabio.org/timeline/2014-first-industrial-biotech-derived-perfume-product-clearwood/) - Nominated by: Scienceindustries Switzerland Organisation in nomination: Firmenich Terpenes are complex natural compounds and important raw materials for the fragrance & flavour and the pharmaceutical industries. However, problems exist through limited and fluctuating supplies. Work at Firmenich to address this through biotechnology started as early as 2001, with the discovery of sesquiterpene synthases, creating potential - [2007: Landmark European publication behind ‘Knowledge Based Bioeconomy’ in Europe](https://www.europabio.org/timeline/2007-landmark-european-publication-behind-knowledge-based-bioeconomy-in-europe/) - Nominated by: BIO Deutschland Under the German Presidency of the Council of the European Union, 42 experts from academia and industry across 13 countries were invited to contribute towards an expert paper which outlines the perspectives of a Knowledge-Based Bio-Economy (KBBE) within the next 20 years. The resulting paper ‘En Route to the Knowledge-Based Bio-Economy - [2007: First production of spider silk through biotechnology](https://www.europabio.org/timeline/2007-first-production-of-spider-silk-through-biotechnology/) - Nominated by: BIO Deutschland Organisation in nomination: AMSilk Spider silk has long been hailed for its properties, the ultimate biomaterial, however production from spiders directly on a scale large enough for industrial use has always been beyond reach. Natural extraction of spider silk (milking) is complex and expensive, compared to the silk produced by silk - [2003: Human Genome Project completion](https://www.europabio.org/timeline/2003-human-genome-project-completion/) - Nominated by: Voisin Consulting Life Sciences Launched in 1990, the Human Genome project was an unprecedented international scientific research project with the primary goal to discover the complete set of human genes and determine the complete sequence of DNA bases in the human genome. It was the world’s largest collaborative project, with global contributions, multiple - [1996: First European Commission-approved product following European Agency for the Evaluation of Medicinal Products (EMEA, later EMA) recommendation](https://www.europabio.org/timeline/1996-first-european-commission-approved-product-following-european-agency-for-the-evaluation-of-medicinal-products-emea-later-ema-recommendation/) - Nominated by: Voisin Consulting Life Sciences Organisation in nomination: European Commission 1996 saw the first legal/regulatory framework for medicinal products in the European Union. GONAL-f from Serono Laboratories was the first product recommended for approval via a centralised procedure and published in the EU Journal on 26 January. The landmark approval demonstrated the EU integrated - [2014: Checkpoint inhibitor innovation as key part of cancer immunotherapy](https://www.europabio.org/timeline/2014-first-checkpoint-inhibitor-approved-as-key-part-of-cancer-immunotherapy/) - Nominated by: UK BioIndustry Association Organisation in nomination: LifeArc (From 2004) US Biotech company Organon’s scientists focused on the discovery of antibodies as therapeutics and partnered with the UK’s Medical Research Council Technology (which became LifeArc) to successfully humanise the antibody. In 2007, LifeArc entered a collaboration with Organon –who were ultimately acquired by Merck – - [2016: First curative gene therapy for ADA-SCID approved for infants](https://www.europabio.org/timeline/2016-first-curative-gene-therapy-for-ada-scid-approved-for-infants/) - Nominated by: Federchimica Assobiotec Organisation in nomination: GlaxoSmithKline (GSK), currently moved to Orchard Therapeutics, Telethon Foundation (Telethon), l’IRCCS San Raffaele Hospital (SRH) Italy and Molecular Medicine SpA now AGC Biologics, Italy Adenosine deaminase severe combined immunodeficiency (ADA-SCID) is a rare, inherited, paediatric disorder that can be fatal if untreated. Patients will usually be diagnosed - [1996: Introduction of law in Italy for early access to drugs (648/1996) to support rare disease patients](https://www.europabio.org/timeline/1996-story/) - Nominated by: Federchimica Assobiotec Organisation in nomination: Government of Italy Early access programmes for novel medicines can benefit patients suffering from serious illnesses for which effective therapeutics are not yet available. For rare diseases, this is particularly important where no therapeutic alternatives are available, and the disease itself may be life-threatening or have a serious - [2006: Globally accessible Gene Sequencing Technology](https://www.europabio.org/timeline/2006-story/) - Nominated by: UK BioIndustry Association Organisation in nomination: Solexa: Professor Sir Shankar Balasubramanian and Professor Sir David Klenerman Following establishment of UK SME Solexa in 1997, Professor Sir Shankar Balasubramanian and Professor Sir David Klenerman worked to develop their idea to improve the speed and cost of decoding DNA by a factor of 100,000-fold. In 2004, Solexa acquired Swiss - [1997: First clinical trial with D2E7 (Humira), the first fully human monoclonal antibody approved by the US Food and Drug Administration (FDA)](https://www.europabio.org/timeline/1997-story-1/) - Nominated by: BIO Deutschland Organisations in nomination: BASF, Abbott, AbbVie, Cambridge Antibody Technology (now MedImmune) Diseases linked to the immune system, such as rheumatoid arthritis were very challenging drug targets, with prolonged treatment often bringing serious side effects and limited effectiveness. Immunotherapeutics were a high priority for the emerging global biotech sector but it was not - [1999: Messenger RNA (mRNA) patented in relation to therapeutic applications](https://www.europabio.org/timeline/1999-story/) - Nominated by: Nominees: Dr Ingmar Hoerr, co-founder CureVac Professor Katalin Karikó, University of Pennsylvania and BioNTech The existence of mRNA was hypothesized early in the days of DNA breakthroughs in the 1960s. Research from the 1990s started to reveal its potential as a therapeutic tool, making use of its ability to create a specific protein, - [2000: Vitamin B2 shifts from chemical synthesis to exclusive biotechnological production in less than 15 years](https://www.europabio.org/timeline/2000/) - Nominated by: DSM, BASF Organisation in nomination: DSM, BASF Vitamin B2 (riboflavin), is a water-soluble compound, which can be synthesized by plants and microorganisms but not by animals, making it essential for humans and animals to access through their diet. Manufactured riboflavin is used in a variety of applications, including food and feeds, pharmaceuticals - [2001: First enzyme replacement therapy for to treat Fabry disease approved in the European Union, plus world’s largest database of Fabry disease patients](https://www.europabio.org/timeline/2001-story/) - Nominated by: Sanofi Organisation in nomination: Sanofi Genzyme Fabry disease (also Anderson–Fabry) disease, is a rare and heritable genetic disorder. The genetic fault behind the disease affects the function of an enzyme called alpha-galactosidase A (alpha-GAL) that help processes a lipid called globotriaosylceramide (GL-3). In Fabry disease, first described in 1898, GL-3 can accumulate in - [CRISPR-Cas genome editing technology](https://www.europabio.org/timeline/2003-story-2/) - Nominated by: Spanish Bioindustry Association – AseBio, Lithianian Biotechnology Association People in nomination: Professor Francisco Martinez Mojica, Department of Physiology, Genetics and Microbiology, University of Alicante, Spain Dr. Virginijus Šikšnys, Life Sciences Center, Vilnius University, Lithuania In a nutshell: CRISPR is a family of DNA sequences found within the genomes of microorganisms such as - [2003: Targeting regulation of protein production for new medicines](https://www.europabio.org/timeline/2003-story/) - Nominated by: PTC Therapeutics Organisation in nomination: PTC Therapeutics Diseases associated with protein disorders, such as Duchenne muscular dystrophy and spinal muscular atrophy have long been a target for the development of medicines, however the complexity of protein production, especially from faulty genes, have made it difficult to do anything other than try and manage - [It's coming...](https://www.europabio.org/timeline/2004-story/) - [2005: Europe’s largest medicines biotechnology facilities open: Pfizer Grange Castle, Dublin](https://www.europabio.org/timeline/2005-story/) - Nominated by: Pfizer Organisations in nomination: Pfizer The Pfizer Grange Castle Biotechnology facility commenced construction in 2000 and was licensed and officially opened in 2005. It was the first mammalian cell culture facility in Ireland1, and at >1 million square feet, one of the largest integrated biotech facilities in the world. It fulfilled the need - [2007: Trabectedin (ET-743, Yondelis®) first anti-cancer drug from marine origins approved in Europe](https://www.europabio.org/timeline/2007-story/) - Nominated by: Spanish Bioindustry Association - AseBio Organisation in nomination: Pharmamar (Spain) Marine environments are considered more biologically diverse than terrestrial environments. Thirty-two different animal phyla are represented in the oceans of the 33 recognized phyla. Fifteen different phyla are represented only in marine environments, while only 1 is - [It's coming...](https://www.europabio.org/timeline/2008-story/) - [It's coming...](https://www.europabio.org/timeline/2009-story/) - [It's coming...](https://www.europabio.org/timeline/2010-story/) - [2018: First CAR T cell therapy approved in the US for adult patients with DLBCL and amongst the first approved in Europe](https://www.europabio.org/timeline/2018-story/) - Nominated by: Kite (a Gilead Company) Organisations in nomination: Kite (a Gilead Company) Non-Hodgkin lymphoma (NHL) can occur at any age, and accounts for an estimated 510,000 new cases and 248,724 deaths worldwide every year. Diffuse large B-cell lymphoma (DLBCL) is the most common and aggressive form of NHL. DLBCL patients for whom two - [2012: Collaborative patient partnership delivers first treatment approved in Europe for genetic disease, Alkaptonuria (AKU)](https://www.europabio.org/timeline/2012-story/) - Nominated by: Sobi, Swedish Orphan Biovitrum Organisations in nomination: DevelopAKUre Consortium AKU is a serious, multi-system disorder affecting approximately 1 in 250,000 people, first described as early as 1902 by Archibald Edward Garrod. Morbidity is caused by inability to metabolise the amino acid tyrosine, resulting in increased levels homogentisic acid (HGA). This leads to early - [2013: First approved cancer treatment using antibody glycosylation (glycoMAb) - Gazyvaro](https://www.europabio.org/timeline/2013-story/) - Nominated by: Swiss Biotech Association Organisations in nomination: Glycart Biotechnology (now Roche Glycart AG) Pioneer in antibody glycosylation (glycoMAb) technology increasing immune-mediated killing of cancer cells leading to improved cancer medicines. Antibodies are proteins that are part of the immune system that identify and neutralise foreign invaders in the body. During their production in cells, - [2000: Provitamin A enriched "Golden Rice" to combat vitamin A deficiency and blindness](https://www.europabio.org/timeline/2000-story/) - Nominated by: Scienceindustries Switzerland Organisation in nomination: Swiss Federal Institute of Technology, University of Freiburg In 2000, the research teams of Ingo Potrykus (Swiss Federal Institute of Technology, Zurich, Switzerland) and Peter Beyer (University of Freiburg, Germany) published their ground-breaking proof-of-concept paper describing genetically modified rice with provitamin A enriched endosperm. The aim was - [2020: First large scale application of AI to protein structure determination: AlfaFold](https://www.europabio.org/timeline/event-2020-3/) - Nominated by: UK BioIndustry Association Organisation in nomination: DeepMind An artificial intelligence (AI) network developed by Google AI offshoot DeepMind made a gargantuan leap in solving one of biology’s grandest challenges — determining a protein’s 3D shape from its amino-acid sequence. DeepMind’s program, called AlphaFold, outperformed around 100 other teams in a biennial protein-structure prediction - [2018: Autologous CAR-T cell therapy Kymriah – unique to each patient. First EC approval for two indications (pALL and DLBCL)](https://www.europabio.org/timeline/event-2018-1-2/) - Nominated by: Novartis Organisations in nomination: Novartis Acute lymphoblastic leukaemia (ALL) is a type of cancer that affects white blood cells. It progresses quickly and aggressively and requires immediate treatment. Both adults and children can be affected and is the most common childhood cancer, occurring when a bone marrow cell develops errors in its DNA. - [2018: European "1+ Million Genomes" Initiative launched](https://www.europabio.org/timeline/event-2018-1/) - Nominated by: Voisin Consulting Life Sciences The European “1+ Million Genomes” Initiative builds from the achievements of the Human Genome Project and aims to have at least 1 million sequenced genomes available in the EU by 2022. The initiative aims to ensure secure, federated access to genomic data with ethical and legal implications of genomics - [2020: First vaccine for the prevention of COVID-19 to receive conditional marketing authorization from the European Medicines Agency: COMIRNATY® (BNT162b2/Pfizer-BioNTech COVID-19 vaccine)](https://www.europabio.org/timeline/event-2020-1-2/) - Nominated by: Pfizer Organisations in nomination: Pfizer, BioNTech In March 2020, the WHO declared COVID-19 a pandemic. At “lightspeed,” Pfizer collaborated with BioNTech, a German-based company, to develop an mRNA-based vaccine. The companies moved with urgency, without compromising their high standards for safety, quality, or integrity. Through a rigorous clinical trial programme and - [2016: World’s first industrial scale plant for production of butanediol (1,4 BDO) from renewable materials via biosynthesis (fermentation from micro-organisms)](https://www.europabio.org/timeline/event-2016-1/) - Nominated by: Federchimica Assobiotec Organisation in nomination: Novamont (Italy) 1,4, Butanediol is a chemical intermediate used for a wide range of applications, including industrial processes (as a solvent), and manufacture of diverse products including textiles, electronics, automotive and consumer goods as used in the biopolymer sector. It has traditionally been produced through chemical processes, and ## Categories - [SME Platform](https://www.europabio.org/category/sme-platform/) - [National Associations](https://www.europabio.org/category/national-associations/) - [Position Paper](https://www.europabio.org/category/position-paper/) - [Report](https://www.europabio.org/category/report/) - [Press Release](https://www.europabio.org/category/press-release/) - [Healthcare Biotechnology](https://www.europabio.org/category/healthcare-biotech/) - [Industrial Biotechnology](https://www.europabio.org/category/industrial-biotech/) - [Biomanufacturing Platform](https://www.europabio.org/category/biomanufacturing-platform/) - [Blog Post](https://www.europabio.org/category/blog-post/) - [Members](https://www.europabio.org/category/members/) - [EuropaBio](https://www.europabio.org/category/europabio/) - [Case Study](https://www.europabio.org/category/case-study/) - [Policy Document](https://www.europabio.org/category/policy-document/) - [The EU Biotech Act](https://www.europabio.org/category/the-eu-biotech-act/) ## Tags - [News](https://www.europabio.org/tag/news/) - [Knowledge Hub](https://www.europabio.org/tag/knowledge-hub/) - [Library](https://www.europabio.org/tag/library/) ## Categories - [Timeline Stories](https://www.europabio.org/ctl-stories/timeline-stories/) - All timeline stories. ## Event Categories - [EuropaBio](https://www.europabio.org/events/category/europabio/) - [Healthcare Biotech](https://www.europabio.org/events/category/healthcare-biotech/) - [Industrial Biotech](https://www.europabio.org/events/category/industrial-biotech/) - [External](https://www.europabio.org/events/category/external/) - [SME Platform](https://www.europabio.org/events/category/sme-platform/) - [All](https://www.europabio.org/events/category/all/) - [Biotech Week](https://www.europabio.org/events/category/biotech-week/) - [EFIB](https://www.europabio.org/events/category/europabio/efib/) - [Biomanufacturing Platform](https://www.europabio.org/events/category/biomanufacturing-platform/) - [National Associations](https://www.europabio.org/events/category/national-associations/) ## Client categories - [Corporate members](https://www.europabio.org/client-types/corporate-members/) - [National Associations](https://www.europabio.org/client-types/national-associations/) - [Associate members](https://www.europabio.org/client-types/associate-members/) - [Healthcare](https://www.europabio.org/client-types/healthcare/) - [Industrial](https://www.europabio.org/client-types/industrial/) - [SME](https://www.europabio.org/client-types/sme-members/) ## Testimonial categories - [Study](https://www.europabio.org/testimonial-types/study/) - [EuropaBio for members](https://www.europabio.org/testimonial-types/europabio-for-members/)
Version History
Version 13/28/2026, 11:02:16 AMvalid
264782 bytes
Categories
blognewseducationtechnologybusinesshealthfinancefoodsocial
Visit Website
Explore the original website and see their AI training policy in action.
Visit europabio.orgContent Types
postspagesproductsapireviewscommentsforums
Recent Access
No recent access
API Access
Canonical URL:
https://llmscentral.com/europabio.org/llms.txt
API Endpoint:
/api/llms?domain=europabio.org